{"bbbp": {"tasks": {"p_np": {"Train": {"roc_auc": 1.0, "threshold": -2.2428309294554563}, "Val": {"roc_auc": 0.9533422064477965, "threshold": -3.2894646622635815}, "Test": {"roc_auc": 0.9144042232277526, "threshold": 0.4043768099001088}, "description": "Predicts the blood-brain barrier permeability of molecules. Molecules that can cross this barrier might have potential as central nervous system drugs."}}, "description": "A dataset providing insights on the ability of molecules to penetrate the blood-brain barrier. Crucial for understanding the potential of molecules as central nervous system drugs."}, "clintox": {"tasks": {"FDA_APPROVED": {"Train": {"roc_auc": 0.9968911711901995, "threshold": 0.5321943179981119}, "Val": {"roc_auc": 0.9135338345864662, "threshold": -1.2729673376073825}, "Test": {"roc_auc": 0.9738442822384428, "threshold": -0.5037052767412789}, "description": "Predicts if a molecule is approved by the FDA."}, "CT_TOX": {"Train": {"roc_auc": 0.9960235032190687, "threshold": -0.49420831964777356}, "Val": {"roc_auc": 0.9332472006890611, "threshold": -0.781164384103036}, "Test": {"roc_auc": 0.9761194029850746, "threshold": -0.9074048852777334}, "description": "Predicts if a molecule has been determined to be toxic in clinical trials."}}, "description": "This dataset deals with the FDA approval status and clinical trial toxicity of molecules. Important for understanding the safety and regulatory status of compounds."}, "toxcast": {"tasks": {"ACEA_T47D_80hr_Negative": {"Train": {"roc_auc": 0.9358441851567423, "threshold": 1.1567935418557589}, "Val": {"roc_auc": 0.8232359230220955, "threshold": 0.3451437133926527}, "Test": {"roc_auc": 0.8239067055393586, "threshold": 0.5698987117878067}, "description": "Prediction of negative response in the ACEA T47D 80-hour assay."}, "ACEA_T47D_80hr_Positive": {"Train": {"roc_auc": 0.7549152393704159, "threshold": -0.6058415077828068}, "Val": {"roc_auc": 0.7062423500611995, "threshold": 0.4994885136295961}, "Test": {"roc_auc": 0.6805179945912212, "threshold": -1.6198981660264393}, "description": "Prediction of positive response in the ACEA T47D 80-hour assay."}, "APR_HepG2_CellCycleArrest_24h_dn": {"Train": {"roc_auc": 0.8535690080956625, "threshold": 0.07426239324880957}, "Val": {"roc_auc": 0.6037414965986395, "threshold": -2.213168585622633}, "Test": {"roc_auc": 0.756084876222176, "threshold": -0.7836887578706486}, "description": "Predicts a down-regulation of cell cycle arrest in HepG2 cells at the 24-hour mark."}, "APR_HepG2_CellCycleArrest_24h_up": {"Train": {"roc_auc": 0.8549447613795005, "threshold": -1.319646044894382}, "Val": {"roc_auc": 0.7232394366197183, "threshold": -1.9549812658413037}, "Test": {"roc_auc": 0.6216374269005848, "threshold": -2.0962130715539153}, "description": "Predicts an up-regulation of cell cycle arrest in HepG2 cells at the 24-hour mark."}, "APR_HepG2_CellCycleArrest_72h_dn": {"Train": {"roc_auc": 0.847312299304965, "threshold": 0.5200722525427652}, "Val": {"roc_auc": 0.6854975457385095, "threshold": -0.908158274384232}, "Test": {"roc_auc": 0.7395513086830079, "threshold": -0.6085870769527455}, "description": "Predicts a down-regulation of cell cycle arrest in HepG2 cells at the 72-hour mark."}, "APR_HepG2_CellLoss_24h_dn": {"Train": {"roc_auc": 0.8639592639555346, "threshold": 1.2804509932333765}, "Val": {"roc_auc": 0.684633362547473, "threshold": 0.19946148588850754}, "Test": {"roc_auc": 0.7690781440781441, "threshold": 0.6071734299530851}, "description": "Predicts a decrease in HepG2 cell count at the 24-hour mark."}, "APR_HepG2_CellLoss_72h_dn": {"Train": {"roc_auc": 0.8150195830062477, "threshold": 2.1278445999901567}, "Val": {"roc_auc": 0.6524866015132409, "threshold": -0.72847280130014}, "Test": {"roc_auc": 0.7461007591442375, "threshold": 2.036572694062471}, "description": "Predicts a decrease in HepG2 cell count at the 72-hour mark."}, "APR_HepG2_MicrotubuleCSK_24h_dn": {"Train": {"roc_auc": 0.9036534984343223, "threshold": -0.2112706831625637}, "Val": {"roc_auc": 0.7678500986193294, "threshold": -0.9456467284812584}, "Test": {"roc_auc": 0.8578473413379074, "threshold": -1.2970714569091797}, "description": "Profile for HepG2 cells with Microtubule CSK alteration after 24 hours (downregulated)"}, "APR_HepG2_MicrotubuleCSK_24h_up": {"Train": {"roc_auc": 0.9262600329933693, "threshold": 0.11394694080581935}, "Val": {"roc_auc": 0.6347140039447732, "threshold": -0.6927680292645011}, "Test": {"roc_auc": 0.8442873969375736, "threshold": -0.05267630987339267}, "description": "Profile for HepG2 cells with Microtubule CSK alteration after 24 hours (upregulated)"}, "APR_HepG2_MicrotubuleCSK_72h_dn": {"Train": {"roc_auc": 0.899304444088775, "threshold": 0.7023151204870031}, "Val": {"roc_auc": 0.8599318658280922, "threshold": 0.3575814758335145}, "Test": {"roc_auc": 0.8548456260720413, "threshold": -1.088514272634451}, "description": "Profile for HepG2 cells with Microtubule CSK alteration after 72 hours (downregulated)"}, "APR_HepG2_MicrotubuleCSK_72h_up": {"Train": {"roc_auc": 0.9088705419286709, "threshold": -0.12352500138459455}, "Val": {"roc_auc": 0.6836129469581427, "threshold": -1.251964550476532}, "Test": {"roc_auc": 0.8529804270462633, "threshold": -0.26986686507980195}, "description": "Profile for HepG2 cells with Microtubule CSK alteration after 72 hours (upregulated)"}, "APR_HepG2_MitoMass_24h_dn": {"Train": {"roc_auc": 0.8728839912745365, "threshold": 0.8263699485732996}, "Val": {"roc_auc": 0.7244692877779173, "threshold": 0.7507334192235913}, "Test": {"roc_auc": 0.8247235387045814, "threshold": 1.2938374671134145}, "description": "Predicts a decrease in mitochondrial mass in HepG2 cells at the 24-hour mark."}, "APR_HepG2_MitoMass_24h_up": {"Train": {"roc_auc": 0.9586773085914669, "threshold": -0.9489314329583909}, "Val": {"roc_auc": 0.761336866902238, "threshold": -0.9383867634189977}, "Test": {"roc_auc": 0.6426229508196721, "threshold": -2.5903490387104657}, "description": "Predicts an increase in mitochondrial mass in HepG2 cells at the 24-hour mark."}, "APR_HepG2_MitoMass_72h_dn": {"Train": {"roc_auc": 0.8384084843594837, "threshold": -0.13137986638524524}, "Val": {"roc_auc": 0.7429245283018868, "threshold": 1.3358069711977292}, "Test": {"roc_auc": 0.7264052287581699, "threshold": -0.12204118271370401}, "description": "Predicts a decrease in mitochondrial mass in HepG2 cells at the 72-hour mark."}, "APR_HepG2_MitoMass_72h_up": {"Train": {"roc_auc": 0.797575124345621, "threshold": -0.5122788408258421}, "Val": {"roc_auc": 0.745926800472255, "threshold": -1.7473724468930945}, "Test": {"roc_auc": 0.6979450809238044, "threshold": -2.361511374379064}, "description": "Predicts an increase in mitochondrial mass in HepG2 cells at the 72-hour mark."}, "APR_HepG2_MitoMembPot_1h_dn": {"Train": {"roc_auc": 0.9476407836260327, "threshold": 0.7409254151421631}, "Val": {"roc_auc": 0.7015276145710928, "threshold": -3.075609674802175}, "Test": {"roc_auc": 0.8448074679113184, "threshold": -2.738929524078025}, "description": "Predicts a decrease in mitochondrial membrane potential in HepG2 cells after 1 hour."}, "APR_HepG2_MitoMembPot_24h_dn": {"Train": {"roc_auc": 0.8402584634490253, "threshold": 1.0026427885672238}, "Val": {"roc_auc": 0.7819277108433735, "threshold": -0.7809049097506016}, "Test": {"roc_auc": 0.7043374245891408, "threshold": 0.3897903960746323}, "description": "Predicts a decrease in mitochondrial membrane potential in HepG2 cells at the 24-hour mark."}, "APR_HepG2_MitoMembPot_72h_dn": {"Train": {"roc_auc": 0.8136814779020475, "threshold": -0.26202023757231974}, "Val": {"roc_auc": 0.6556747450668785, "threshold": -0.8236573484686165}, "Test": {"roc_auc": 0.5727651966626937, "threshold": -2.6537244169561713}, "description": "Predicts a decrease in mitochondrial membrane potential in HepG2 cells at the 72-hour mark."}, "APR_HepG2_MitoticArrest_24h_up": {"Train": {"roc_auc": 0.8748198282885254, "threshold": 1.4405556727458038}, "Val": {"roc_auc": 0.7424041240334296, "threshold": 1.2981130067292632}, "Test": {"roc_auc": 0.7986526946107784, "threshold": 0.6165382685484717}, "description": "Profile for HepG2 cells showing Mitotic Arrest after 24 hours (upregulated)"}, "APR_HepG2_MitoticArrest_72h_up": {"Train": {"roc_auc": 0.8131637003510555, "threshold": 0.7849727574292125}, "Val": {"roc_auc": 0.6590480543968916, "threshold": 1.3583946189842182}, "Test": {"roc_auc": 0.7283422459893049, "threshold": 1.6162221930525797}, "description": "Profile for HepG2 cells showing Mitotic Arrest after 72 hours (upregulated)"}, "APR_HepG2_NuclearSize_24h_dn": {"Train": {"roc_auc": 0.9143583511433321, "threshold": 0.7908603631936995}, "Val": {"roc_auc": 0.7737159329140462, "threshold": -0.3886142257932903}, "Test": {"roc_auc": 0.8583006535947713, "threshold": 0.7221056338664411}, "description": "Profile for HepG2 cells with altered Nuclear Size after 24 hours (downregulated)"}, "APR_HepG2_NuclearSize_72h_dn": {"Train": {"roc_auc": 0.8644963752196837, "threshold": 0.1976365268648097}, "Val": {"roc_auc": 0.6174789915966387, "threshold": -0.2882782150436576}, "Test": {"roc_auc": 0.8112543962485346, "threshold": -1.974030261283164}, "description": "Profile for HepG2 cells with altered Nuclear Size after 72 hours (downregulated)"}, "APR_HepG2_NuclearSize_72h_up": {"Train": {"roc_auc": 0.8711955198441685, "threshold": -1.3922036993610973}, "Val": {"roc_auc": 0.8106947697111632, "threshold": -2.2159568203820124}, "Test": {"roc_auc": 0.46339563862928346, "threshold": -1.452157375690816}, "description": "Profile for HepG2 cells with altered Nuclear Size after 72 hours (upregulated)"}, "APR_HepG2_OxidativeStress_24h_up": {"Train": {"roc_auc": 0.8428308271852606, "threshold": 0.39556855553979275}, "Val": {"roc_auc": 0.637817170663886, "threshold": 1.2902606156495242}, "Test": {"roc_auc": 0.7257740249296342, "threshold": 0.7682022905206534}, "description": "Profile for HepG2 cells under Oxidative Stress after 24 hours (upregulated)"}, "APR_HepG2_OxidativeStress_72h_up": {"Train": {"roc_auc": 0.8300715986608279, "threshold": 1.1236077901479362}, "Val": {"roc_auc": 0.6193473961766645, "threshold": 1.3509219840720856}, "Test": {"roc_auc": 0.7837428774928774, "threshold": 1.5290892565691916}, "description": "Profile for HepG2 cells under Oxidative Stress after 72 hours (upregulated)"}, "APR_HepG2_StressKinase_1h_up": {"Train": {"roc_auc": 0.9511408702295222, "threshold": 3.301536573423398}, "Val": {"roc_auc": 0.6946009389671362, "threshold": -5.335972731535857}, "Test": {"roc_auc": 0.7777129521586932, "threshold": -1.4820910858081735}, "description": "Profile for HepG2 cells with Stress Kinase alteration after 1 hour (upregulated)"}, "APR_HepG2_StressKinase_24h_up": {"Train": {"roc_auc": 0.8746185253249292, "threshold": 0.9591371046530242}, "Val": {"roc_auc": 0.5842505241090147, "threshold": -3.774384041806241}, "Test": {"roc_auc": 0.5644287396937574, "threshold": -1.2091281914018897}, "description": "Profile for HepG2 cells with Stress Kinase alteration after 24 hours (upregulated)"}, "APR_HepG2_StressKinase_72h_up": {"Train": {"roc_auc": 0.8751972488332105, "threshold": 1.0235197746956555}, "Val": {"roc_auc": 0.7883703973751367, "threshold": -0.14049574419542843}, "Test": {"roc_auc": 0.7777283511269276, "threshold": 0.712873710168374}, "description": "Profile for HepG2 cells with Stress Kinase alteration after 72 hours (upregulated)"}, "APR_HepG2_p53Act_24h_up": {"Train": {"roc_auc": 0.8578115693865396, "threshold": 0.21790445459497576}, "Val": {"roc_auc": 0.7259176288126832, "threshold": 0.323613617871259}, "Test": {"roc_auc": 0.7812470023980815, "threshold": 0.07426337460736487}, "description": "Profile for HepG2 cells with p53 Activity after 24 hours (upregulated)"}, "APR_HepG2_p53Act_72h_up": {"Train": {"roc_auc": 0.8220251545679942, "threshold": 1.1333231825728314}, "Val": {"roc_auc": 0.669686792158088, "threshold": 1.089659761022161}, "Test": {"roc_auc": 0.7329379405191679, "threshold": 1.7223549877201112}, "description": "Profile for HepG2 cells with p53 Activity after 72 hours (upregulated)"}, "APR_Hepat_Apoptosis_24hr_up": {"Train": {"roc_auc": 0.9074473035625032, "threshold": -0.6734906622358761}, "Val": {"roc_auc": 0.7552693208430914, "threshold": -2.210160660194801}, "Test": {"roc_auc": 0.8199195171026158, "threshold": -1.5337738881001366}, "description": "Profile for Hepatocytes undergoing Apoptosis after 24 hours (upregulated)"}, "APR_Hepat_Apoptosis_48hr_up": {"Train": {"roc_auc": 0.9048350439882697, "threshold": 0.12796793757258307}, "Val": {"roc_auc": 0.6463700234192038, "threshold": -2.5619507609186947}, "Test": {"roc_auc": 0.7313403673309887, "threshold": 0.24650386432269666}, "description": "Profile for Hepatocytes undergoing Apoptosis after 48 hours (upregulated)"}, "APR_Hepat_CellLoss_24hr_dn": {"Train": {"roc_auc": 0.9264429731846813, "threshold": 1.586088389605731}, "Val": {"roc_auc": 0.7830003916960439, "threshold": 0.8932621851339722}, "Test": {"roc_auc": 0.9061032863849765, "threshold": -0.3940818572306881}, "description": "Profile for Hepatocytes with Cell Loss after 24 hours (downregulated)"}, "APR_Hepat_CellLoss_48hr_dn": {"Train": {"roc_auc": 0.8893860823017731, "threshold": 1.926242431720814}, "Val": {"roc_auc": 0.7136701919310615, "threshold": 0.12982496723637027}, "Test": {"roc_auc": 0.7723653395784543, "threshold": -1.0771049555834828}, "description": "Profile for Hepatocytes with Cell Loss after 48 hours (downregulated)"}, "APR_Hepat_DNADamage_24hr_up": {"Train": {"roc_auc": 0.9058541055718474, "threshold": -0.9874166544970571}, "Val": {"roc_auc": 0.5413239326282804, "threshold": -3.5744993598372847}, "Test": {"roc_auc": 0.7490196078431373, "threshold": -0.6781105809025583}, "description": "Profile for Hepatocytes with DNA Damage after 24 hours (upregulated)"}, "APR_Hepat_DNADamage_48hr_up": {"Train": {"roc_auc": 0.9014784731113956, "threshold": 0.5145256053936009}, "Val": {"roc_auc": 0.530281690140845, "threshold": -2.260542115411004}, "Test": {"roc_auc": 0.7138562091503268, "threshold": -0.03926266277874557}, "description": "Profile for Hepatocytes with DNA Damage after 48 hours (upregulated)"}, "APR_Hepat_DNATexture_24hr_up": {"Train": {"roc_auc": 0.9063466855522052, "threshold": 0.40571301549046623}, "Val": {"roc_auc": 0.6431649040344692, "threshold": 0.2277811669014591}, "Test": {"roc_auc": 0.6746359700905156, "threshold": -1.0211391561143506}, "description": "Profile for Hepatocytes with altered DNA Texture after 24 hours (upregulated)"}, "APR_Hepat_DNATexture_48hr_up": {"Train": {"roc_auc": 0.9291140858359741, "threshold": 1.2294905245363772}, "Val": {"roc_auc": 0.6829220524872699, "threshold": 0.9230515248066666}, "Test": {"roc_auc": 0.6705535924617196, "threshold": -0.9891499976615403}, "description": "Profile for Hepatocytes with altered DNA Texture after 48 hours (upregulated)"}, "APR_Hepat_MitoFxnI_1hr_dn": {"Train": {"roc_auc": 0.8497918674656721, "threshold": 2.3001554702017994}, "Val": {"roc_auc": 0.684795321637427, "threshold": -0.993104812977192}, "Test": {"roc_auc": 0.6573756432246999, "threshold": 0.6222915086182983}, "description": "Profile for Hepatocytes with Mitochondrial Function I alteration after 1 hour (downregulated)"}, "APR_Hepat_MitoFxnI_24hr_dn": {"Train": {"roc_auc": 0.673647746515566, "threshold": -0.49448120415031704}, "Val": {"roc_auc": 0.44988276670574445, "threshold": 0.5173722988850358}, "Test": {"roc_auc": 0.7190058479532163, "threshold": 0.26972902477443883}, "description": "Profile for Hepatocytes with Mitochondrial Function I alteration after 24 hours (downregulated)"}, "APR_Hepat_MitoFxnI_48hr_dn": {"Train": {"roc_auc": 0.8170858963093145, "threshold": 0.6903110252128339}, "Val": {"roc_auc": 0.6030160595377987, "threshold": 0.05780197657622388}, "Test": {"roc_auc": 0.702576112412178, "threshold": -1.5063634298227209}, "description": "Profile for Hepatocytes with Mitochondrial Function I alteration after 48 hours (downregulated)"}, "APR_Hepat_NuclearSize_24hr_dn": {"Train": {"roc_auc": 0.9632256234365733, "threshold": -0.27960263835536736}, "Val": {"roc_auc": 0.7771929824561404, "threshold": -1.6357833167931464}, "Test": {"roc_auc": 0.8391812865497076, "threshold": -1.8811354990955351}, "description": "Profile for Hepatocytes with altered Nuclear Size after 24 hours (downregulated)"}, "APR_Hepat_NuclearSize_48hr_dn": {"Train": {"roc_auc": 0.9537808980547023, "threshold": -0.5350312541077678}, "Val": {"roc_auc": 0.7943013270882123, "threshold": -2.827093323191127}, "Test": {"roc_auc": 0.8542399374755764, "threshold": -1.6345044186523374}, "description": "Profile for Hepatocytes with altered Nuclear Size after 48 hours (downregulated)"}, "APR_Hepat_Steatosis_24hr_up": {"Train": {"roc_auc": 0.933491014026885, "threshold": 1.4466783143617246}, "Val": {"roc_auc": 0.8210526315789475, "threshold": -1.8588710024550155}, "Test": {"roc_auc": 0.6400233372228705, "threshold": -1.7810419572366252}, "description": "Profile for Hepatocytes displaying Steatosis after 24 hours (upregulated)"}, "APR_Hepat_Steatosis_48hr_up": {"Train": {"roc_auc": 0.9451183864367144, "threshold": 1.8935873124215217}, "Val": {"roc_auc": 0.5538011695906433, "threshold": -3.8107541588333635}, "Test": {"roc_auc": 0.7969661610268378, "threshold": -2.4923078925521285}, "description": "Profile for Hepatocytes displaying Steatosis after 48 hours (upregulated)"}, "ATG_AP_1_CIS_dn": {"Train": {"roc_auc": 0.863574121772592, "threshold": -0.263730341249758}, "Val": {"roc_auc": 0.8553459119496856, "threshold": -2.516787219990243}, "Test": {"roc_auc": 0.675175644028103, "threshold": -3.1344986022175014}, "description": "Predicts a down-regulation related to the AP-1 cis-regulatory element."}, "ATG_AP_1_CIS_up": {"Train": {"roc_auc": 0.8517310952080195, "threshold": -0.4752134684924485}, "Val": {"roc_auc": 0.6651033620245715, "threshold": -0.8644253112174365}, "Test": {"roc_auc": 0.6295379812003852, "threshold": -1.6546856158965815}, "description": "Predicts an up-regulation related to the AP-1 cis-regulatory element."}, "ATG_AP_2_CIS_dn": {"Train": {"roc_auc": 0.8927753109612047, "threshold": -0.11182400772163525}, "Val": {"roc_auc": 0.6527270266612532, "threshold": -1.5730252265930185}, "Test": {"roc_auc": 0.682350267075804, "threshold": 0.1048300240013571}, "description": "Predicts a down-regulation related to the AP-2 cis-regulatory element."}, "ATG_AP_2_CIS_up": {"Train": {"roc_auc": 0.9073987624487405, "threshold": -1.6590700163855576}, "Val": {"roc_auc": 0.7428571428571429, "threshold": -3.9893277056582335}, "Test": {"roc_auc": 0.6969555035128806, "threshold": -3.6520955011293337}, "description": "Profile for target genes with AP-2 binding sites in cis-regulatory regions (upregulated)"}, "ATG_AR_TRANS_dn": {"Train": {"roc_auc": 0.7665024799924355, "threshold": -0.9868780432998001}, "Val": {"roc_auc": 0.5416178194607268, "threshold": -3.3967700201469855}, "Test": {"roc_auc": 0.5484247374562428, "threshold": -6.649719533022937}, "description": "Predicts a down-regulation in the androgen receptor (AR) transcriptional activity."}, "ATG_AR_TRANS_up": {"Train": {"roc_auc": 0.8875644220901515, "threshold": -0.013498917475596173}, "Val": {"roc_auc": 0.9883177570093458, "threshold": -1.404867570798796}, "Test": {"roc_auc": 0.993006993006993, "threshold": -1.5598427139602986}, "description": "Predicts an up-regulation in the androgen receptor (AR) transcriptional activity."}, "ATG_Ahr_CIS_dn": {"Train": {"roc_auc": 0.7100146999905731, "threshold": -0.6929713685710626}, "Val": {"roc_auc": 0.6001040428061831, "threshold": -1.830386070159821}, "Test": {"roc_auc": 0.6546992481203007, "threshold": -1.0461132103377757}, "description": "Predicts a down-regulation related to the Aryl hydrocarbon receptor (AhR) cis-regulatory element."}, "ATG_Ahr_CIS_up": {"Train": {"roc_auc": 0.8224482311876312, "threshold": -0.41758293098396315}, "Val": {"roc_auc": 0.6885273398188526, "threshold": -1.0044861694236653}, "Test": {"roc_auc": 0.7239872573076757, "threshold": -0.4757443457633048}, "description": "Predicts an up-regulation related to the Aryl hydrocarbon receptor (AhR) cis-regulatory element."}, "ATG_BRE_CIS_dn": {"Train": {"roc_auc": 0.8357745680533423, "threshold": -1.6178903284373582}, "Val": {"roc_auc": 0.7123966942148761, "threshold": -1.367940951754023}, "Test": {"roc_auc": 0.765807962529274, "threshold": -2.322092919378309}, "description": "Predicts a down-regulation related to the BRE cis-regulatory element."}, "ATG_BRE_CIS_up": {"Train": {"roc_auc": 0.9139616793243288, "threshold": -0.17792653178309514}, "Val": {"roc_auc": 0.7666615162752369, "threshold": -1.0037268446730412}, "Test": {"roc_auc": 0.7030055083159528, "threshold": 0.1684598686458827}, "description": "Predicts an up-regulation related to the BRE cis-regulatory element."}, "ATG_CAR_TRANS_dn": {"Train": {"roc_auc": 0.9101462828134393, "threshold": -0.3413537103492583}, "Val": {"roc_auc": 0.8339954972851278, "threshold": -1.864721075013593}, "Test": {"roc_auc": 0.8095424836601306, "threshold": -1.937638530263433}, "description": "Predicts a down-regulation in the Constitutive Androstane Receptor (CAR) transcriptional activity."}, "ATG_CAR_TRANS_up": {"Train": {"roc_auc": 0.9143462580550674, "threshold": -2.2192443738112573}, "Val": {"roc_auc": 0.48830409356725146, "threshold": -6.796840725002346}, "Test": {"roc_auc": 0.4957165109034268, "threshold": -7.003540292516485}, "description": "Predicts an up-regulation in the Constitutive Androstane Receptor (CAR) transcriptional activity."}, "ATG_CMV_CIS_dn": {"Train": {"roc_auc": 0.9212672162345789, "threshold": -0.4748391560964027}, "Val": {"roc_auc": 0.8635824436536181, "threshold": -1.4486445885998114}, "Test": {"roc_auc": 0.6353118712273642, "threshold": -0.6591798643450124}, "description": "Predicts a down-regulation related to the CMV cis-regulatory element."}, "ATG_CMV_CIS_up": {"Train": {"roc_auc": 0.8705612797491014, "threshold": -0.2122608562847521}, "Val": {"roc_auc": 0.7558275058275059, "threshold": 0.09655761647152872}, "Test": {"roc_auc": 0.6648383253215004, "threshold": -0.662977069705815}, "description": "Predicts an up-regulation related to the CMV cis-regulatory element."}, "ATG_CRE_CIS_dn": {"Train": {"roc_auc": 0.8786754772393539, "threshold": -1.3443477007600517}, "Val": {"roc_auc": 0.7500979240109675, "threshold": -2.902262071947437}, "Test": {"roc_auc": 0.8581871345029239, "threshold": -2.874863960124829}, "description": "Predicts a down-regulation related to the CRE (cAMP Response Element) cis-regulatory element."}, "ATG_CRE_CIS_up": {"Train": {"roc_auc": 0.9119584510421279, "threshold": 0.10894977008258167}, "Val": {"roc_auc": 0.6906395754034202, "threshold": -1.6871548806344192}, "Test": {"roc_auc": 0.6608275955177534, "threshold": -1.3409460080159201}, "description": "Predicts an up-regulation related to the CRE (cAMP Response Element) cis-regulatory element."}, "ATG_C_EBP_CIS_dn": {"Train": {"roc_auc": 0.8928800813552065, "threshold": -1.5726638798778119}, "Val": {"roc_auc": 0.6969747899159664, "threshold": -1.5555370065185041}, "Test": {"roc_auc": 0.6007843137254902, "threshold": -2.2389361531407506}, "description": "Predicts a down-regulation related to the C/EBP (CCAAT/Enhancer Binding Protein) cis-regulatory element."}, "ATG_C_EBP_CIS_up": {"Train": {"roc_auc": 0.9021708173065145, "threshold": -0.6109085555549134}, "Val": {"roc_auc": 0.71975318284777, "threshold": -0.8871749912773641}, "Test": {"roc_auc": 0.6764418377321604, "threshold": 0.03802119599686904}, "description": "Predicts an up-regulation related to the C/EBP (CCAAT/Enhancer Binding Protein) cis-regulatory element."}, "ATG_DR4_LXR_CIS_dn": {"Train": {"roc_auc": 0.868382846706315, "threshold": -0.263586409457095}, "Val": {"roc_auc": 0.717661267405513, "threshold": -1.580196376319405}, "Test": {"roc_auc": 0.7526596660354623, "threshold": -0.1363496957001864}, "description": "Predicts a down-regulation related to the DR4-LXR cis-regulatory element."}, "ATG_DR4_LXR_CIS_up": {"Train": {"roc_auc": 0.8556295692527739, "threshold": -1.898540868057502}, "Val": {"roc_auc": 0.6347107438016528, "threshold": -2.152130611069328}, "Test": {"roc_auc": 0.5754248366013072, "threshold": -2.4333242436906355}, "description": "Predicts an up-regulation related to the DR4-LXR cis-regulatory element."}, "ATG_DR5_CIS_dn": {"Train": {"roc_auc": 0.8543913365778193, "threshold": -1.70661988684365}, "Val": {"roc_auc": 0.8155977830562153, "threshold": -2.6158307861160113}, "Test": {"roc_auc": 0.8860979462875198, "threshold": -3.14877788464467}, "description": "Predicts a down-regulation related to the DR5 cis-regulatory element."}, "ATG_DR5_CIS_up": {"Train": {"roc_auc": 0.8773996886890347, "threshold": -0.7207724836853542}, "Val": {"roc_auc": 0.7616310892172962, "threshold": -1.0695105587039988}, "Test": {"roc_auc": 0.759908599916909, "threshold": -0.33181464582592124}, "description": "Predicts an up-regulation related to the DR5 cis-regulatory element."}, "ATG_E2F_CIS_dn": {"Train": {"roc_auc": 0.8638254541463481, "threshold": -1.481716194489339}, "Val": {"roc_auc": 0.7779173470669514, "threshold": -1.43195888015243}, "Test": {"roc_auc": 0.5442982456140351, "threshold": -1.0450339526743502}, "description": "Predicts a down-regulation related to the E2F cis-regulatory element."}, "ATG_E2F_CIS_up": {"Train": {"roc_auc": 0.9002632348639953, "threshold": -1.98894895280565}, "Val": {"roc_auc": 0.6931684334511189, "threshold": -2.9380935047481875}, "Test": {"roc_auc": 0.7866043613707164, "threshold": -3.865952648796715}, "description": "Predicts an up-regulation related to the E2F cis-regulatory element."}, "ATG_EGR_CIS_up": {"Train": {"roc_auc": 0.9072911539566999, "threshold": 0.2735937083208988}, "Val": {"roc_auc": 0.7021421582331563, "threshold": -1.7745326789649756}, "Test": {"roc_auc": 0.7058580858085808, "threshold": -1.5914265689429818}, "description": "Predicts an up-regulation related to the EGR (Early Growth Response) cis-regulatory element."}, "ATG_ERE_CIS_dn": {"Train": {"roc_auc": 0.8035288120376265, "threshold": -0.3147990696423051}, "Val": {"roc_auc": 0.6442577030812325, "threshold": -2.2835987308719856}, "Test": {"roc_auc": 0.7035950906918649, "threshold": -0.3509712505626972}, "description": "Predicts a down-regulation related to the ERE (Estrogen Response Element) cis-regulatory element."}, "ATG_ERE_CIS_up": {"Train": {"roc_auc": 0.7700061995952227, "threshold": -0.2597674836625563}, "Val": {"roc_auc": 0.7336678925324344, "threshold": -0.2726457083189451}, "Test": {"roc_auc": 0.6973649538866931, "threshold": -0.12224102330518072}, "description": "Predicts an up-regulation related to the ERE (Estrogen Response Element) cis-regulatory element."}, "ATG_ERRa_TRANS_dn": {"Train": {"roc_auc": 0.9290994061559049, "threshold": -1.7192214272759703}, "Val": {"roc_auc": 0.7424882629107982, "threshold": -2.0394912961725}, "Test": {"roc_auc": 0.7260233918128656, "threshold": -3.604324784484114}, "description": "Predicts a down-regulation in the ERRa (Estrogen Related Receptor Alpha) transcriptional activity."}, "ATG_ERRg_TRANS_dn": {"Train": {"roc_auc": 0.8487968110005852, "threshold": -2.0215926973430722}, "Val": {"roc_auc": 0.8212192262602579, "threshold": -4.402235194846794}, "Test": {"roc_auc": 0.8425553319919518, "threshold": -2.9997484452492955}, "description": "Predicts a down-regulation in the ERRg (Estrogen Related Receptor Gamma) transcriptional activity."}, "ATG_ERRg_TRANS_up": {"Train": {"roc_auc": 0.9483224213142122, "threshold": 1.942199374581719}, "Val": {"roc_auc": 0.9883177570093458, "threshold": -3.147914116447036}, "Test": {"roc_auc": 0.6468531468531469, "threshold": -6.524376981370562}, "description": "Predicts an up-regulation in the ERRg (Estrogen Related Receptor Gamma) transcriptional activity."}, "ATG_ERa_TRANS_up": {"Train": {"roc_auc": 0.8449817309569633, "threshold": -0.5433473596582425}, "Val": {"roc_auc": 0.8116129032258064, "threshold": 0.49667851941602237}, "Test": {"roc_auc": 0.8288055826030509, "threshold": -0.7738502366884092}, "description": "Predicts an up-regulation in the ERa (Estrogen Receptor Alpha) transcriptional activity."}, "ATG_E_Box_CIS_dn": {"Train": {"roc_auc": 0.8675437878373538, "threshold": 0.327891125931993}, "Val": {"roc_auc": 0.5795970827355332, "threshold": -1.982529894606368}, "Test": {"roc_auc": 0.6133520950594122, "threshold": 0.17580501262370873}, "description": "Predicts a down-regulation related to the E-Box cis-regulatory element."}, "ATG_E_Box_CIS_up": {"Train": {"roc_auc": 0.8989171503041672, "threshold": -1.2467885232186529}, "Val": {"roc_auc": 0.7370513647109391, "threshold": 0.4711268208287027}, "Test": {"roc_auc": 0.7279159519725558, "threshold": -1.6897698479729737}, "description": "Predicts an up-regulation related to the E-Box cis-regulatory element."}, "ATG_Ets_CIS_dn": {"Train": {"roc_auc": 0.8896864055066301, "threshold": -0.21027703614564341}, "Val": {"roc_auc": 0.7231899836690256, "threshold": -0.5643841302072685}, "Test": {"roc_auc": 0.650119189511323, "threshold": 0.09505593144261226}, "description": "Predicts a down-regulation related to the Ets (E26 transformation-specific) cis-regulatory element."}, "ATG_Ets_CIS_up": {"Train": {"roc_auc": 0.9219867584886596, "threshold": -1.7064443208553168}, "Val": {"roc_auc": 0.6232394366197184, "threshold": -2.9662918877434565}, "Test": {"roc_auc": 0.8053613053613053, "threshold": -5.406954962570031}, "description": "Predicts an up-regulation related to the Ets (E26 transformation-specific) cis-regulatory element."}, "ATG_FXR_TRANS_up": {"Train": {"roc_auc": 0.9408002166622855, "threshold": -1.313618983890679}, "Val": {"roc_auc": 0.8035244922341696, "threshold": -1.3942035586984307}, "Test": {"roc_auc": 0.76072267920094, "threshold": -0.9144288562797573}, "description": "Predicts an up-regulation in the FXR (Farnesoid X Receptor) transcriptional activity."}, "ATG_FoxA2_CIS_dn": {"Train": {"roc_auc": 0.9098589715459602, "threshold": -0.6996512775783899}, "Val": {"roc_auc": 0.7692488262910798, "threshold": -1.7730660599631225}, "Test": {"roc_auc": 0.8923976608187134, "threshold": -1.1501622507880054}, "description": "Predicts a down-regulation related to the FoxA2 cis-regulatory element."}, "ATG_FoxA2_CIS_up": {"Train": {"roc_auc": 0.9140070803553536, "threshold": -1.169797855812508}, "Val": {"roc_auc": 0.7815387921770901, "threshold": -1.7239247501433432}, "Test": {"roc_auc": 0.6955063715627096, "threshold": -2.060279717077842}, "description": "Predicts an up-regulation related to the FoxA2 cis-regulatory element."}, "ATG_FoxO_CIS_dn": {"Train": {"roc_auc": 0.8734381072122529, "threshold": -0.6079374605470953}, "Val": {"roc_auc": 0.5789473684210525, "threshold": -3.7437592430993005}, "Test": {"roc_auc": 0.5817535545023697, "threshold": 0.2917314292909623}, "description": "Predicts a down-regulation related to the FoxO (Forkhead box O) cis-regulatory element."}, "ATG_FoxO_CIS_up": {"Train": {"roc_auc": 0.8536072389337246, "threshold": -1.8909534308779694}, "Val": {"roc_auc": 0.6597303634232122, "threshold": -5.505361850793894}, "Test": {"roc_auc": 0.7283625730994152, "threshold": -2.5930041708387765}, "description": "Predicts an up-regulation related to the FoxO (Forkhead box O) cis-regulatory element."}, "ATG_GAL4_TRANS_dn": {"Train": {"roc_auc": 0.8642491447546733, "threshold": -0.6287618836125102}, "Val": {"roc_auc": 0.8640661938534279, "threshold": -1.748455292469746}, "Test": {"roc_auc": 0.8739766081871345, "threshold": -1.0616104357593406}, "description": "Predicts a down-regulation related to the GAL4 transcriptional activity."}, "ATG_GATA_CIS_dn": {"Train": {"roc_auc": 0.8894036666887286, "threshold": -1.5898596032842383}, "Val": {"roc_auc": 0.6554821216742924, "threshold": -2.1842930767987223}, "Test": {"roc_auc": 0.5716123499142367, "threshold": -1.1617355421856717}, "description": "Predicts a down-regulation related to the GATA cis-regulatory element."}, "ATG_GATA_CIS_up": {"Train": {"roc_auc": 0.8490909090909091, "threshold": -1.7328148919182862}, "Val": {"roc_auc": 0.852112676056338, "threshold": -2.8669505095458003}, "Test": {"roc_auc": 0.8459743290548425, "threshold": -3.768202499107078}, "description": "Predicts an up-regulation related to the GATA cis-regulatory element."}, "ATG_GLI_CIS_dn": {"Train": {"roc_auc": 0.8099131344845633, "threshold": -1.6402205937617529}, "Val": {"roc_auc": 0.7203985932004688, "threshold": -4.234859743633786}, "Test": {"roc_auc": 0.6967836257309942, "threshold": -4.768309558834042}, "description": "Predicts a down-regulation related to the GLI (Glioma-associated oncogene homolog) cis-regulatory element."}, "ATG_GLI_CIS_up": {"Train": {"roc_auc": 0.9262348894767624, "threshold": -0.7479479697134881}, "Val": {"roc_auc": 0.6977884615384615, "threshold": -0.706858266282965}, "Test": {"roc_auc": 0.7635024549918168, "threshold": -0.9317517543101577}, "description": "Predicts an up-regulation related to the GLI cis-regulatory element."}, "ATG_GRE_CIS_dn": {"Train": {"roc_auc": 0.8699029426310585, "threshold": -0.7108230266246469}, "Val": {"roc_auc": 0.6071004914421285, "threshold": -2.170323152799864}, "Test": {"roc_auc": 0.5658096968003353, "threshold": -0.2866958684033465}, "description": "Predicts a down-regulation related to the GRE (Glucocorticoid Response Element) cis-regulatory element."}, "ATG_GRE_CIS_up": {"Train": {"roc_auc": 0.910232247354969, "threshold": -1.0469513526549923}, "Val": {"roc_auc": 0.6110458284371328, "threshold": -2.612834040109102}, "Test": {"roc_auc": 0.951048951048951, "threshold": -2.7085997440196854}, "description": "Predicts an up-regulation related to the GRE cis-regulatory element."}, "ATG_GR_TRANS_dn": {"Train": {"roc_auc": 0.813304564072557, "threshold": -1.7845163742701224}, "Val": {"roc_auc": 0.7417936694021101, "threshold": -2.9189604211736606}, "Test": null, "description": "Predicts a down-regulation in the GR (Glucocorticoid Receptor) transcriptional activity."}, "ATG_GR_TRANS_up": {"Train": {"roc_auc": 0.9062102417302799, "threshold": -1.4465239842732753}, "Val": {"roc_auc": 0.8709243697478992, "threshold": 1.045439697004058}, "Test": {"roc_auc": 0.5074941451990633, "threshold": -1.3774631030566695}, "description": "Predicts an up-regulation in the GR transcriptional activity."}, "ATG_HIF1a_CIS_dn": {"Train": {"roc_auc": 0.6469512817221712, "threshold": -1.1516626857899812}, "Val": {"roc_auc": 0.5459694027655193, "threshold": -1.4351075280595706}, "Test": {"roc_auc": 0.5164835164835165, "threshold": -1.4356566258483348}, "description": "Predicts a down-regulation related to the HIF1a (Hypoxia-inducible factor 1-alpha) cis-regulatory element."}, "ATG_HIF1a_CIS_up": {"Train": {"roc_auc": 0.8420842550811761, "threshold": -0.765648356190435}, "Val": {"roc_auc": 0.6042696744952617, "threshold": -2.014451785130544}, "Test": {"roc_auc": 0.6514991181657849, "threshold": -1.474625491045856}, "description": "Predicts an up-regulation related to the HIF1a cis-regulatory element."}, "ATG_HNF4a_TRANS_dn": {"Train": {"roc_auc": 0.8472026612956148, "threshold": -2.3489165888414965}, "Val": {"roc_auc": 0.7652582159624414, "threshold": -1.8668910832973094}, "Test": {"roc_auc": 0.6666666666666667, "threshold": -4.564190303241168}, "description": "Predicts a down-regulation in the HNF4a (Hepatocyte Nuclear Factor 4 Alpha) transcriptional activity."}, "ATG_HNF4a_TRANS_up": {"Train": {"roc_auc": 0.9661004806724638, "threshold": 1.2612641919721224}, "Val": {"roc_auc": 0.7602579132473622, "threshold": -1.2010129773700324}, "Test": {"roc_auc": 0.7671339563862929, "threshold": -1.440311411360243}, "description": "Predicts an up-regulation in the HNF4a transcriptional activity."}, "ATG_HNF6_CIS_dn": {"Train": {"roc_auc": 0.9247278772145557, "threshold": -0.4853082261643973}, "Val": {"roc_auc": 0.6701183431952663, "threshold": -2.693118567253138}, "Test": {"roc_auc": 0.778021978021978, "threshold": -1.1880654343613628}, "description": "Predicts a down-regulation related to the HNF6 (Hepatocyte Nuclear Factor 6) cis-regulatory element."}, "ATG_HNF6_CIS_up": {"Train": {"roc_auc": 0.8696250104980263, "threshold": -0.869077669607627}, "Val": {"roc_auc": 0.5605042016806723, "threshold": -2.678011035060023}, "Test": {"roc_auc": 0.5333333333333333, "threshold": -4.302702761269188}, "description": "Predicts an up-regulation related to the HNF6 cis-regulatory element."}, "ATG_HSE_CIS_dn": {"Train": {"roc_auc": 0.8269260218731257, "threshold": -1.6962124022158296}, "Val": {"roc_auc": 0.49472450175849936, "threshold": -3.4232735526454343}, "Test": {"roc_auc": 0.5707307542008597, "threshold": -1.3902197090593784}, "description": "Predicts a down-regulation related to the HSE (Heat Shock Element) cis-regulatory element."}, "ATG_HSE_CIS_up": {"Train": {"roc_auc": 0.9156620306914801, "threshold": 0.0730513476275334}, "Val": {"roc_auc": 0.7441228070175439, "threshold": -0.8500831435034586}, "Test": {"roc_auc": 0.6735386919086582, "threshold": -2.2147850376946305}, "description": "Predicts an up-regulation related to the HSE cis-regulatory element."}, "ATG_IR1_CIS_dn": {"Train": {"roc_auc": 0.8894766027233229, "threshold": -0.2869654081247237}, "Val": {"roc_auc": 0.6960754017305315, "threshold": -1.1741964218017458}, "Test": {"roc_auc": 0.7324890556597874, "threshold": -0.6723779300311667}, "description": "Predicts a down-regulation related to the IR1 (Insulin Response Element 1) cis-regulatory element."}, "ATG_IR1_CIS_up": {"Train": {"roc_auc": 0.8722685205354975, "threshold": -0.8618432359771813}, "Val": {"roc_auc": 0.7403008709422012, "threshold": -2.127158631314267}, "Test": {"roc_auc": 0.504884720593982, "threshold": -2.416861216227213}, "description": "Predicts an up-regulation related to the IR1 cis-regulatory element."}, "ATG_ISRE_CIS_dn": {"Train": {"roc_auc": 0.8760077202041309, "threshold": 0.31098311083452757}, "Val": {"roc_auc": 0.6854983807124865, "threshold": -0.35222205600223067}, "Test": {"roc_auc": 0.6745041039671682, "threshold": -0.5417923927307129}, "description": "Predicts a down-regulation related to the ISRE (Interferon-Stimulated Response Element) cis-regulatory element."}, "ATG_ISRE_CIS_up": {"Train": {"roc_auc": 0.8639620835438326, "threshold": -2.8335879825137633}, "Val": {"roc_auc": 0.6682242990654206, "threshold": -5.1304579234576675}, "Test": {"roc_auc": 0.574095682613769, "threshold": -2.693137497276634}, "description": "Predicts an up-regulation related to the ISRE cis-regulatory element."}, "ATG_LXRa_TRANS_dn": {"Train": {"roc_auc": 0.7835606300280213, "threshold": -2.741224139779657}, "Val": {"roc_auc": 0.5824499411071848, "threshold": -3.117024354032568}, "Test": {"roc_auc": 0.42397660818713456, "threshold": -2.8157277083373047}, "description": "Predicts a down-regulation in the LXRa (Liver X Receptor Alpha) transcriptional activity."}, "ATG_LXRa_TRANS_up": {"Train": {"roc_auc": 0.7717296810082295, "threshold": -2.31617832738716}, "Val": {"roc_auc": 0.6650943396226415, "threshold": -0.7745507144414869}, "Test": {"roc_auc": 0.52037691401649, "threshold": -3.5002167640147626}, "description": "Predicts an up-regulation in the LXRa transcriptional activity."}, "ATG_LXRb_TRANS_dn": {"Train": {"roc_auc": 0.8291031455742501, "threshold": -2.293468610660449}, "Val": {"roc_auc": 0.683411214953271, "threshold": -4.72293911323891}, "Test": null, "description": "Predicts a down-regulation in the LXRb (Liver X Receptor Beta) transcriptional activity."}, "ATG_LXRb_TRANS_up": {"Train": {"roc_auc": 0.8357864945944415, "threshold": -1.2975263528757033}, "Val": {"roc_auc": 0.8505275498241501, "threshold": -0.3926533822182776}, "Test": {"roc_auc": 0.46579476861167, "threshold": -3.9590047971980353}, "description": "Predicts an up-regulation in the LXRb transcriptional activity."}, "ATG_MRE_CIS_up": {"Train": {"roc_auc": 0.8849501587116815, "threshold": 0.6916121706232286}, "Val": {"roc_auc": 0.6847354606989916, "threshold": -1.1084114779700505}, "Test": {"roc_auc": 0.6846138334341602, "threshold": 0.1446555975798498}, "description": "Predicts an up-regulation related to the MRE (Metal Response Element) cis-regulatory element."}, "ATG_M_06_TRANS_up": {"Train": {"roc_auc": 0.9281480398843743, "threshold": -2.2406954514729733}, "Val": {"roc_auc": 0.7083821805392732, "threshold": -2.798973798990488}, "Test": {"roc_auc": 0.1048951048951049, "threshold": -7.86494176738613}, "description": "Predicts an up-regulation in the transcriptional activity related to M_06 target."}, "ATG_M_19_CIS_dn": {"Train": {"roc_auc": 0.801123193102645, "threshold": -1.689208614933598}, "Val": {"roc_auc": 0.525383707201889, "threshold": -2.5755792881275434}, "Test": {"roc_auc": 0.7878965922444183, "threshold": -2.5262308235283015}, "description": "Predicts a down-regulation related to the M_19 cis-regulatory element."}, "ATG_M_19_TRANS_dn": {"Train": {"roc_auc": 0.8040381791483112, "threshold": -2.3134976472701876}, "Val": {"roc_auc": 0.7348008385744234, "threshold": -1.6968534400871205}, "Test": {"roc_auc": 0.6527498323272971, "threshold": -3.4105810224114954}, "description": "Predicts a down-regulation in the M_19 transcriptional activity."}, "ATG_M_19_TRANS_up": {"Train": {"roc_auc": 0.7910712851737608, "threshold": -1.3627155669577968}, "Val": {"roc_auc": 0.22420867526377491, "threshold": -7.819873048020555}, "Test": {"roc_auc": 0.5046674445740957, "threshold": -3.9997688499656876}, "description": "Predicts an up-regulation in the M_19 transcriptional activity."}, "ATG_M_32_CIS_dn": {"Train": {"roc_auc": 0.8000893031904482, "threshold": -1.8027858027705443}, "Val": {"roc_auc": 0.5199530516431925, "threshold": -3.2394769669056416}, "Test": {"roc_auc": 0.7223524814380617, "threshold": -3.5705068784433083}, "description": "Predicts a down-regulation related to the M_32 cis-regulatory element."}, "ATG_M_32_CIS_up": {"Train": {"roc_auc": 0.8782285053440271, "threshold": -1.8671088224953714}, "Val": {"roc_auc": 0.7677310924369747, "threshold": -1.7304655665511248}, "Test": {"roc_auc": 0.5965732087227413, "threshold": -3.6250460181269677}, "description": "Predicts an up-regulation related to the M_32 cis-regulatory element."}, "ATG_M_32_TRANS_dn": {"Train": {"roc_auc": 0.8049148311306902, "threshold": -1.8122147783502793}, "Val": {"roc_auc": 0.6108508977361435, "threshold": -2.6217844622271196}, "Test": {"roc_auc": 0.4205231388329981, "threshold": -5.609329980176252}, "description": "Predicts a down-regulation in the M_32 transcriptional activity."}, "ATG_M_32_TRANS_up": {"Train": {"roc_auc": 0.8925539424232596, "threshold": -1.0334097759143734}, "Val": {"roc_auc": 0.911737089201878, "threshold": -3.0300779867697294}, "Test": {"roc_auc": 0.5309218203033839, "threshold": -5.820887410962904}, "description": "Predicts an up-regulation in the M_32 transcriptional activity."}, "ATG_M_61_TRANS_up": {"Train": {"roc_auc": 0.9141329482253225, "threshold": -1.9773605664571114}, "Val": {"roc_auc": 0.8215123094958968, "threshold": -2.06231679692044}, "Test": {"roc_auc": 0.2389277389277389, "threshold": -7.263752449024189}, "description": "Predicts an up-regulation in the transcriptional activity related to M_61 target."}, "ATG_Myb_CIS_dn": {"Train": {"roc_auc": 0.8869508788428776, "threshold": -0.6980439578448685}, "Val": {"roc_auc": 0.7409270216962525, "threshold": -2.6845013083996356}, "Test": {"roc_auc": 0.6327186963979418, "threshold": -0.42796269527546027}, "description": "Predicts a down-regulation related to the Myb (Myb proto-oncogene protein) cis-regulatory element."}, "ATG_Myb_CIS_up": {"Train": {"roc_auc": 0.7840240819120257, "threshold": -2.254215927811357}, "Val": {"roc_auc": 0.48192488262910804, "threshold": -3.0456365412539306}, "Test": {"roc_auc": 0.6550351288056206, "threshold": -2.8946921175067963}, "description": "Predicts an up-regulation related to the Myb cis-regulatory element."}, "ATG_Myc_CIS_dn": {"Train": {"roc_auc": 0.9267961876832844, "threshold": 0.33718525778662567}, "Val": {"roc_auc": 0.7348008385744235, "threshold": -2.2982924533140903}, "Test": {"roc_auc": 0.7432905484247374, "threshold": -4.360574280356502}, "description": "Predicts a down-regulation related to the Myc (Myc proto-oncogene protein) cis-regulatory element."}, "ATG_Myc_CIS_up": {"Train": {"roc_auc": 0.8789310395544583, "threshold": -0.9334157143269213}, "Val": {"roc_auc": 0.6504836075869865, "threshold": -1.029243573173507}, "Test": {"roc_auc": 0.6891537544696067, "threshold": -3.117026123437318}, "description": "Predicts an up-regulation related to the Myc cis-regulatory element."}, "ATG_NFI_CIS_dn": {"Train": {"roc_auc": 0.8777068307869322, "threshold": -1.0014977362734054}, "Val": {"roc_auc": 0.9131455399061033, "threshold": -1.4870796711953194}, "Test": {"roc_auc": 0.7198830409356725, "threshold": -4.144630231656828}, "description": "Predicts a down-regulation related to the NFI (Nuclear Factor I) cis-regulatory element."}, "ATG_NFI_CIS_up": {"Train": {"roc_auc": 0.8988643301315786, "threshold": -0.2849192015520927}, "Val": {"roc_auc": 0.7018507807981492, "threshold": -0.6565554591270528}, "Test": {"roc_auc": 0.6963051251489868, "threshold": 0.47215553112812714}, "description": "Predicts an up-regulation related to the NFI cis-regulatory element."}, "ATG_NF_kB_CIS_dn": {"Train": {"roc_auc": 0.8510035238745629, "threshold": 0.10898732041214743}, "Val": {"roc_auc": 0.6510078294186241, "threshold": -1.5314336101094757}, "Test": {"roc_auc": 0.6718257847290106, "threshold": -0.5989966192045015}, "description": "Predicts a down-regulation related to the NF-kB (Nuclear Factor kappa B) cis-regulatory element."}, "ATG_NF_kB_CIS_up": {"Train": {"roc_auc": 0.9025088757396449, "threshold": -0.9610146685942524}, "Val": {"roc_auc": 0.7992296918767507, "threshold": -1.6037182763174131}, "Test": {"roc_auc": 0.5846638427283588, "threshold": -2.2765828918766324}, "description": "Predicts an up-regulation related to the NF-kB cis-regulatory element."}, "ATG_NRF1_CIS_dn": {"Train": {"roc_auc": 0.860752080980466, "threshold": -1.01084895391722}, "Val": {"roc_auc": 0.7694577831132453, "threshold": -1.2463063909574315}, "Test": {"roc_auc": 0.6306346381969158, "threshold": -2.8445995602760465}, "description": "Predicts a down-regulation related to the NRF1 (Nuclear Respiratory Factor 1) cis-regulatory element."}, "ATG_NRF1_CIS_up": {"Train": {"roc_auc": 0.928419779919251, "threshold": -1.2715510483141292}, "Val": {"roc_auc": 0.6590411957710536, "threshold": -2.7403226803253604}, "Test": {"roc_auc": 0.7069281045751633, "threshold": -0.7613147628438597}, "description": "Predicts an up-regulation related to the NRF1 cis-regulatory element."}, "ATG_NRF2_ARE_CIS_dn": {"Train": {"roc_auc": 0.8605428720919845, "threshold": -1.9616446788604547}, "Val": {"roc_auc": 0.5193889541715628, "threshold": -2.988714533883172}, "Test": {"roc_auc": 0.5353801169590644, "threshold": -1.2218708955310849}, "description": "Predicts a down-regulation related to the NRF2-ARE (Nuclear factor erythroid 2\u2013Antioxidant Response Element) cis-regulatory element."}, "ATG_NRF2_ARE_CIS_up": {"Train": {"roc_auc": 0.8087773993049606, "threshold": 0.6243946144172741}, "Val": {"roc_auc": 0.6867650273224043, "threshold": 0.7551943007651509}, "Test": {"roc_auc": 0.658369554718439, "threshold": -0.3822211832613558}, "description": "Predicts an up-regulation related to the NRF2-ARE cis-regulatory element."}, "ATG_NURR1_TRANS_dn": {"Train": {"roc_auc": 0.7922505251402591, "threshold": -2.1277429121989275}, "Val": {"roc_auc": 0.79109243697479, "threshold": -2.8012868420139805}, "Test": {"roc_auc": 0.9247374562427071, "threshold": -3.3201119558469907}, "description": "Predicts a down-regulation in the NURR1 (Nuclear receptor related 1 protein) transcriptional activity."}, "ATG_NURR1_TRANS_up": {"Train": {"roc_auc": 0.8359973173369766, "threshold": -1.082114024205251}, "Val": {"roc_auc": 0.8000446229361892, "threshold": -1.0581830402498724}, "Test": {"roc_auc": 0.6992481203007519, "threshold": -2.3198468868319573}, "description": "Predicts an up-regulation in the NURR1 transcriptional activity."}, "ATG_Oct_MLP_CIS_dn": {"Train": {"roc_auc": 0.8214276035145347, "threshold": -2.005845496604394}, "Val": {"roc_auc": 0.4835680751173709, "threshold": -5.543115139484883}, "Test": {"roc_auc": 0.5177985948477752, "threshold": -4.535694783872312}, "description": "Predicts a down-regulation related to the Oct-MLP (Octamer Motif - Myelin-related Lipid Protein) cis-regulatory element."}, "ATG_Oct_MLP_CIS_up": {"Train": {"roc_auc": 0.8906070743969041, "threshold": 0.5553587471042665}, "Val": {"roc_auc": 0.7021467225746335, "threshold": -1.1969062768899876}, "Test": {"roc_auc": 0.7141486024626621, "threshold": 0.6872006231122789}, "description": "Predicts an up-regulation related to the Oct-MLP cis-regulatory element."}, "ATG_PBREM_CIS_dn": {"Train": {"roc_auc": 0.860119970738844, "threshold": -2.333155233938772}, "Val": {"roc_auc": 0.6088992974238876, "threshold": -6.6374632975718635}, "Test": {"roc_auc": 0.9174454828660435, "threshold": -4.254443792967467}, "description": "Predicts a down-regulation related to the PBREM (Phenobarbital Response Element Module) cis-regulatory element."}, "ATG_PBREM_CIS_up": {"Train": {"roc_auc": 0.8969594795203117, "threshold": -0.5128671328226719}, "Val": {"roc_auc": 0.7443912512907161, "threshold": -0.40423601418286115}, "Test": {"roc_auc": 0.7697737846943686, "threshold": -0.49052215052080594}, "description": "Predicts an up-regulation related to the PBREM cis-regulatory element."}, "ATG_PPARa_TRANS_dn": {"Train": {"roc_auc": 0.8838443528961527, "threshold": -0.6868058001553567}, "Val": {"roc_auc": 0.9077568134171907, "threshold": -2.789926285619612}, "Test": {"roc_auc": 0.8882398753894082, "threshold": -1.9112890802465516}, "description": "Predicts a down-regulation in the PPARa (Peroxisome proliferator-activated receptor alpha) transcriptional activity."}, "ATG_PPARa_TRANS_up": {"Train": {"roc_auc": 0.8840109570521877, "threshold": -0.4332034299084846}, "Val": {"roc_auc": 0.6735994397759104, "threshold": -0.4542117117642164}, "Test": {"roc_auc": 0.71494695236114, "threshold": -0.34796751440466345}, "description": "Predicts an up-regulation in the PPARa transcriptional activity."}, "ATG_PPARd_TRANS_up": {"Train": {"roc_auc": 0.9084047027756073, "threshold": -0.9263610141771341}, "Val": {"roc_auc": 0.6491090146750524, "threshold": -2.074985194850612}, "Test": {"roc_auc": 0.8069558421258304, "threshold": -1.9763613183935131}, "description": "Predicts an up-regulation in the PPARd (Peroxisome proliferator-activated receptor delta) transcriptional activity."}, "ATG_PPARg_TRANS_up": {"Train": {"roc_auc": 0.8549984832593645, "threshold": -0.8703639839027257}, "Val": {"roc_auc": 0.7536510486902133, "threshold": -0.9066879878173006}, "Test": {"roc_auc": 0.7293855106771219, "threshold": -0.48045099533355984}, "description": "Predicts an up-regulation in the PPARg (Peroxisome proliferator-activated receptor gamma) transcriptional activity."}, "ATG_PPRE_CIS_dn": {"Train": {"roc_auc": 0.8190491507607829, "threshold": -1.5713008138629885}, "Val": {"roc_auc": 0.6211334120425029, "threshold": -1.545509284681028}, "Test": {"roc_auc": 0.7172723720203205, "threshold": -1.4167825456138123}, "description": "Predicts a down-regulation related to the PPRE (Peroxisome proliferator-activated receptor response element) cis-regulatory element."}, "ATG_PPRE_CIS_up": {"Train": {"roc_auc": 0.8716558457202052, "threshold": -0.43129180787919896}, "Val": {"roc_auc": 0.7934662673392183, "threshold": -0.46319825907011314}, "Test": {"roc_auc": 0.799558122238264, "threshold": -0.7295700993027179}, "description": "Predicts an up-regulation related to the PPRE cis-regulatory element."}, "ATG_PXRE_CIS_dn": {"Train": {"roc_auc": 0.7433054035433535, "threshold": -1.137435478968425}, "Val": {"roc_auc": 0.5713261648745519, "threshold": -2.3941440515451364}, "Test": {"roc_auc": 0.6459758879113718, "threshold": -0.8441271960914314}, "description": "Predicts a down-regulation related to the PXRE (Pregnane X Receptor Element) cis-regulatory element."}, "ATG_PXRE_CIS_up": {"Train": {"roc_auc": 0.7550113615225432, "threshold": 0.24508034216391117}, "Val": {"roc_auc": 0.7201369091612992, "threshold": 0.5542153949374788}, "Test": {"roc_auc": 0.6822842647350967, "threshold": -0.7504063349467023}, "description": "Predicts an up-regulation related to the PXRE cis-regulatory element."}, "ATG_PXR_TRANS_dn": {"Train": {"roc_auc": 0.843257601155324, "threshold": -1.2319937568527095}, "Val": {"roc_auc": 0.7760844079718641, "threshold": -3.9203701377272973}, "Test": {"roc_auc": 0.6715285880980164, "threshold": -5.341293170526101}, "description": "Predicts a down-regulation in the PXR (Pregnane X Receptor) transcriptional activity."}, "ATG_PXR_TRANS_up": {"Train": {"roc_auc": 0.8399984450923228, "threshold": 0.14345535931286513}, "Val": {"roc_auc": 0.7745622799505186, "threshold": 0.34726787257838865}, "Test": {"roc_auc": 0.7122879109225875, "threshold": -0.05330523785886143}, "description": "Predicts an up-regulation in the PXR transcriptional activity."}, "ATG_Pax6_CIS_up": {"Train": {"roc_auc": 0.9064413364379171, "threshold": 0.3445635214224243}, "Val": {"roc_auc": 0.716996891996892, "threshold": -1.3037130703797208}, "Test": {"roc_auc": 0.6901171185624899, "threshold": -2.004603342728333}, "description": "Predicts an up-regulation related to the Pax6 cis-regulatory element."}, "ATG_RARa_TRANS_dn": {"Train": {"roc_auc": 0.834495546963664, "threshold": -0.7410748455975504}, "Val": {"roc_auc": 0.6346634615384615, "threshold": -2.1042264226201297}, "Test": {"roc_auc": 0.6906606125356125, "threshold": -3.146255325626683}, "description": "Predicts a down-regulation in the RARa (Retinoic Acid Receptor alpha) transcriptional activity."}, "ATG_RARa_TRANS_up": {"Train": {"roc_auc": 0.9184093067071392, "threshold": -0.6934932065797632}, "Val": {"roc_auc": 0.9079088759939823, "threshold": -1.9685993855063977}, "Test": {"roc_auc": 0.804641598119859, "threshold": -1.2017882725855964}, "description": "Predicts an up-regulation in the RARa transcriptional activity."}, "ATG_RARb_TRANS_dn": {"Train": {"roc_auc": 0.8420625793174651, "threshold": -0.9021258743198306}, "Val": {"roc_auc": 0.6646105826397146, "threshold": -1.9164632870270326}, "Test": {"roc_auc": 0.7662717219589258, "threshold": -1.5879516773395705}, "description": "Predicts a down-regulation in the RARb (Retinoic Acid Receptor beta) transcriptional activity."}, "ATG_RARb_TRANS_up": {"Train": {"roc_auc": 0.8572482650429418, "threshold": -2.2689841479749173}, "Val": {"roc_auc": 0.8257309941520469, "threshold": -3.1047916445765527}, "Test": {"roc_auc": 0.9475524475524475, "threshold": -3.3440993310691596}, "description": "Predicts an up-regulation in the RARb transcriptional activity."}, "ATG_RARg_TRANS_dn": {"Train": {"roc_auc": 0.8960365782897638, "threshold": -1.2652151598944688}, "Val": {"roc_auc": 0.6837054445750098, "threshold": -1.7789645597144768}, "Test": {"roc_auc": 0.42562305295950154, "threshold": -3.0722804441824323}, "description": "Predicts a down-regulation in the RARg (Retinoic Acid Receptor gamma) transcriptional activity."}, "ATG_RARg_TRANS_up": {"Train": {"roc_auc": 0.9093869293933429, "threshold": 1.575490145831255}, "Val": {"roc_auc": 0.9623529411764705, "threshold": -2.658361050340387}, "Test": {"roc_auc": 0.5667337357478202, "threshold": -4.366465667107919}, "description": "Predicts an up-regulation in the RARg transcriptional activity."}, "ATG_RORE_CIS_dn": {"Train": {"roc_auc": 0.8551784669397309, "threshold": -2.8336864545180633}, "Val": {"roc_auc": 0.6631455399061033, "threshold": -3.344591970319624}, "Test": {"roc_auc": 0.8076923076923077, "threshold": -5.076943129032582}, "description": "Predicts a down-regulation related to the RORE (Retinoid-related Orphan Receptor Element) cis-regulatory element."}, "ATG_RORE_CIS_up": {"Train": {"roc_auc": 0.9058483360672126, "threshold": -0.23810193440816363}, "Val": {"roc_auc": 0.7268640350877194, "threshold": -1.2521568547498}, "Test": {"roc_auc": 0.7485290482076639, "threshold": -1.0544284070218284}, "description": "Predicts an up-regulation related to the RORE cis-regulatory element."}, "ATG_RORb_TRANS_dn": {"Train": {"roc_auc": 0.842976735876265, "threshold": -2.1727915888911378}, "Val": {"roc_auc": 0.6835983510011778, "threshold": -1.7837882557430778}, "Test": {"roc_auc": 0.8613053613053613, "threshold": -4.029814395639631}, "description": "Predicts a down-regulation in the RORb (Retinoid-related Orphan Receptor beta) transcriptional activity."}, "ATG_RORg_TRANS_dn": {"Train": {"roc_auc": 0.8837980980248721, "threshold": -1.7325706804120866}, "Val": {"roc_auc": 0.7248243559718969, "threshold": -2.397827706895434}, "Test": {"roc_auc": 0.8033838973162194, "threshold": -4.478274159125976}, "description": "Predicts a down-regulation in the RORg (Retinoid-related Orphan Receptor gamma) transcriptional activity."}, "ATG_RORg_TRANS_up": {"Train": {"roc_auc": 0.89433582586597, "threshold": -2.3255410582811624}, "Val": {"roc_auc": 0.624561403508772, "threshold": -3.5838994970312115}, "Test": {"roc_auc": 0.8578660436137071, "threshold": -3.376866945812295}, "description": "Predicts an up-regulation in the RORg transcriptional activity."}, "ATG_RXRa_TRANS_dn": {"Train": {"roc_auc": 0.8721130212576331, "threshold": -3.068498353700381}, "Val": null, "Test": {"roc_auc": 0.6331775700934579, "threshold": -4.611793562217995}, "description": "Predicts a down-regulation in the RXRa (Retinoid X Receptor alpha) transcriptional activity."}, "ATG_RXRa_TRANS_up": {"Train": {"roc_auc": 0.8839791564089939, "threshold": -1.3745363787249154}, "Val": {"roc_auc": 0.7955135773317592, "threshold": -1.8190959330435632}, "Test": {"roc_auc": 0.7843137254901961, "threshold": -3.396184469665493}, "description": "Predicts an up-regulation in the RXRa transcriptional activity."}, "ATG_RXRb_TRANS_dn": {"Train": {"roc_auc": 0.7371793259161892, "threshold": -2.0088073197785796}, "Val": {"roc_auc": 0.8376168224299065, "threshold": -3.024634733393386}, "Test": {"roc_auc": 0.6625730994152048, "threshold": -2.930078811473675}, "description": "Predicts a down-regulation in the RXRb (Retinoid X Receptor beta) transcriptional activity."}, "ATG_RXRb_TRANS_up": {"Train": {"roc_auc": 0.840614127093204, "threshold": -0.9171083247936043}, "Val": {"roc_auc": 0.7662141779788839, "threshold": -1.6970260742309695}, "Test": {"roc_auc": 0.7945879458794588, "threshold": -1.1070115702288286}, "description": "Predicts an up-regulation in the RXRb transcriptional activity."}, "ATG_SREBP_CIS_dn": {"Train": {"roc_auc": 0.8064059956189518, "threshold": -2.400421499132036}, "Val": {"roc_auc": 0.27251461988304093, "threshold": -6.05145303479902}, "Test": {"roc_auc": 0.6922716627634661, "threshold": -4.656438269056715}, "description": "Predicts a down-regulation related to the SREBP (Sterol Regulatory Element-Binding Protein) cis-regulatory element."}, "ATG_SREBP_CIS_up": {"Train": {"roc_auc": 0.8565692905065098, "threshold": -0.34692714736984254}, "Val": {"roc_auc": 0.6515038924274592, "threshold": -1.6782227163916241}, "Test": {"roc_auc": 0.778160200250313, "threshold": -1.3490704430474176}, "description": "Predicts an up-regulation related to the SREBP cis-regulatory element."}, "ATG_STAT3_CIS_dn": {"Train": {"roc_auc": 0.852318186145578, "threshold": -1.632490925244741}, "Val": {"roc_auc": 0.6393152302243211, "threshold": -1.8240690011758582}, "Test": {"roc_auc": 0.5375214408233278, "threshold": -1.1828127085744917}, "description": "Predicts a down-regulation related to the STAT3 (Signal Transducer and Activator of Transcription 3) cis-regulatory element."}, "ATG_STAT3_CIS_up": {"Train": {"roc_auc": 0.8850937619594337, "threshold": -1.1805478488360794}, "Val": {"roc_auc": 0.5990758650333118, "threshold": -2.333272058684547}, "Test": {"roc_auc": 0.7086651053864169, "threshold": -2.97555330207756}, "description": "Predicts an up-regulation related to the STAT3 cis-regulatory element."}, "ATG_Sox_CIS_dn": {"Train": {"roc_auc": 0.8441671731838545, "threshold": -1.0038267115692232}, "Val": {"roc_auc": 0.5755868544600939, "threshold": -3.8445182951005012}, "Test": {"roc_auc": 0.8722287047841307, "threshold": -3.571961156598798}, "description": "Predicts a down-regulation related to the Sox (Sex-determining Region Y-box) cis-regulatory element."}, "ATG_Sox_CIS_up": {"Train": {"roc_auc": 0.9117138926467255, "threshold": -0.34142520609083427}, "Val": {"roc_auc": 0.6391056422569028, "threshold": -1.1913502994361709}, "Test": {"roc_auc": 0.7417756638921918, "threshold": 1.3583515551951795}, "description": "Predicts an up-regulation related to the Sox cis-regulatory element."}, "ATG_Sp1_CIS_dn": {"Train": {"roc_auc": 0.8749532497520204, "threshold": -0.4097007909217272}, "Val": {"roc_auc": 0.791226008617313, "threshold": -2.279742784686275}, "Test": {"roc_auc": 0.6767794632438741, "threshold": -4.108482738156934}, "description": "Predicts a down-regulation related to the Sp1 (Specificity Protein 1) cis-regulatory element."}, "ATG_Sp1_CIS_up": {"Train": {"roc_auc": 0.9021694221650937, "threshold": 0.013249855499726237}, "Val": {"roc_auc": 0.6347613219094247, "threshold": 0.3067425201843701}, "Test": {"roc_auc": 0.6752941176470588, "threshold": -0.950717676389921}, "description": "Predicts an up-regulation related to the Sp1 cis-regulatory element."}, "ATG_TAL_CIS_dn": {"Train": {"roc_auc": 0.817196971285945, "threshold": -2.3379779339910627}, "Val": {"roc_auc": 0.6138103651354535, "threshold": -4.493212106110933}, "Test": {"roc_auc": 0.583921568627451, "threshold": -1.7858923147390549}, "description": "Predicts a down-regulation related to the TAL (T-cell Acute Lymphocytic Leukemia) cis-regulatory element."}, "ATG_TAL_CIS_up": {"Train": {"roc_auc": 0.8739421311440811, "threshold": -0.882465794279768}, "Val": {"roc_auc": 0.6706443914081146, "threshold": -1.000472055899131}, "Test": {"roc_auc": 0.7633206037461358, "threshold": -0.7613751315497774}, "description": "Predicts an up-regulation related to the TAL cis-regulatory element."}, "ATG_TA_CIS_dn": {"Train": {"roc_auc": 0.7376113188366441, "threshold": -2.5997408719153494}, "Val": {"roc_auc": 0.7859649122807018, "threshold": -4.66982386324618}, "Test": {"roc_auc": 0.4579914028917546, "threshold": -6.680008807101169}, "description": "Predicts a down-regulation related to the TA (Ternary Complex Factor) cis-regulatory element."}, "ATG_TA_CIS_up": {"Train": {"roc_auc": 0.9056757314695008, "threshold": 0.21283074685403136}, "Val": {"roc_auc": 0.7094109921196201, "threshold": -0.5672789326420524}, "Test": {"roc_auc": 0.7213500784929356, "threshold": -1.068627870595968}, "description": "Predicts an up-regulation related to the TA cis-regulatory element."}, "ATG_TCF_b_cat_CIS_dn": {"Train": {"roc_auc": 0.8210957430156391, "threshold": -0.10896744599213459}, "Val": {"roc_auc": 0.6598448368111289, "threshold": -0.4953120392006083}, "Test": {"roc_auc": 0.6728632478632479, "threshold": 0.8610543608068824}, "description": "Predicts a down-regulation related to the TCF-b-cat (T-Cell Factor-beta-catenin) cis-regulatory element."}, "ATG_TCF_b_cat_CIS_up": {"Train": {"roc_auc": 0.8766928106315831, "threshold": -2.1772417056787248}, "Val": {"roc_auc": 0.6600938967136151, "threshold": -2.7969838427351768}, "Test": {"roc_auc": 0.7180685358255451, "threshold": -2.3635331803971935}, "description": "Predicts an up-regulation related to the TCF-b-cat cis-regulatory element."}, "ATG_TGFb_CIS_dn": {"Train": {"roc_auc": 0.7740307975480288, "threshold": -1.460566019272064}, "Val": {"roc_auc": 0.6403353057199213, "threshold": -1.980608631242383}, "Test": {"roc_auc": 0.4952718676122932, "threshold": -2.5517260522933096}, "description": "Predicts a down-regulation related to the TGFb (Transforming Growth Factor beta) cis-regulatory element."}, "ATG_TGFb_CIS_up": {"Train": {"roc_auc": 0.8683911000953624, "threshold": -1.3713311855499448}, "Val": {"roc_auc": 0.8063321385902031, "threshold": -1.8513788634592352}, "Test": {"roc_auc": 0.6547436076568395, "threshold": -1.332645215191044}, "description": "Predicts an up-regulation related to the TGFb cis-regulatory element."}, "ATG_THRa1_TRANS_dn": {"Train": {"roc_auc": 0.8117082234915056, "threshold": -2.417745405011946}, "Val": {"roc_auc": 0.7567409144196952, "threshold": -2.142492850382884}, "Test": {"roc_auc": 0.3512461059190031, "threshold": -2.0087260449374167}, "description": "Predicts a down-regulation in the THRa1 (Thyroid Hormone Receptor alpha 1) transcriptional activity."}, "ATG_THRa1_TRANS_up": {"Train": {"roc_auc": 0.87561531656194, "threshold": -0.14123321868278005}, "Val": {"roc_auc": 0.7260355029585799, "threshold": -1.4272669091954961}, "Test": {"roc_auc": 0.610839578581514, "threshold": -2.090777683544445}, "description": "Predicts an up-regulation in the THRa1 transcriptional activity."}, "ATG_VDRE_CIS_dn": {"Train": {"roc_auc": 0.8075147639064393, "threshold": -2.9649153309422083}, "Val": {"roc_auc": 0.552046783625731, "threshold": -6.202097006865569}, "Test": {"roc_auc": 0.9545454545454546, "threshold": -4.917256883195452}, "description": "Profile for target genes with Vitamin D Receptor Element (VDRE) binding sites in cis-regulatory regions (downregulated)"}, "ATG_VDRE_CIS_up": {"Train": {"roc_auc": 0.8541421994022605, "threshold": 0.24779088647515923}, "Val": {"roc_auc": 0.7332481440915176, "threshold": -0.37431693673730493}, "Test": {"roc_auc": 0.7292230952827912, "threshold": 0.6159098492012376}, "description": "Profile for target genes with Vitamin D Receptor Element (VDRE) binding sites in cis-regulatory regions (upregulated)"}, "ATG_VDR_TRANS_dn": {"Train": {"roc_auc": 0.8343812448213676, "threshold": -2.281307886312673}, "Val": {"roc_auc": 0.587431693989071, "threshold": -4.771060396839788}, "Test": {"roc_auc": 0.24592074592074598, "threshold": -6.2600312968035485}, "description": "Profile for target genes influenced by Vitamin D Receptor (VDR) in trans-regulatory regions (downregulated)"}, "ATG_VDR_TRANS_up": {"Train": {"roc_auc": 0.8974064575665555, "threshold": -1.883063452976483}, "Val": {"roc_auc": 0.727699530516432, "threshold": -2.2021748310810807}, "Test": {"roc_auc": 0.776608187134503, "threshold": -4.347571044593482}, "description": "Profile for target genes influenced by Vitamin D Receptor (VDR) in trans-regulatory regions (upregulated)"}, "ATG_XTT_Cytotoxicity_up": {"Train": {"roc_auc": 0.860834736065879, "threshold": -0.5221946886232542}, "Val": {"roc_auc": 0.7622523461939521, "threshold": -0.7760067468171599}, "Test": {"roc_auc": 0.8135391923990498, "threshold": 0.2954875632926619}, "description": "Profile for target genes associated with XTT cytotoxicity (upregulated)"}, "ATG_Xbp1_CIS_dn": {"Train": {"roc_auc": 0.8110920128730252, "threshold": -1.9067884847089225}, "Val": {"roc_auc": 0.4543859649122807, "threshold": -6.260016547309029}, "Test": {"roc_auc": 0.6397660818713451, "threshold": -4.9222216286339435}, "description": "Profile for target genes with Xbp1 binding sites in cis-regulatory regions (downregulated)"}, "ATG_Xbp1_CIS_up": {"Train": {"roc_auc": 0.9120884555053415, "threshold": 0.10520639958921052}, "Val": {"roc_auc": 0.6991498205176648, "threshold": -1.6831584578161838}, "Test": {"roc_auc": 0.7206872235399705, "threshold": -0.3305126983482207}, "description": "Profile for target genes with Xbp1 binding sites in cis-regulatory regions (upregulated)"}, "ATG_p53_CIS_dn": {"Train": {"roc_auc": 0.866465144422668, "threshold": -0.17645628626520704}, "Val": {"roc_auc": 0.722109044121589, "threshold": -1.468719250447041}, "Test": {"roc_auc": 0.645934099153567, "threshold": -1.2061175722498314}, "description": "Profile for target genes with p53 binding sites in cis-regulatory regions (downregulated)"}, "ATG_p53_CIS_up": {"Train": {"roc_auc": 0.9228219787911964, "threshold": -1.4520178499880494}, "Val": {"roc_auc": 0.6694182389937107, "threshold": -3.0623722045390576}, "Test": {"roc_auc": 0.7104829210836279, "threshold": -2.7406378093066524}, "description": "Profile for target genes with p53 binding sites in cis-regulatory regions (upregulated)"}, "BSK_3C_Eselectin_down": {"Train": {"roc_auc": 0.9141262173587785, "threshold": 1.7402680552638206}, "Val": {"roc_auc": 0.75259979872526, "threshold": 2.7559579213460275}, "Test": {"roc_auc": 0.7098159509202454, "threshold": -0.07554449190248569}, "description": "Profile for 3C cells with downregulated E-selectin expression"}, "BSK_3C_HLADR_down": {"Train": {"roc_auc": 0.8850604158661032, "threshold": 2.5341369497167463}, "Val": {"roc_auc": 0.7361605945676742, "threshold": 0.08185284703343498}, "Test": {"roc_auc": 0.7330778301886792, "threshold": 0.22949797636992386}, "description": "Profile for 3C cells with downregulated HLA-DR expression"}, "BSK_3C_ICAM1_down": {"Train": {"roc_auc": 0.9650867345295236, "threshold": 0.2682473122536617}, "Val": {"roc_auc": 0.8137155354213856, "threshold": 0.5451645044473796}, "Test": {"roc_auc": 0.8131868131868132, "threshold": -0.6469425696868445}, "description": "Profile for 3C cells with downregulated ICAM1 expression"}, "BSK_3C_IL8_down": {"Train": {"roc_auc": 0.924437206580558, "threshold": 0.8525149199339719}, "Val": {"roc_auc": 0.7702038631829903, "threshold": -1.3954194558633342}, "Test": {"roc_auc": 0.7986568986568987, "threshold": 1.771121434621266}, "description": "Profile for 3C cells with downregulated IL8 expression"}, "BSK_3C_MCP1_down": {"Train": {"roc_auc": 0.9249761185468863, "threshold": 1.8415689582939265}, "Val": {"roc_auc": 0.7580024406270534, "threshold": -0.47628889761648896}, "Test": {"roc_auc": 0.7486229210118187, "threshold": 0.7922605012391539}, "description": "Profile for 3C cells with downregulated MCP1 expression"}, "BSK_3C_MIG_down": {"Train": {"roc_auc": 0.9698141762197043, "threshold": 0.19642790946158506}, "Val": {"roc_auc": 0.802846425419241, "threshold": -0.2928691382880686}, "Test": {"roc_auc": 0.8635728542914172, "threshold": -0.6006423398419791}, "description": "Profile for 3C cells with downregulated MIG expression"}, "BSK_3C_Proliferation_down": {"Train": {"roc_auc": 0.8788411264127804, "threshold": 1.0065259732999605}, "Val": {"roc_auc": 0.7458049733809556, "threshold": 0.2638441058131189}, "Test": {"roc_auc": 0.743876182408584, "threshold": 0.8370572310668214}, "description": "Profile for 3C cells showing decreased proliferation"}, "BSK_3C_SRB_down": {"Train": {"roc_auc": 0.9127286609859465, "threshold": 2.3931222677946806}, "Val": {"roc_auc": 0.7714815933710241, "threshold": 1.091350060922128}, "Test": {"roc_auc": 0.7651230705047977, "threshold": 1.4210793931443657}, "description": "Profile for 3C cells with downregulated SRB expression"}, "BSK_3C_Thrombomodulin_down": {"Train": {"roc_auc": 0.9025097680695683, "threshold": -0.39996787849011994}, "Val": {"roc_auc": 0.6875732708089097, "threshold": -1.2080303757517665}, "Test": {"roc_auc": 0.9055555555555556, "threshold": -1.5005696408741462}, "description": "Profile for 3C cells with downregulated Thrombomodulin expression"}, "BSK_3C_Thrombomodulin_up": {"Train": {"roc_auc": 0.9313039160107756, "threshold": 0.081715068301639}, "Val": {"roc_auc": 0.7946629585485365, "threshold": -0.6374205187395656}, "Test": {"roc_auc": 0.8124553039332539, "threshold": -1.8382893143234789}, "description": "Profile for 3C cells with upregulated Thrombomodulin expression"}, "BSK_3C_TissueFactor_down": {"Train": {"roc_auc": 0.9264414165906755, "threshold": 0.681351223507443}, "Val": {"roc_auc": 0.8103625875566544, "threshold": -0.32114198472764777}, "Test": {"roc_auc": 0.8028520499108734, "threshold": -0.2929697256307815}, "description": "Profile for 3C cells with downregulated Tissue Factor expression"}, "BSK_3C_TissueFactor_up": {"Train": {"roc_auc": 0.8942622922857016, "threshold": -1.2585979858795557}, "Val": {"roc_auc": 0.7395465253239105, "threshold": -1.2046940949586062}, "Test": {"roc_auc": 0.7977777777777777, "threshold": -1.316836031289908}, "description": "Profile for 3C cells with upregulated Tissue Factor expression"}, "BSK_3C_VCAM1_down": {"Train": {"roc_auc": 0.9350791744322497, "threshold": 1.887899712399319}, "Val": {"roc_auc": 0.7867268746579091, "threshold": -0.98157567901535}, "Test": {"roc_auc": 0.779964349376114, "threshold": 1.4154996299170879}, "description": "Profile for 3C cells with downregulated VCAM1 expression"}, "BSK_3C_Vis_down": {"Train": {"roc_auc": 0.8943367869445514, "threshold": 1.5090928960729535}, "Val": {"roc_auc": 0.7263983853694703, "threshold": 1.1824085562078803}, "Test": {"roc_auc": 0.7493094245985299, "threshold": 0.8821608655087578}, "description": "Profile for 3C cells with downregulated Vis expression"}, "BSK_3C_uPAR_down": {"Train": {"roc_auc": 0.9031276337672407, "threshold": 1.8754960252000057}, "Val": {"roc_auc": 0.778489627335023, "threshold": 0.6594674308020778}, "Test": {"roc_auc": 0.7393825615352524, "threshold": -1.6093769818096906}, "description": "Profile for 3C cells with downregulated uPAR expression"}, "BSK_4H_Eotaxin3_down": {"Train": {"roc_auc": 0.8986355696567534, "threshold": 1.8464576971304183}, "Val": {"roc_auc": 0.7755142503097894, "threshold": -0.25156596759418104}, "Test": {"roc_auc": 0.7713727907932594, "threshold": 1.6538488719317765}, "description": "Profile for 4H cells with downregulated Eotaxin3 expression"}, "BSK_4H_MCP1_down": {"Train": {"roc_auc": 0.9180302888471431, "threshold": 1.5448748270670585}, "Val": {"roc_auc": 0.7768938841045103, "threshold": 0.14376882938770663}, "Test": {"roc_auc": 0.8105781057810578, "threshold": 0.7475753493972483}, "description": "Profile for 4H cells with downregulated MCP1 expression"}, "BSK_4H_Pselectin_down": {"Train": {"roc_auc": 0.92744508551816, "threshold": 2.318819221672234}, "Val": {"roc_auc": 0.7745862616186806, "threshold": 0.14875686347663652}, "Test": {"roc_auc": 0.7919687674288902, "threshold": 1.8874412528029438}, "description": "Profile for 4H cells with downregulated P-selectin expression"}, "BSK_4H_Pselectin_up": {"Train": {"roc_auc": 0.8616032291057861, "threshold": -0.19845552702207847}, "Val": {"roc_auc": 0.5633802816901409, "threshold": -1.1622501495960833}, "Test": {"roc_auc": 0.25757575757575757, "threshold": -5.679199730311786}, "description": "Profile for 4H cells with upregulated P-selectin expression"}, "BSK_4H_SRB_down": {"Train": {"roc_auc": 0.919264592691454, "threshold": 1.643815452033456}, "Val": {"roc_auc": 0.761363073110285, "threshold": 2.540369812790697}, "Test": {"roc_auc": 0.7551524313429074, "threshold": 1.094724445133}, "description": "Profile for 4H cells with downregulated SRB expression"}, "BSK_4H_VCAM1_down": {"Train": {"roc_auc": 0.9124514888026879, "threshold": 2.603489473894671}, "Val": {"roc_auc": 0.7381509794553273, "threshold": -0.6865071477116764}, "Test": {"roc_auc": 0.7799731887859183, "threshold": 1.3399995292151896}, "description": "Profile for 4H cells with downregulated VCAM1 expression"}, "BSK_4H_VEGFRII_down": {"Train": {"roc_auc": 0.9464720051470357, "threshold": 0.4101267748766837}, "Val": {"roc_auc": 0.817418340361661, "threshold": -1.6836081670449898}, "Test": {"roc_auc": 0.808725371934057, "threshold": -1.4733610153198242}, "description": "Profile for 4H cells with downregulated VEGFRII expression"}, "BSK_4H_uPAR_down": {"Train": {"roc_auc": 0.9119323140615743, "threshold": 1.1612857870153475}, "Val": {"roc_auc": 0.7556847008901802, "threshold": -0.9098814471705898}, "Test": {"roc_auc": 0.7361387695210146, "threshold": 0.8081488315765561}, "description": "Profile for 4H cells with downregulated uPAR expression"}, "BSK_4H_uPAR_up": {"Train": {"roc_auc": 0.9124159356725148, "threshold": -2.364491435321602}, "Val": null, "Test": {"roc_auc": 0.46736596736596736, "threshold": -5.606714659267002}, "description": "Profile for 4H cells with upregulated uPAR expression"}, "BSK_BE3C_HLADR_down": {"Train": {"roc_auc": 0.9083883175709763, "threshold": 1.8660370938412765}, "Val": {"roc_auc": 0.7573339378825663, "threshold": -0.8726951925604194}, "Test": {"roc_auc": 0.792214663643235, "threshold": 0.7427327010008664}, "description": "Profile for BE3C cells with downregulated HLA-DR expression"}, "BSK_BE3C_IL1a_down": {"Train": {"roc_auc": 0.9312605018158943, "threshold": 1.4707417521510173}, "Val": {"roc_auc": 0.8442570223715246, "threshold": 1.7868232770009094}, "Test": {"roc_auc": 0.8072093965168083, "threshold": 0.034521963025953895}, "description": "Profile for BE3C cells with downregulated IL1a expression"}, "BSK_BE3C_IP10_down": {"Train": {"roc_auc": 0.9004853329221068, "threshold": 0.9920304788125538}, "Val": {"roc_auc": 0.8077878643096035, "threshold": -0.6984780887225721}, "Test": {"roc_auc": 0.7909987669543774, "threshold": 1.454563662096545}, "description": "Profile for BE3C cells with downregulated IP10 expression"}, "BSK_BE3C_MIG_down": {"Train": {"roc_auc": 0.9654429250891794, "threshold": 1.2786609260169595}, "Val": {"roc_auc": 0.844762946184488, "threshold": 0.12531412829149957}, "Test": {"roc_auc": 0.8469464063149149, "threshold": 0.7345343600283627}, "description": "Profile for BE3C cells with downregulated MIG expression"}, "BSK_BE3C_MMP1_down": {"Train": {"roc_auc": 0.9026915287497536, "threshold": 0.8465285076870703}, "Val": {"roc_auc": 0.8272445286920559, "threshold": -0.4851650418461979}, "Test": {"roc_auc": 0.8025912035458576, "threshold": -0.16468300260939017}, "description": "Profile for BE3C cells with downregulated MMP1 expression"}, "BSK_BE3C_MMP1_up": {"Train": {"roc_auc": 0.9036185307010648, "threshold": -0.19840289928295007}, "Val": {"roc_auc": 0.651553166069295, "threshold": -1.3950652763530886}, "Test": {"roc_auc": 0.7063015229844908, "threshold": 0.6608386901286512}, "description": "Profile for BE3C cells with upregulated MMP1 expression"}, "BSK_BE3C_PAI1_down": {"Train": {"roc_auc": 0.9103637665592551, "threshold": 0.647590417642375}, "Val": {"roc_auc": 0.7788493794028849, "threshold": 0.08659111630093275}, "Test": {"roc_auc": 0.8050976800976801, "threshold": 0.40377534115994607}, "description": "Profile for BE3C cells with downregulated PAI1 expression"}, "BSK_BE3C_SRB_down": {"Train": {"roc_auc": 0.9507099130431257, "threshold": 0.38903691985824373}, "Val": {"roc_auc": 0.8080612656187021, "threshold": -0.023697922776291236}, "Test": {"roc_auc": 0.8521009673518742, "threshold": -0.7715328338745238}, "description": "Profile for BE3C cells with downregulated SRB expression"}, "BSK_BE3C_TGFb1_down": {"Train": {"roc_auc": 0.9146606012315404, "threshold": 0.45159743474171865}, "Val": {"roc_auc": 0.8370303835038663, "threshold": 0.9934745966135212}, "Test": {"roc_auc": 0.7948532368315239, "threshold": 0.15655736951856625}, "description": "Profile for BE3C cells with downregulated TGFb1 expression"}, "BSK_BE3C_tPA_down": {"Train": {"roc_auc": 0.9339977422338284, "threshold": 1.1576325184590104}, "Val": {"roc_auc": 0.8161832564271588, "threshold": -1.3801360099284619}, "Test": {"roc_auc": 0.8252623083131558, "threshold": 0.3049959415668724}, "description": "Profile for BE3C cells with downregulated tPA expression"}, "BSK_BE3C_uPAR_down": {"Train": {"roc_auc": 0.9604591836734695, "threshold": 0.9188199659009602}, "Val": {"roc_auc": 0.8127602865234049, "threshold": 1.4980164096878088}, "Test": {"roc_auc": 0.7964782345828295, "threshold": 0.3330364384808693}, "description": "Profile for BE3C cells with downregulated uPAR expression"}, "BSK_BE3C_uPAR_up": {"Train": {"roc_auc": 0.9208779448659509, "threshold": -1.151298708624548}, "Val": {"roc_auc": 0.7685446009389671, "threshold": -3.9116557066863002}, "Test": {"roc_auc": 0.8126463700234192, "threshold": -3.271440313862369}, "description": "Profile for BE3C cells with upregulated uPAR expression"}, "BSK_BE3C_uPA_down": {"Train": {"roc_auc": 0.9107659680638723, "threshold": 1.780770929010064}, "Val": {"roc_auc": 0.8116358487422954, "threshold": 1.2568973005712927}, "Test": {"roc_auc": 0.7839333021661213, "threshold": 0.8254746875247436}, "description": "Profile for BE3C cells with downregulated uPA expression"}, "BSK_CASM3C_HLADR_down": {"Train": {"roc_auc": 0.9116456501716488, "threshold": 1.8298023894981092}, "Val": {"roc_auc": 0.778241223496698, "threshold": 2.3021423518359363}, "Test": {"roc_auc": 0.7928159576125915, "threshold": 0.6252399994446343}, "description": "Profile for CASM3C cells with downregulated HLA-DR expression"}, "BSK_CASM3C_IL6_down": {"Train": {"roc_auc": 0.8843324163521207, "threshold": 0.7712250615025429}, "Val": {"roc_auc": 0.8087790637055573, "threshold": 0.8723283467946699}, "Test": {"roc_auc": 0.6524148120786777, "threshold": 0.4222573904661804}, "description": "Profile for CASM3C cells with downregulated IL6 expression"}, "BSK_CASM3C_IL6_up": {"Train": {"roc_auc": 0.9264415436127699, "threshold": -1.6015556211824773}, "Val": {"roc_auc": 0.6260257913247362, "threshold": -2.9025220484346947}, "Test": {"roc_auc": 0.9157874169597499, "threshold": -1.175053856394312}, "description": "Profile for CASM3C cells with upregulated IL6 expression"}, "BSK_CASM3C_IL8_down": {"Train": {"roc_auc": 0.9428194115323856, "threshold": 0.019817120320087867}, "Val": {"roc_auc": 0.7908602150537634, "threshold": 0.49372822362500735}, "Test": {"roc_auc": 0.7206368080327653, "threshold": -2.53333973240208}, "description": "Profile for CASM3C cells with downregulated IL8 expression"}, "BSK_CASM3C_LDLR_down": {"Train": {"roc_auc": 0.935269492222902, "threshold": 0.7316834733292854}, "Val": {"roc_auc": 0.8176918889493741, "threshold": 0.6574513857309761}, "Test": {"roc_auc": 0.7661654135338346, "threshold": -2.2003126855607746}, "description": "Profile for CASM3C cells with downregulated LDLR expression"}, "BSK_CASM3C_LDLR_up": {"Train": {"roc_auc": 0.9017594015095852, "threshold": 0.6953248734230737}, "Val": {"roc_auc": 0.7060047562425684, "threshold": -0.46529429047195947}, "Test": {"roc_auc": 0.9154860291223927, "threshold": -0.5834257966643932}, "description": "Profile for CASM3C cells with upregulated LDLR expression"}, "BSK_CASM3C_MCP1_down": {"Train": {"roc_auc": 0.9244076492537313, "threshold": 0.049558854317879764}, "Val": {"roc_auc": 0.7852884615384615, "threshold": 0.5796694053901925}, "Test": {"roc_auc": 0.6690486082260075, "threshold": -0.8453099854118946}, "description": "Profile for CASM3C cells with downregulated MCP1 expression"}, "BSK_CASM3C_MCP1_up": {"Train": {"roc_auc": 0.8761814151890265, "threshold": -1.118995725437328}, "Val": {"roc_auc": 0.5467289719626168, "threshold": -4.80101362124339}, "Test": {"roc_auc": 0.5747663551401869, "threshold": -2.274515348631102}, "description": "Profile for CASM3C cells with upregulated MCP1 expression"}, "BSK_CASM3C_MCSF_down": {"Train": {"roc_auc": 0.9089277694666433, "threshold": 1.122177918752035}, "Val": {"roc_auc": 0.7430491029947823, "threshold": -0.054882392272338265}, "Test": {"roc_auc": 0.7861238055670959, "threshold": 0.12395758719535}, "description": "Profile for CASM3C cells with downregulated MCSF expression"}, "BSK_CASM3C_MCSF_up": {"Train": {"roc_auc": 0.900562865497076, "threshold": -1.6240530138139846}, "Val": {"roc_auc": 0.7666666666666666, "threshold": -3.0154315630594892}, "Test": null, "description": "Profile for CASM3C cells with upregulated MCSF expression"}, "BSK_CASM3C_MIG_down": {"Train": {"roc_auc": 0.9568638945131278, "threshold": 0.7810997547688068}, "Val": {"roc_auc": 0.794393032117583, "threshold": -0.6328374282256499}, "Test": {"roc_auc": 0.8278041074249605, "threshold": -0.3100390515408602}, "description": "Profile for CASM3C cells with downregulated MIG expression"}, "BSK_CASM3C_Proliferation_down": {"Train": {"roc_auc": 0.8863531133780415, "threshold": 1.8084748414185672}, "Val": {"roc_auc": 0.7402572180743171, "threshold": 1.930577913920084}, "Test": {"roc_auc": 0.7509578544061303, "threshold": -0.2709927029079857}, "description": "Profile for CASM3C cells with downregulated Proliferation expression"}, "BSK_CASM3C_Proliferation_up": {"Train": {"roc_auc": 0.8325287692607763, "threshold": -0.04666776580734222}, "Val": {"roc_auc": 0.4994152046783626, "threshold": -4.305123686671138}, "Test": {"roc_auc": 0.8774795799299883, "threshold": -2.1307948312243905}, "description": "Profile for CASM3C cells with upregulated Proliferation expression"}, "BSK_CASM3C_SAA_down": {"Train": {"roc_auc": 0.9455669219339353, "threshold": 0.899825881789992}, "Val": {"roc_auc": 0.8085254096084421, "threshold": 0.2767823145792896}, "Test": {"roc_auc": 0.7948300206364722, "threshold": -0.6282219271044109}, "description": "Profile for CASM3C cells with downregulated SAA expression"}, "BSK_CASM3C_SAA_up": {"Train": {"roc_auc": 0.844089787554366, "threshold": -2.1944779533523695}, "Val": {"roc_auc": 0.9355971896955504, "threshold": -2.7698756269029188}, "Test": {"roc_auc": 0.5801169590643275, "threshold": -5.048678750390405}, "description": "Profile for CASM3C cells with upregulated SAA expression"}, "BSK_CASM3C_SRB_down": {"Train": {"roc_auc": 0.9351390590486386, "threshold": 0.18248444443588951}, "Val": {"roc_auc": 0.7701346389228886, "threshold": 0.4343622014806545}, "Test": {"roc_auc": 0.8120897382633984, "threshold": -0.2851043296409195}, "description": "Profile for CASM3C cells with downregulated SRB expression"}, "BSK_CASM3C_Thrombomodulin_down": {"Train": {"roc_auc": 0.9643956969933837, "threshold": 0.4182479994910384}, "Val": {"roc_auc": 0.8524654832347142, "threshold": -2.196006549013269}, "Test": {"roc_auc": 0.7626143790849673, "threshold": -1.160277684529623}, "description": "Profile for CASM3C cells with downregulated Thrombomodulin expression"}, "BSK_CASM3C_Thrombomodulin_up": {"Train": {"roc_auc": 0.9138592709310082, "threshold": 0.07889763538066497}, "Val": {"roc_auc": 0.7695520853415591, "threshold": -1.116883405336031}, "Test": {"roc_auc": 0.8073319580539797, "threshold": -1.0805748475564494}, "description": "Profile for CASM3C cells with upregulated Thrombomodulin expression"}, "BSK_CASM3C_TissueFactor_down": {"Train": {"roc_auc": 0.9018229788741656, "threshold": 1.186602837330586}, "Val": {"roc_auc": 0.7642124051762607, "threshold": 0.7912605808781201}, "Test": {"roc_auc": 0.7668714387464388, "threshold": -0.6692978474232287}, "description": "Profile for CASM3C cells with downregulated TissueFactor expression"}, "BSK_CASM3C_VCAM1_down": {"Train": {"roc_auc": 0.9201951130743292, "threshold": 1.390708983481467}, "Val": {"roc_auc": 0.830962761775427, "threshold": 1.1117507788512082}, "Test": {"roc_auc": 0.8442115768463074, "threshold": 0.5242667747092788}, "description": "Profile for CASM3C cells with downregulated VCAM1 expression"}, "BSK_CASM3C_VCAM1_up": {"Train": {"roc_auc": 0.9437641944593503, "threshold": -0.44784333040048274}, "Val": {"roc_auc": 0.7015276145710928, "threshold": -1.171760830196651}, "Test": {"roc_auc": 0.6714285714285714, "threshold": -2.5765596386548637}, "description": "Profile for CASM3C cells with upregulated VCAM1 expression"}, "BSK_CASM3C_uPAR_down": {"Train": {"roc_auc": 0.9165437035538716, "threshold": 0.5816269188194543}, "Val": {"roc_auc": 0.7914373525838039, "threshold": 0.2651766346500928}, "Test": {"roc_auc": 0.5885225885225885, "threshold": -0.45548276118449316}, "description": "Profile for CASM3C cells with downregulated uPAR expression"}, "BSK_CASM3C_uPAR_up": {"Train": {"roc_auc": 0.9217873656513744, "threshold": -1.9959887212461194}, "Val": {"roc_auc": 0.896174863387978, "threshold": -2.2977367131201714}, "Test": {"roc_auc": 0.7424242424242424, "threshold": -3.9624126587544115}, "description": "Profile for CASM3C cells with upregulated uPAR expression"}, "BSK_KF3CT_ICAM1_down": {"Train": {"roc_auc": 0.9562640742718956, "threshold": 0.9078095811265374}, "Val": {"roc_auc": 0.8174830832597823, "threshold": 1.175711364001483}, "Test": {"roc_auc": 0.8256766381766382, "threshold": 0.22422629576903574}, "description": "Profile for KF3CT cells with downregulated ICAM1 expression"}, "BSK_KF3CT_IL1a_down": {"Train": {"roc_auc": 0.9221977215017544, "threshold": 0.6631347877723908}, "Val": {"roc_auc": 0.8032135553607946, "threshold": 0.40276883290455956}, "Test": {"roc_auc": 0.7514631419740909, "threshold": 0.15648519670641114}, "description": "Profile for KF3CT cells with downregulated IL1a expression"}, "BSK_KF3CT_IP10_down": {"Train": {"roc_auc": 0.9060399839421919, "threshold": 1.223289957514277}, "Val": {"roc_auc": 0.7118862396443726, "threshold": 1.2776126914076862}, "Test": {"roc_auc": 0.7617826617826617, "threshold": 0.5581509873673722}, "description": "Profile for KF3CT cells with downregulated IP10 expression"}, "BSK_KF3CT_IP10_up": {"Train": {"roc_auc": 0.834025324290172, "threshold": -1.8493276046322382}, "Val": {"roc_auc": 0.4812865497076023, "threshold": -4.093006245486133}, "Test": {"roc_auc": 0.4728337236533958, "threshold": -4.74069346465148}, "description": "Profile for KF3CT cells with upregulated IP10 expression"}, "BSK_KF3CT_MCP1_down": {"Train": {"roc_auc": 0.9198821378331207, "threshold": 0.4454435829643746}, "Val": {"roc_auc": 0.7906119650305697, "threshold": 1.3522368937999278}, "Test": {"roc_auc": 0.7688935912938332, "threshold": 0.1191623709700611}, "description": "Profile for KF3CT cells with downregulated MCP1 expression"}, "BSK_KF3CT_MCP1_up": {"Train": {"roc_auc": 0.8968814188780994, "threshold": -1.7930801063925177}, "Val": null, "Test": {"roc_auc": 0.956242707117853, "threshold": -2.187985140878756}, "description": "Profile for KF3CT cells with upregulated MCP1 expression"}, "BSK_KF3CT_MMP9_down": {"Train": {"roc_auc": 0.9204965221488193, "threshold": 1.2512061149627716}, "Val": {"roc_auc": 0.7523839397741531, "threshold": -0.3431991051147891}, "Test": {"roc_auc": 0.7781053162005542, "threshold": 1.6279954041565983}, "description": "Profile for KF3CT cells with downregulated MMP9 expression"}, "BSK_KF3CT_SRB_down": {"Train": {"roc_auc": 0.9595544846577498, "threshold": 0.7395699704373566}, "Val": {"roc_auc": 0.8115481010217852, "threshold": 0.04650370757262401}, "Test": {"roc_auc": 0.8109885126964934, "threshold": -0.8024720429658156}, "description": "Profile for KF3CT cells with downregulated SRB expression"}, "BSK_KF3CT_TGFb1_down": {"Train": {"roc_auc": 0.9200918398072869, "threshold": 1.0110221453257147}, "Val": {"roc_auc": 0.8321033210332103, "threshold": -0.8578051859671412}, "Test": {"roc_auc": 0.7969694679564692, "threshold": 1.1244037358968466}, "description": "Profile for KF3CT cells with downregulated TGFb1 expression"}, "BSK_KF3CT_TIMP2_down": {"Train": {"roc_auc": 0.9159610916646197, "threshold": 0.7864927343420067}, "Val": {"roc_auc": 0.8263550099179757, "threshold": -1.370306141980298}, "Test": {"roc_auc": 0.744670542635659, "threshold": 0.5240837551571342}, "description": "Profile for KF3CT cells with downregulated TIMP2 expression"}, "BSK_KF3CT_uPA_down": {"Train": {"roc_auc": 0.9268907714760567, "threshold": 1.1397607820528037}, "Val": {"roc_auc": 0.7965544826009943, "threshold": 0.2898968991574584}, "Test": {"roc_auc": 0.7710763812458727, "threshold": 0.7688231978927167}, "description": "Profile for KF3CT cells with downregulated uPA expression"}, "BSK_LPS_CD40_down": {"Train": {"roc_auc": 0.9155516213778204, "threshold": 1.4898322308743683}, "Val": {"roc_auc": 0.7758552631578948, "threshold": -1.1464601522451403}, "Test": {"roc_auc": 0.7827441285537701, "threshold": 0.4574132858215272}, "description": "Profile for cells treated with LPS showing downregulated CD40 expression"}, "BSK_LPS_Eselectin_down": {"Train": {"roc_auc": 0.9374635818783428, "threshold": 1.085229097543893}, "Val": {"roc_auc": 0.76230012300123, "threshold": 1.2125328620513525}, "Test": {"roc_auc": 0.7996337852579087, "threshold": 1.0552695764077669}, "description": "Profile for cells treated with LPS showing downregulated Eselectin expression"}, "BSK_LPS_Eselectin_up": {"Train": {"roc_auc": 0.9311705392371766, "threshold": -2.0607325934075025}, "Val": {"roc_auc": 0.8014018691588785, "threshold": -3.5200932720401985}, "Test": {"roc_auc": 0.4137426900584795, "threshold": -6.7524367134134335}, "description": "Profile for cells treated with LPS showing upregulated Eselectin expression"}, "BSK_LPS_IL1a_down": {"Train": {"roc_auc": 0.9305939615370178, "threshold": 1.4476199393515845}, "Val": {"roc_auc": 0.7567415429153488, "threshold": -0.35384183984857565}, "Test": {"roc_auc": 0.7834224598930482, "threshold": 1.1204844103441811}, "description": "Profile for cells treated with LPS showing downregulated IL1a expression"}, "BSK_LPS_IL1a_up": {"Train": {"roc_auc": 0.8198788528370522, "threshold": -1.6557801833023902}, "Val": {"roc_auc": 0.9157894736842105, "threshold": -3.0208135234701032}, "Test": {"roc_auc": 0.627039627039627, "threshold": -4.41755325085408}, "description": "Profile for cells treated with LPS showing upregulated IL1a expression"}, "BSK_LPS_IL8_down": {"Train": {"roc_auc": 0.9174725530975044, "threshold": 0.910395296724948}, "Val": {"roc_auc": 0.7666595185761004, "threshold": -0.3867243784922616}, "Test": {"roc_auc": 0.8142163661581137, "threshold": -1.007083214081085}, "description": "Profile for cells treated with LPS showing downregulated IL8 expression"}, "BSK_LPS_IL8_up": {"Train": {"roc_auc": 0.8173623645597888, "threshold": -2.692475609354548}, "Val": {"roc_auc": 0.9462616822429907, "threshold": -3.0874950134002406}, "Test": {"roc_auc": 0.9043173862310385, "threshold": -2.6574922252345727}, "description": "Profile for cells treated with LPS showing upregulated IL8 expression"}, "BSK_LPS_MCP1_down": {"Train": {"roc_auc": 0.9278077070049378, "threshold": 1.1234481485040355}, "Val": {"roc_auc": 0.7799281616898086, "threshold": 1.5067277355595028}, "Test": {"roc_auc": 0.811073847570198, "threshold": 0.5082903853407856}, "description": "Profile for cells treated with LPS showing downregulated MCP1 expression"}, "BSK_LPS_MCSF_down": {"Train": {"roc_auc": 0.9202713524415997, "threshold": 1.262599687318545}, "Val": {"roc_auc": 0.7617729809510632, "threshold": 1.8394178117479054}, "Test": {"roc_auc": 0.7913709821694794, "threshold": 1.415689270775598}, "description": "Profile for cells treated with LPS showing downregulated MCSF expression"}, "BSK_LPS_PGE2_down": {"Train": {"roc_auc": 0.9100051913254626, "threshold": 0.46706435057494033}, "Val": {"roc_auc": 0.7710779380521078, "threshold": 0.7291842795707089}, "Test": {"roc_auc": 0.8108018280016618, "threshold": -0.18483096438723834}, "description": "Profile for cells treated with LPS showing downregulated PGE2 expression"}, "BSK_LPS_PGE2_up": {"Train": {"roc_auc": 0.890647278578313, "threshold": -0.8642403028748769}, "Val": {"roc_auc": 0.8099173553719008, "threshold": -0.9530412414529783}, "Test": {"roc_auc": 0.7467532467532468, "threshold": -1.00769879152109}, "description": "Profile for cells treated with LPS showing upregulated PGE2 expression"}, "BSK_LPS_SRB_down": {"Train": {"roc_auc": 0.9263373313443025, "threshold": 1.132176214987572}, "Val": {"roc_auc": 0.75831342570473, "threshold": -1.0629100398616398}, "Test": {"roc_auc": 0.8064930300807043, "threshold": 0.7642104909704024}, "description": "Profile for cells treated with LPS showing downregulated SRB expression"}, "BSK_LPS_TNFa_down": {"Train": {"roc_auc": 0.9017581467690459, "threshold": 0.6053339162985001}, "Val": {"roc_auc": 0.7015605686032138, "threshold": -1.7861693747886065}, "Test": {"roc_auc": 0.6783768190268606, "threshold": 0.6722020186461481}, "description": "Profile for cells treated with LPS showing downregulated TNFa expression"}, "BSK_LPS_TNFa_up": {"Train": {"roc_auc": 0.8627942766533321, "threshold": -1.7649427229935704}, "Val": {"roc_auc": 0.7199373286329808, "threshold": -2.221206986749017}, "Test": {"roc_auc": 0.6965611567018366, "threshold": -0.7616907712575545}, "description": "Profile for cells treated with LPS showing upregulated TNFa expression"}, "BSK_LPS_TissueFactor_down": {"Train": {"roc_auc": 0.9333111270227196, "threshold": 0.9910717545090257}, "Val": {"roc_auc": 0.7424724602203182, "threshold": 0.01607600203505477}, "Test": {"roc_auc": 0.8187736633114784, "threshold": 0.0046779300357480125}, "description": "Profile for cells treated with LPS showing downregulated TissueFactor expression"}, "BSK_LPS_TissueFactor_up": {"Train": {"roc_auc": 0.9258095924029022, "threshold": -0.5079486138589147}, "Val": {"roc_auc": 0.768757327080891, "threshold": -0.03041628626612436}, "Test": {"roc_auc": 0.8791079812206571, "threshold": 0.16623083559481167}, "description": "Profile for cells treated with LPS showing upregulated TissueFactor expression"}, "BSK_LPS_VCAM1_down": {"Train": {"roc_auc": 0.9085235889517927, "threshold": 2.0825207484019046}, "Val": {"roc_auc": 0.7390350877192983, "threshold": -1.0282981636765252}, "Test": {"roc_auc": 0.727907932593506, "threshold": -0.3921239111158581}, "description": "Represents the downregulation of VCAM1 due to LPS exposure in a specific bioassay."}, "BSK_SAg_CD38_down": {"Train": {"roc_auc": 0.9170623290553581, "threshold": 2.1973205056634395}, "Val": {"roc_auc": 0.7663728478457863, "threshold": -1.2095976229067205}, "Test": {"roc_auc": 0.7582700713135495, "threshold": 0.620349056369907}, "description": "Indicates the decrease in CD38 expression following superantigen (SAg) exposure in a specific bioassay."}, "BSK_SAg_CD40_down": {"Train": {"roc_auc": 0.9174379977503234, "threshold": 2.295333430812404}, "Val": {"roc_auc": 0.7679500315258512, "threshold": 0.8222170506153734}, "Test": {"roc_auc": 0.7621143311952806, "threshold": 1.0134883256287903}, "description": "Indicates the decrease in CD40 expression following superantigen (SAg) exposure in a specific bioassay."}, "BSK_SAg_CD69_down": {"Train": {"roc_auc": 0.9184843144982486, "threshold": 2.102949657001057}, "Val": {"roc_auc": 0.77860799778608, "threshold": 0.35376527001549896}, "Test": {"roc_auc": 0.7991603829081768, "threshold": 0.03614150726043519}, "description": "Indicates the decrease in CD69 expression following superantigen (SAg) exposure in a specific bioassay."}, "BSK_SAg_Eselectin_down": {"Train": {"roc_auc": 0.9236660438169461, "threshold": 1.4409053390090527}, "Val": {"roc_auc": 0.7466008771929824, "threshold": -1.0816414750016126}, "Test": {"roc_auc": 0.7586148320714425, "threshold": -0.22047705120510575}, "description": "Represents the downregulation of Eselectin due to superantigen (SAg) exposure in a specific bioassay."}, "BSK_SAg_Eselectin_up": {"Train": {"roc_auc": 0.8888387415328118, "threshold": -1.2500657812432134}, "Val": {"roc_auc": 0.8583138173302107, "threshold": -2.402450773451064}, "Test": {"roc_auc": 0.9372365339578455, "threshold": 0.31003979107997104}, "description": "Represents the upregulation of Eselectin due to superantigen (SAg) exposure in a specific bioassay."}, "BSK_SAg_IL8_down": {"Train": {"roc_auc": 0.9322510231430159, "threshold": 1.0261791217792506}, "Val": {"roc_auc": 0.7904616945712836, "threshold": 1.4412871180353939}, "Test": {"roc_auc": 0.8303025004371394, "threshold": 1.238811624658716}, "description": "Indicates the decrease in IL8 expression following superantigen (SAg) exposure in a specific bioassay."}, "BSK_SAg_IL8_up": {"Train": {"roc_auc": 0.847002409795493, "threshold": -1.4580375420319296}, "Val": {"roc_auc": 0.8847953216374269, "threshold": -2.057815424792163}, "Test": {"roc_auc": 0.7744730679156909, "threshold": -1.8759369553030432}, "description": "Indicates the increase in IL8 expression following superantigen (SAg) exposure in a specific bioassay."}, "BSK_SAg_MCP1_down": {"Train": {"roc_auc": 0.9191323611141854, "threshold": 1.0657097584492448}, "Val": {"roc_auc": 0.7772490706319702, "threshold": 1.405605462220338}, "Test": {"roc_auc": 0.7335790335790335, "threshold": 0.07940823323017732}, "description": "Indicates the decrease in MCP1 expression following superantigen (SAg) exposure in a specific bioassay."}, "BSK_SAg_MIG_down": {"Train": {"roc_auc": 0.9576622009499665, "threshold": 0.7931868025251809}, "Val": {"roc_auc": 0.7803161750530172, "threshold": 0.8688024749030347}, "Test": {"roc_auc": 0.8303724481845098, "threshold": -0.014497243367635804}, "description": "Indicates the decrease in MIG expression following superantigen (SAg) exposure in a specific bioassay."}, "BSK_SAg_PBMCCytotoxicity_down": {"Train": {"roc_auc": 0.9267665517160752, "threshold": 1.9417803456952747}, "Val": {"roc_auc": 0.7466007416563658, "threshold": -0.7447255791367233}, "Test": {"roc_auc": 0.8171636615811373, "threshold": 0.6767698742367241}, "description": "Represents the cytotoxic effect on peripheral blood mononuclear cells (PBMC) due to superantigen (SAg) exposure, resulting in a decrease."}, "BSK_SAg_PBMCCytotoxicity_up": {"Train": {"roc_auc": 0.9216832755058, "threshold": -0.9028496103840435}, "Val": {"roc_auc": 0.8359154929577465, "threshold": -2.79649228567595}, "Test": {"roc_auc": 0.7930718954248366, "threshold": -0.5015226923548308}, "description": "Represents the cytotoxic effect on peripheral blood mononuclear cells (PBMC) due to superantigen (SAg) exposure, resulting in an increase."}, "BSK_SAg_Proliferation_down": {"Train": {"roc_auc": 0.8733232949681626, "threshold": 2.494054219147584}, "Val": {"roc_auc": 0.7534494498799412, "threshold": 0.49911092494701137}, "Test": {"roc_auc": 0.7355543987506508, "threshold": 1.7129522138410378}, "description": "Represents the decrease in cell proliferation following superantigen (SAg) exposure in a specific bioassay."}, "BSK_SAg_SRB_down": {"Train": {"roc_auc": 0.9219035575788231, "threshold": 1.3767032861948252}, "Val": {"roc_auc": 0.7552788442109516, "threshold": 1.9650859116791963}, "Test": {"roc_auc": 0.8320223438212494, "threshold": 0.9961162864028275}, "description": "Represents the downregulation of SRB due to superantigen (SAg) exposure in a specific bioassay."}, "BSK_hDFCGF_CollagenIII_down": {"Train": {"roc_auc": 0.896254826290456, "threshold": 1.3238806843876958}, "Val": {"roc_auc": 0.784065244667503, "threshold": 0.2714552554759653}, "Test": {"roc_auc": 0.7856569870046526, "threshold": 0.3350341584947376}, "description": "Indicates the decrease in CollagenIII expression following hDFCGF exposure in a specific bioassay."}, "BSK_hDFCGF_EGFR_down": {"Train": {"roc_auc": 0.9450478093187198, "threshold": -0.2724508852572054}, "Val": {"roc_auc": 0.8060174188440222, "threshold": 0.5350715441030776}, "Test": {"roc_auc": 0.807064147973239, "threshold": -0.9391131836014832}, "description": "Indicates the decrease in EGFR expression following hDFCGF exposure in a specific bioassay."}, "BSK_hDFCGF_EGFR_up": {"Train": {"roc_auc": 0.9145767280329667, "threshold": -0.924260640645528}, "Val": {"roc_auc": 0.7585193889541716, "threshold": -1.5357622628932717}, "Test": {"roc_auc": 0.5863618601016021, "threshold": -3.531165774818417}, "description": "Indicates the increase in EGFR expression following hDFCGF exposure in a specific bioassay."}, "BSK_hDFCGF_IL8_down": {"Train": {"roc_auc": 0.9635671768707484, "threshold": 1.4103436999850807}, "Val": {"roc_auc": 0.7868560606060606, "threshold": -0.12157070266830594}, "Test": {"roc_auc": 0.8379929537447437, "threshold": 0.8181248818551232}, "description": "Indicates the decrease in IL8 expression following hDFCGF exposure in a specific bioassay."}, "BSK_hDFCGF_IP10_down": {"Train": {"roc_auc": 0.9016980478784316, "threshold": 1.3934727564707652}, "Val": {"roc_auc": 0.7236622807017543, "threshold": -0.8006659317780302}, "Test": {"roc_auc": 0.7096740383607588, "threshold": 0.23732648167882164}, "description": "Indicates the decrease in IP10 expression following hDFCGF exposure in a specific bioassay."}, "BSK_hDFCGF_MCSF_down": {"Train": {"roc_auc": 0.9285570056636296, "threshold": 1.2007847748719183}, "Val": {"roc_auc": 0.7614374920351726, "threshold": -0.27814825161083245}, "Test": {"roc_auc": 0.8048191533086724, "threshold": 0.16111547071057863}, "description": "Indicates the decrease in MCSF expression following hDFCGF exposure in a specific bioassay."}, "BSK_hDFCGF_MIG_down": {"Train": {"roc_auc": 0.9428240441746317, "threshold": 1.6883358568758577}, "Val": {"roc_auc": 0.7656826568265683, "threshold": -1.8561261466315555}, "Test": {"roc_auc": 0.8222451435447825, "threshold": 0.9178701444669777}, "description": "Indicates the decrease in MIG expression following hDFCGF exposure in a specific bioassay."}, "BSK_hDFCGF_MMP1_down": {"Train": {"roc_auc": 0.9334476137393732, "threshold": 1.200897686951631}, "Val": {"roc_auc": 0.7526621787025704, "threshold": -0.3385433009914207}, "Test": {"roc_auc": 0.813751507840772, "threshold": 0.5057620744447444}, "description": "Indicates the decrease in MMP1 expression following hDFCGF exposure in a specific bioassay."}, "BSK_hDFCGF_MMP1_up": {"Train": {"roc_auc": 0.9504287812041117, "threshold": -0.9536148625928469}, "Val": {"roc_auc": 0.7265533411488864, "threshold": -0.29471095277740567}, "Test": {"roc_auc": 0.781437908496732, "threshold": -1.0386410282180822}, "description": "Indicates the increase in MMP1 expression following hDFCGF exposure in a specific bioassay."}, "BSK_hDFCGF_PAI1_down": {"Train": {"roc_auc": 0.9026721867546897, "threshold": 1.537637820353618}, "Val": {"roc_auc": 0.7492735574927356, "threshold": -0.6819658217368065}, "Test": {"roc_auc": 0.7724003288121661, "threshold": -0.030773529896626073}, "description": "Indicates the decrease in PAI1 expression following hDFCGF exposure in a specific bioassay."}, "BSK_hDFCGF_Proliferation_down": {"Train": {"roc_auc": 0.8417318489116246, "threshold": 2.7094815686658347}, "Val": {"roc_auc": 0.7119521004848526, "threshold": 0.17446986380759366}, "Test": {"roc_auc": 0.7203980619749729, "threshold": 1.6767952396824315}, "description": "Represents the decrease in cell proliferation following hDFCGF exposure in a specific bioassay."}, "BSK_hDFCGF_SRB_down": {"Train": {"roc_auc": 0.9356568835098336, "threshold": 0.8644723166693922}, "Val": {"roc_auc": 0.7698450223272918, "threshold": 1.4284456031577832}, "Test": {"roc_auc": 0.835506241331484, "threshold": 0.8257957091918584}, "description": "Represents the downregulation of SRB due to hDFCGF exposure in a specific bioassay."}, "BSK_hDFCGF_TIMP1_down": {"Train": {"roc_auc": 0.9308145645645647, "threshold": 0.9410837553404239}, "Val": {"roc_auc": 0.8011409942950285, "threshold": -1.677460023948738}, "Test": {"roc_auc": 0.7993566546039406, "threshold": 0.5309917690517674}, "description": "Indicates the decrease in TIMP1 expression following hDFCGF exposure in a specific bioassay."}, "BSK_hDFCGF_VCAM1_down": {"Train": {"roc_auc": 0.9184930942163247, "threshold": 2.087636913265193}, "Val": {"roc_auc": 0.740569823434992, "threshold": -1.1314041292345198}, "Test": {"roc_auc": 0.7477798624140087, "threshold": 1.2687374407106695}, "description": "Represents the downregulation of VCAM1 due to hDFCGF exposure in a specific bioassay."}, "CEETOX_H295R_11DCORT_dn": {"Train": {"roc_auc": 0.8321763508965181, "threshold": 0.315021903187902}, "Val": {"roc_auc": 0.6329302700523982, "threshold": 0.46623042395880976}, "Test": {"roc_auc": 0.6863522261857578, "threshold": 1.08927922635465}, "description": "Represents the downregulation in 11-Deoxycortisol in H295R assay due to exposure in CEETOX study."}, "CEETOX_H295R_ANDR_dn": {"Train": {"roc_auc": 0.845434528734697, "threshold": 0.8580827815635317}, "Val": {"roc_auc": 0.7018741633199465, "threshold": 0.06181950612111109}, "Test": {"roc_auc": 0.5766564382316172, "threshold": 0.031013041525870477}, "description": "Indicates the downregulation of Androgen in H295R assay due to exposure in CEETOX study."}, "CEETOX_H295R_CORTISOL_dn": {"Train": {"roc_auc": 0.8755198618932932, "threshold": 1.379833625959562}, "Val": {"roc_auc": 0.6972789115646258, "threshold": -1.2552165350279174}, "Test": {"roc_auc": 0.7715948354246226, "threshold": 1.5888218879699698}, "description": "Signifies the downregulation of Cortisol in H295R assay as a result of CEETOX exposure."}, "CEETOX_H295R_DOC_dn": {"Train": {"roc_auc": 0.8713437772550867, "threshold": -0.4718411171639163}, "Val": {"roc_auc": 0.7295630202140309, "threshold": -0.49128984307145007}, "Test": {"roc_auc": 0.7576500422654269, "threshold": 0.27077803239450127}, "description": "Represents the decrease in DOC in H295R assay post CEETOX exposure."}, "CEETOX_H295R_DOC_up": {"Train": {"roc_auc": 0.8342449538516289, "threshold": -1.0932083924611407}, "Val": {"roc_auc": 0.7444183313748531, "threshold": -1.3074828005648467}, "Test": {"roc_auc": 0.5693624557260921, "threshold": -1.7650793971003473}, "description": "Represents the increase in DOC in H295R assay post CEETOX exposure."}, "CEETOX_H295R_ESTRADIOL_dn": {"Train": {"roc_auc": 0.9422786229763994, "threshold": -1.2346638164243426}, "Val": {"roc_auc": 0.6242016806722689, "threshold": -1.3794167667060524}, "Test": {"roc_auc": 0.7180327868852459, "threshold": -1.761434076307295}, "description": "Indicates a decrease in Estradiol in the H295R assay due to CEETOX exposure."}, "CEETOX_H295R_ESTRADIOL_up": {"Train": {"roc_auc": 0.913660060295382, "threshold": 0.14198552595602365}, "Val": {"roc_auc": 0.8085983510011778, "threshold": -0.0856121433628454}, "Test": {"roc_auc": 0.6765272835112692, "threshold": 0.1737702221006483}, "description": "Indicates an increase in Estradiol in the H295R assay due to CEETOX exposure."}, "CEETOX_H295R_ESTRONE_dn": {"Train": {"roc_auc": 0.9483260126891166, "threshold": 0.31892989514706827}, "Val": {"roc_auc": 0.6344339622641509, "threshold": -0.8894899020920528}, "Test": {"roc_auc": 0.7369846878680801, "threshold": 1.3348698816499898}, "description": "Signifies the downregulation of Estrone in H295R assay following CEETOX exposure."}, "CEETOX_H295R_ESTRONE_up": {"Train": {"roc_auc": 0.9336187701234498, "threshold": -0.31509087656114687}, "Val": {"roc_auc": 0.8322689075630254, "threshold": 0.1742433973022166}, "Test": {"roc_auc": 0.712313383538116, "threshold": -0.5442140904573103}, "description": "Signifies the upregulation of Estrone in H295R assay following CEETOX exposure."}, "CEETOX_H295R_OHPREG_up": {"Train": {"roc_auc": 0.946447179887977, "threshold": 2.6258000539945776}, "Val": {"roc_auc": 0.8186582809224319, "threshold": -1.357313968039847}, "Test": {"roc_auc": 0.5590694682675814, "threshold": 2.387606122472265}, "description": "Indicates an upregulation of OHPREG in the H295R assay post CEETOX study exposure."}, "CEETOX_H295R_OHPROG_dn": {"Train": {"roc_auc": 0.8282976702091626, "threshold": 1.2038114068505763}, "Val": {"roc_auc": 0.6123249299719888, "threshold": -0.08870509078910782}, "Test": {"roc_auc": 0.6942000651678071, "threshold": 0.250225860435326}, "description": "Represents the decrease in OHPROG in H295R assay following CEETOX exposure."}, "CEETOX_H295R_OHPROG_up": {"Train": {"roc_auc": 0.9322191965404343, "threshold": 1.2225407981299785}, "Val": {"roc_auc": 0.8305588585017836, "threshold": -0.14672770371308186}, "Test": {"roc_auc": 0.6082840236686391, "threshold": 0.8073715738825369}, "description": "Represents the increase in OHPROG in H295R assay following CEETOX exposure."}, "CEETOX_H295R_PROG_up": {"Train": {"roc_auc": 0.9051138043156961, "threshold": -0.07976586157614562}, "Val": {"roc_auc": 0.8582788347205708, "threshold": -0.4189637258604124}, "Test": {"roc_auc": 0.6641207492271322, "threshold": 0.46203873894952086}, "description": "Indicates upregulation of Progesterone in the H295R assay after CEETOX study exposure."}, "CEETOX_H295R_TESTO_dn": {"Train": {"roc_auc": 0.8435184916084372, "threshold": 0.6639260601353003}, "Val": {"roc_auc": 0.7022318998366902, "threshold": -0.013871300327885194}, "Test": {"roc_auc": 0.4957740213523132, "threshold": -0.7118980686466498}, "description": "Represents downregulation of Testosterone in H295R assay due to CEETOX study exposure."}, "CLD_ABCB1_48hr": {"Train": {"roc_auc": 0.968932535046729, "threshold": 0.12229540183379406}, "Val": {"roc_auc": 0.7829820452771272, "threshold": -1.1748643941707435}, "Test": {"roc_auc": 0.9426900584795322, "threshold": -1.259415338705252}, "description": "Indicates the reaction or expression level of ABCB1 gene in a Cellular Level Detection (CLD) assay after 48 hours."}, "CLD_ABCG2_48hr": {"Train": {"roc_auc": 0.9160089642404755, "threshold": -0.09753213057646803}, "Val": {"roc_auc": 0.7231308411214954, "threshold": -1.9107687645130316}, "Test": {"roc_auc": 0.77953216374269, "threshold": -2.2030528783798227}, "description": "Shows the response of ABCG2 gene in a CLD assay at the 48-hour mark."}, "CLD_CYP1A1_24hr": {"Train": {"roc_auc": 0.9108327068678517, "threshold": 1.846277513780871}, "Val": {"roc_auc": 0.8505312868949233, "threshold": 1.1292194986009267}, "Test": {"roc_auc": 0.6630434782608695, "threshold": 1.3453160229626597}, "description": "Measures the expression or activity of the CYP1A1 gene in CLD assay at 24 hours."}, "CLD_CYP1A1_48hr": {"Train": {"roc_auc": 0.8957743362831858, "threshold": 1.8428103797309277}, "Val": {"roc_auc": 0.7749704840613931, "threshold": 0.6030564394083111}, "Test": {"roc_auc": 0.7076877234803337, "threshold": 0.8886193341321063}, "description": "Measures the expression or activity of the CYP1A1 gene in CLD assay at 48 hours."}, "CLD_CYP1A1_6hr": {"Train": {"roc_auc": 0.8679687799600768, "threshold": 1.1337866224684152}, "Val": {"roc_auc": 0.8891509433962264, "threshold": 0.6083120419098451}, "Test": {"roc_auc": 0.5908547844031715, "threshold": 0.47334022827453914}, "description": "Indicates the response of the CYP1A1 gene in a CLD assay 6 hours post-exposure."}, "CLD_CYP1A2_24hr": {"Train": {"roc_auc": 0.9198690215088501, "threshold": 1.0877420737578696}, "Val": {"roc_auc": 0.8219428325811304, "threshold": 1.73400543067787}, "Test": {"roc_auc": 0.7047309552599758, "threshold": 0.009374375099891807}, "description": "Reflects the 24-hour response of the CYP1A2 gene in a CLD assay."}, "CLD_CYP1A2_48hr": {"Train": {"roc_auc": 0.894157113972191, "threshold": 1.3361611552424622}, "Val": {"roc_auc": 0.8204518430439952, "threshold": 0.8056646710759532}, "Test": {"roc_auc": 0.7369521511861681, "threshold": -0.19733252205528906}, "description": "Reflects the 48-hour response of the CYP1A2 gene in a CLD assay."}, "CLD_CYP1A2_6hr": {"Train": {"roc_auc": 0.9292916666666667, "threshold": 0.6525361373259848}, "Val": {"roc_auc": 0.925942285041225, "threshold": 0.5474210334373071}, "Test": {"roc_auc": 0.6723754448398576, "threshold": -0.6132657243921473}, "description": "Indicates the reaction of the CYP1A2 gene 6 hours into a CLD assay."}, "CLD_CYP2B6_24hr": {"Train": {"roc_auc": 0.8330817195658968, "threshold": 2.860695635592256}, "Val": {"roc_auc": 0.7408590963139121, "threshold": 2.8408572881429395}, "Test": {"roc_auc": 0.6458207376058042, "threshold": 1.3088079047751977}, "description": "Monitors the activity or expression of CYP2B6 gene in a CLD assay after 24 hours."}, "CLD_CYP2B6_48hr": {"Train": {"roc_auc": 0.897607889902343, "threshold": 1.4565562934608192}, "Val": {"roc_auc": 0.7664982164090369, "threshold": 1.9452312121520174}, "Test": {"roc_auc": 0.7064827801153187, "threshold": 1.109532123810058}, "description": "Shows the activity or expression of CYP2B6 gene in CLD assay 48 hours post-exposure."}, "CLD_CYP2B6_6hr": {"Train": {"roc_auc": 0.8807876625950346, "threshold": 2.3465843429794546}, "Val": {"roc_auc": 0.8296918767507002, "threshold": 2.9624659339706225}, "Test": {"roc_auc": 0.7699757869249394, "threshold": 1.9217802726470667}, "description": "Indicates the response of CYP2B6 gene in a CLD assay 6 hours after treatment."}, "CLD_CYP3A4_24hr": {"Train": {"roc_auc": 0.8675490929988129, "threshold": 0.7906279513785792}, "Val": {"roc_auc": 0.6980495807510025, "threshold": 0.6273289397433475}, "Test": {"roc_auc": 0.7136467651341794, "threshold": 1.3460745515527428}, "description": "Represents the 24-hour response of the CYP3A4 gene in a CLD study."}, "CLD_CYP3A4_48hr": {"Train": {"roc_auc": 0.8620990751672571, "threshold": 1.1317424898271682}, "Val": {"roc_auc": 0.723511712873415, "threshold": 0.8802924411552207}, "Test": {"roc_auc": 0.7237186043868621, "threshold": 0.8256469574776499}, "description": "Details the expression or activity of the CYP3A4 gene in a CLD assay at the 48-hour mark."}, "CLD_CYP3A4_6hr": {"Train": {"roc_auc": 0.8853635919960956, "threshold": -0.783507470254067}, "Val": {"roc_auc": 0.8188405797101449, "threshold": -0.7198076805433598}, "Test": {"roc_auc": 0.7837908496732027, "threshold": -0.5667661556133163}, "description": "Reflects the 6-hour activity or expression level of CYP3A4 in a CLD assay."}, "CLD_GSTA2_48hr": {"Train": {"roc_auc": 0.8542741559264442, "threshold": -0.26081014562536176}, "Val": {"roc_auc": 0.4067135050741608, "threshold": -1.2919360543633838}, "Test": {"roc_auc": 0.6676814988290398, "threshold": -1.9838992835761786}, "description": "Indicates the response of GSTA2 gene in CLD assay at 48 hours post-exposure."}, "CLD_SULT2A_24hr": {"Train": {"roc_auc": 0.8234330161026013, "threshold": 2.02645022160298}, "Val": {"roc_auc": 0.4012490241998438, "threshold": -4.092582462070224}, "Test": {"roc_auc": 0.6008566978193146, "threshold": -2.3670344037694613}, "description": "Measures the 24-hour activity or response of the SULT2A gene in a CLD assay."}, "CLD_SULT2A_48hr": {"Train": {"roc_auc": 0.8337261586126388, "threshold": -1.0367109195606128}, "Val": {"roc_auc": 0.5645539906103286, "threshold": -2.743843743750999}, "Test": {"roc_auc": 0.7619883040935672, "threshold": -0.9467854886441618}, "description": "Represents the 48-hour activity of SULT2A in a CLD assay."}, "CLD_UGT1A1_24hr": {"Train": {"roc_auc": 0.9634464349087318, "threshold": -0.4443796747797606}, "Val": {"roc_auc": 0.7708578143360753, "threshold": -0.28068500094943616}, "Test": {"roc_auc": 0.8016431924882629, "threshold": -0.6812906378024328}, "description": "Shows the expression or activity level of the UGT1A1 gene in a CLD assay after 24 hours."}, "CLD_UGT1A1_48hr": {"Train": {"roc_auc": 0.9394556824344772, "threshold": 0.23241906302111204}, "Val": {"roc_auc": 0.8129107981220658, "threshold": 1.1690187215566397}, "Test": {"roc_auc": 0.7577725304998032, "threshold": -0.9307148475666063}, "description": "Details the expression of UGT1A1 gene 48 hours post-exposure in a CLD study."}, "NCCT_HEK293T_CellTiterGLO": {"Train": {"roc_auc": 0.8023272924298191, "threshold": 4.380125461994588}, "Val": {"roc_auc": 0.6795833333333333, "threshold": 4.125863597915695}, "Test": {"roc_auc": 0.6765272835112693, "threshold": 3.9263895949324574}, "description": "Indicates the CellTiterGLO response in HEK293T cells under the National Center for Computational Toxicology (NCCT) guidelines."}, "NCCT_QuantiLum_inhib_2_dn": {"Train": {"roc_auc": 0.8849073149555025, "threshold": 0.874577851624819}, "Val": {"roc_auc": 0.7988731656184486, "threshold": 0.14349216455453817}, "Test": {"roc_auc": 0.6672131147540984, "threshold": 0.7077365241370517}, "description": "Reflects downregulation or inhibition in the QuantiLum assay under NCCT, type 2."}, "NCCT_QuantiLum_inhib_dn": {"Train": {"roc_auc": 0.8298804703569073, "threshold": 1.426382456694518}, "Val": {"roc_auc": 0.786479250334672, "threshold": 0.8992762026247441}, "Test": {"roc_auc": 0.7599699828473413, "threshold": 2.117132696661505}, "description": "Indicates downregulation or inhibition in the QuantiLum assay under NCCT guidelines."}, "NCCT_TPO_AUR_dn": {"Train": {"roc_auc": 0.7303201704898523, "threshold": 3.302629097087963}, "Val": {"roc_auc": 0.6701637972262076, "threshold": 2.5330007169339748}, "Test": {"roc_auc": 0.6825814536340852, "threshold": 3.0416465335422087}, "description": "Reflects downregulation in the Thyroid Peroxidase (TPO) assay with aurora kinase exposure under NCCT guidelines."}, "NCCT_TPO_GUA_dn": {"Train": {"roc_auc": 0.6954987505909368, "threshold": 2.5567436046428504}, "Val": {"roc_auc": 0.41520467836257313, "threshold": 0.02945605126229145}, "Test": {"roc_auc": 0.44080996884735196, "threshold": -0.10453528613299579}, "description": "Indicates downregulation in the TPO assay with guanylate kinase exposure under NCCT guidelines."}, "NHEERL_ZF_144hpf_TERATOSCORE_up": {"Train": {"roc_auc": 0.8349551282051282, "threshold": 3.5298060253933734}, "Val": {"roc_auc": 0.7364232209737828, "threshold": 1.5521259823360953}, "Test": {"roc_auc": 0.733133574551485, "threshold": 2.5789555429338336}, "description": "Represents upregulation in the TERATOSCORE assay in Zebrafish (ZF) at 144 hours post-fertilization, as per NHEERL guidelines."}, "NVS_ADME_hCYP19A1": {"Train": {"roc_auc": 0.7813441042251579, "threshold": 0.6822817160918548}, "Val": {"roc_auc": 0.7065716547901821, "threshold": -0.3270775245593951}, "Test": {"roc_auc": 0.8569751844399732, "threshold": 0.5696878781667101}, "description": "Represents the interaction or modulation of human CYP19A1 enzyme under the NVS ADME assay guidelines."}, "NVS_ADME_hCYP1A1": {"Train": {"roc_auc": 0.9232004650340536, "threshold": 1.889727370994347}, "Val": {"roc_auc": 0.7013754566946057, "threshold": 2.8361629859821225}, "Test": {"roc_auc": 0.8415783274440518, "threshold": 1.9215198026166433}, "description": "Details the interaction or response of human CYP1A1 enzyme in the NVS ADME study."}, "NVS_ADME_hCYP1A2": {"Train": {"roc_auc": 0.8713971531199045, "threshold": 1.9852645700280966}, "Val": {"roc_auc": 0.7476961950059453, "threshold": 2.094303927264056}, "Test": {"roc_auc": 0.6336743772241993, "threshold": 3.3223514685759667}, "description": "Indicates the activity or modulation of human CYP1A2 enzyme in the NVS ADME assay."}, "NVS_ADME_hCYP2A6": {"Train": {"roc_auc": 0.9624159110851126, "threshold": 0.7876755884579101}, "Val": {"roc_auc": 0.7650273224043715, "threshold": 0.8489837775359277}, "Test": {"roc_auc": 0.9148191365227538, "threshold": -0.03131884461766621}, "description": "Measures the response or interaction of human CYP2A6 enzyme as per NVS ADME guidelines."}, "NVS_ADME_hCYP2B6": {"Train": {"roc_auc": 0.8225541763096992, "threshold": 3.2452081674570072}, "Val": {"roc_auc": 0.5581585227986434, "threshold": 3.680749026862709}, "Test": {"roc_auc": 0.6609602518693427, "threshold": 3.5568532184795574}, "description": "Represents the interaction or modulation of human CYP2B6 enzyme in the NVS ADME assay."}, "NVS_ADME_hCYP2C19": {"Train": {"roc_auc": 0.7920301379489115, "threshold": 2.375047570114975}, "Val": {"roc_auc": 0.6790391676866585, "threshold": 2.1497018313384033}, "Test": {"roc_auc": 0.6968875677566009, "threshold": 2.9944892817431388}, "description": "Details the response of human CYP2C19 enzyme under the NVS ADME study guidelines."}, "NVS_ADME_hCYP2C9": {"Train": {"roc_auc": 0.7321859005040772, "threshold": 7.141493488957098}, "Val": {"roc_auc": 0.5923694779116466, "threshold": 5.548037851178968}, "Test": {"roc_auc": 0.649994569349408, "threshold": 5.3281524236257125}, "description": "Indicates the modulation or activity of human CYP2C9 enzyme in the NVS ADME assay."}, "NVS_ADME_hCYP2D6": {"Train": {"roc_auc": 0.876904152192918, "threshold": 5.417746019792986}, "Val": {"roc_auc": 0.7074371126503828, "threshold": 3.0187157104919855}, "Test": {"roc_auc": 0.8269729093050648, "threshold": 4.137603433759841}, "description": "Represents the interaction or activity of human CYP2D6 enzyme in the NVS ADME study."}, "NVS_ADME_hCYP3A4": {"Train": {"roc_auc": 0.867143537904673, "threshold": 0.7605833362888648}, "Val": {"roc_auc": 0.700633412509897, "threshold": -0.46919748040887566}, "Test": {"roc_auc": 0.7786304604486423, "threshold": 0.4336513828586881}, "description": "Indicates the response or modulation of human CYP3A4 enzyme as per NVS ADME guidelines."}, "NVS_ADME_hCYP4F12": {"Train": {"roc_auc": 0.718139619883041, "threshold": 4.426791695145157}, "Val": {"roc_auc": 0.2511723329425557, "threshold": -2.158174488995526}, "Test": {"roc_auc": 0.312280701754386, "threshold": -2.9216861896686726}, "description": "Measures the interaction or modulation of human CYP4F12 enzyme in the NVS ADME assay."}, "NVS_ADME_rCYP2C12": {"Train": {"roc_auc": 0.9618507990410236, "threshold": 2.548735350817889}, "Val": {"roc_auc": 0.875438596491228, "threshold": 1.522910740998415}, "Test": {"roc_auc": 0.9906213364595545, "threshold": 1.7904270103385862}, "description": "Details the response or interaction of rat CYP2C12 enzyme under the NVS ADME guidelines."}, "NVS_ENZ_hAChE": {"Train": {"roc_auc": 0.7779608431597197, "threshold": 2.310129590936609}, "Val": {"roc_auc": 0.7255868544600939, "threshold": 2.0884845149409665}, "Test": {"roc_auc": 0.5861826697892272, "threshold": 2.7761696752485223}, "description": "Indicates the modulation or interaction with human Acetylcholinesterase enzyme in the NVS enzyme study."}, "NVS_ENZ_hAMPKa1": {"Train": {"roc_auc": 0.8788352001438023, "threshold": 4.254080790537852}, "Val": {"roc_auc": 0.8326494724501758, "threshold": 1.2395722548644228}, "Test": {"roc_auc": 0.8073099415204679, "threshold": -1.74849234639226}, "description": "Reflects the activity or modulation of human AMPK alpha-1 enzyme in the NVS enzyme assay."}, "NVS_ENZ_hAurA": {"Train": {"roc_auc": 0.9212642042176044, "threshold": 2.3333117520367654}, "Val": {"roc_auc": 0.8668224299065421, "threshold": -0.191869815906605}, "Test": {"roc_auc": 0.817367601246106, "threshold": -0.5257899338776646}, "description": "Indicates the response or interaction of human Aurora A kinase in the NVS enzyme study."}, "NVS_ENZ_hBACE": {"Train": {"roc_auc": 0.8536772929112718, "threshold": 3.7329866907618054}, "Val": {"roc_auc": 0.5277240490006447, "threshold": 0.8307037196001845}, "Test": {"roc_auc": 0.7402597402597402, "threshold": 0.8244133511105103}, "description": "Details the modulation or activity of human Beta-Secretase enzyme in the NVS enzyme assay."}, "NVS_ENZ_hCASP5": {"Train": {"roc_auc": 0.917701317715959, "threshold": 2.6066460079616967}, "Val": {"roc_auc": 0.5812206572769953, "threshold": 2.128437741024716}, "Test": {"roc_auc": 0.9585764294049007, "threshold": 2.7332829627188833}, "description": "Measures the response or interaction of human Caspase 5 enzyme as per NVS enzyme guidelines."}, "NVS_ENZ_hCK1D": {"Train": {"roc_auc": 0.8423684210526314, "threshold": 1.3973744357073743}, "Val": {"roc_auc": 0.473915592028136, "threshold": -0.874467853549961}, "Test": {"roc_auc": 0.704225352112676, "threshold": 0.8553824300641892}, "description": "Indicates the activity or modulation of human Casein Kinase 1 Delta in the NVS enzyme study."}, "NVS_ENZ_hDUSP3": {"Train": {"roc_auc": 0.8501425622480177, "threshold": 4.012344361306192}, "Val": {"roc_auc": 0.5243697478991597, "threshold": 3.108863444418998}, "Test": {"roc_auc": 0.7116060961313013, "threshold": 2.079125100069934}, "description": "Reflects the response or modulation of human Dual Specificity Phosphatase 3 in the NVS enzyme assay."}, "NVS_ENZ_hES": {"Train": {"roc_auc": 0.8381966764339089, "threshold": 3.502983156267229}, "Val": {"roc_auc": 0.7631757329266226, "threshold": 3.236762470669216}, "Test": {"roc_auc": 0.9231372549019609, "threshold": 2.645624684857892}, "description": "Indicates the interaction or response of human Estrogen enzyme in the NVS enzyme study."}, "NVS_ENZ_hElastase": {"Train": {"roc_auc": 0.8927105241705389, "threshold": 3.751048832445651}, "Val": {"roc_auc": 0.7375586854460094, "threshold": 3.0917700737923592}, "Test": {"roc_auc": 0.8935672514619883, "threshold": 3.487177084635448}, "description": "Details the modulation or activity of human Elastase enzyme as per NVS enzyme guidelines."}, "NVS_ENZ_hFGFR1": {"Train": {"roc_auc": 0.9345536753343381, "threshold": 3.885133850681889}, "Val": {"roc_auc": 0.7819460726846424, "threshold": 1.065761618666702}, "Test": {"roc_auc": 0.8695482866043613, "threshold": 0.12310386348415037}, "description": "Indicates the response or interaction of human Fibroblast Growth Factor Receptor 1 in the NVS enzyme assay."}, "NVS_ENZ_hGSK3b": {"Train": {"roc_auc": 0.8983991228070176, "threshold": 0.9596034442340295}, "Val": {"roc_auc": 0.7380952380952381, "threshold": -1.237294038375457}, "Test": {"roc_auc": 0.48018648018648014, "threshold": -2.20683636822858}, "description": "Measures the modulation or activity of human Glycogen Synthase Kinase 3 Beta in the NVS enzyme study."}, "NVS_ENZ_hMMP1": {"Train": {"roc_auc": 0.8357945945466086, "threshold": 3.1540629026052116}, "Val": {"roc_auc": 0.910105757931845, "threshold": 1.965330151108292}, "Test": {"roc_auc": 0.8524590163934426, "threshold": 2.388048293712261}, "description": "Represents the response or interaction of human Matrix Metallopeptidase 1 in the NVS enzyme assay."}, "NVS_ENZ_hMMP13": {"Train": {"roc_auc": 0.83954577017369, "threshold": 2.8713166663596574}, "Val": {"roc_auc": 0.8521008403361345, "threshold": 3.068579520549144}, "Test": {"roc_auc": 0.8801140174379611, "threshold": 2.7274888936463775}, "description": "Indicates the modulation or interaction with human Matrix Metallopeptidase 13 as measured in the NVS enzyme assay."}, "NVS_ENZ_hMMP2": {"Train": {"roc_auc": 0.8228178493050475, "threshold": 2.62606362609176}, "Val": {"roc_auc": 0.5917840375586855, "threshold": -0.893766007981859}, "Test": {"roc_auc": 0.672599531615925, "threshold": 2.1451845169067383}, "description": "Details the response or activity of human Matrix Metallopeptidase 2 under the NVS enzyme study."}, "NVS_ENZ_hMMP3": {"Train": {"roc_auc": 0.9378896410380668, "threshold": 2.7766493595875534}, "Val": {"roc_auc": 0.6635441061670571, "threshold": -0.9241043526131114}, "Test": {"roc_auc": 0.8477246207701283, "threshold": -0.0006325509813098762}, "description": "Describes the interaction or modulation of human Matrix Metallopeptidase 3 in the context of the NVS enzyme assay."}, "NVS_ENZ_hMMP7": {"Train": {"roc_auc": 0.9081528316848212, "threshold": 0.7301276018908309}, "Val": {"roc_auc": 0.6957796014067995, "threshold": 0.4129130408331916}, "Test": {"roc_auc": 0.660233918128655, "threshold": -1.2922545338536167}, "description": "Represents the activity or modulation of human Matrix Metallopeptidase 7 as measured in the NVS enzyme study."}, "NVS_ENZ_hMMP9": {"Train": {"roc_auc": 0.8035376251268305, "threshold": 2.5207763162103145}, "Val": {"roc_auc": 0.562867215041128, "threshold": 1.9266394151223674}, "Test": {"roc_auc": 0.5845029239766082, "threshold": 1.9168863547098889}, "description": "Captures the response or interaction of human Matrix Metallopeptidase 9 as per NVS enzyme guidelines."}, "NVS_ENZ_hPDE10": {"Train": {"roc_auc": 0.9271959316504974, "threshold": 2.8785514874501263}, "Val": {"roc_auc": 0.5478971962616823, "threshold": -1.366721574966614}, "Test": {"roc_auc": 0.7157092614302462, "threshold": 1.1033064715258467}, "description": "Indicates the activity or modulation of human Phosphodiesterase 10 in the NVS enzyme assay."}, "NVS_ENZ_hPDE4A1": {"Train": {"roc_auc": 0.8991102811950791, "threshold": 0.4970181950100425}, "Val": {"roc_auc": 0.842020023557126, "threshold": 0.41615383951990914}, "Test": {"roc_auc": 0.566983749504558, "threshold": 0.4223631316119123}, "description": "Reflects the response or modulation of human Phosphodiesterase 4A1 in the NVS enzyme study."}, "NVS_ENZ_hPDE5": {"Train": {"roc_auc": 0.8011649822166423, "threshold": 0.8283585127409507}, "Val": {"roc_auc": 0.43492343934040045, "threshold": -0.7925977179476686}, "Test": {"roc_auc": 0.4192753001715266, "threshold": -1.0699048161625981}, "description": "Denotes the interaction or activity of human Phosphodiesterase 5 under the NVS enzyme study guidelines."}, "NVS_ENZ_hPI3Ka": {"Train": {"roc_auc": 0.9557718793038688, "threshold": 2.9874674617587864}, "Val": {"roc_auc": 0.8483568075117371, "threshold": -0.4279750074829538}, "Test": {"roc_auc": 0.9463869463869464, "threshold": -0.11843469216897606}, "description": "Signifies the modulation or response of human Phosphoinositide 3-Kinase alpha as per the NVS enzyme assay."}, "NVS_ENZ_hPTEN": {"Train": {"roc_auc": 0.9269858104154476, "threshold": 1.438684684020263}, "Val": {"roc_auc": 0.453755868544601, "threshold": -2.09192404112181}, "Test": {"roc_auc": 0.33080513418903146, "threshold": -3.085267740446287}, "description": "Describes the interaction or modulation of human Phosphatase and tensin homolog in the NVS enzyme study."}, "NVS_ENZ_hPTPN11": {"Train": {"roc_auc": 0.87466143059066, "threshold": 1.4389353438063308}, "Val": {"roc_auc": 0.46374269005847957, "threshold": -1.4869358145796858}, "Test": {"roc_auc": 0.7832167832167832, "threshold": -1.3484704702108115}, "description": "Measures the response or activity of human Protein Tyrosine Phosphatase N11 in the NVS enzyme assay."}, "NVS_ENZ_hPTPN12": {"Train": {"roc_auc": 0.867301641034321, "threshold": 3.4939222230806255}, "Val": {"roc_auc": 0.6092896174863388, "threshold": -0.6045787055213174}, "Test": {"roc_auc": 0.4552180685358255, "threshold": 0.6460852694583012}, "description": "Reflects the modulation or interaction with human Protein Tyrosine Phosphatase N12 as studied under NVS enzyme guidelines."}, "NVS_ENZ_hPTPN13": {"Train": {"roc_auc": 0.8633602910130241, "threshold": 2.13899051964104}, "Val": {"roc_auc": 0.9492583918813426, "threshold": 1.2044221717674093}, "Test": {"roc_auc": 0.5007788161993769, "threshold": 0.3542591515962066}, "description": "Indicates the response or activity of human Protein Tyrosine Phosphatase N13 as per the NVS enzyme study."}, "NVS_ENZ_hPTPN9": {"Train": {"roc_auc": 0.8119981599197056, "threshold": 2.558790778731918}, "Val": {"roc_auc": 0.34462616822429903, "threshold": -1.1613306469387479}, "Test": {"roc_auc": 0.7745327102803738, "threshold": 1.03426894960222}, "description": "Details the interaction or modulation of human Protein Tyrosine Phosphatase N9 in the context of the NVS enzyme assay."}, "NVS_ENZ_hPTPRC": {"Train": {"roc_auc": 0.9071511955648472, "threshold": 4.13327261730954}, "Val": {"roc_auc": 0.8936915887850467, "threshold": 1.474771380782486}, "Test": {"roc_auc": 0.6099415204678363, "threshold": -0.5636568613596511}, "description": "Captures the modulation or response of human Protein Tyrosine Phosphatase Receptor Type C as studied in the NVS enzyme assay."}, "NVS_ENZ_hSIRT1": {"Train": {"roc_auc": 0.8377449546651068, "threshold": 4.354786661890772}, "Val": {"roc_auc": 0.5460140679953107, "threshold": -1.5072846335095083}, "Test": null, "description": "Signifies the interaction or activity of human Sirtuin 1 in the NVS enzyme study."}, "NVS_ENZ_hSIRT2": {"Train": {"roc_auc": 0.9313119811661883, "threshold": 1.4391751456427748}, "Val": {"roc_auc": 0.6215962441314554, "threshold": 0.7194808620113031}, "Test": {"roc_auc": 0.7288056206088993, "threshold": -1.0541960195497468}, "description": "Details the response or modulation of human Sirtuin 2 under the NVS enzyme guidelines."}, "NVS_ENZ_hTrkA": {"Train": {"roc_auc": 0.9398607866043613, "threshold": 2.436411386018282}, "Val": {"roc_auc": 0.8279342723004695, "threshold": 0.9714349669379159}, "Test": {"roc_auc": 0.8476608187134503, "threshold": 1.0587171606115398}, "description": "Describes the activity or interaction of human Tropomyosin receptor kinase A in the context of the NVS enzyme study."}, "NVS_ENZ_hVEGFR2": {"Train": {"roc_auc": 0.9499187662789798, "threshold": 2.7897131731798943}, "Val": {"roc_auc": 0.7485311398354876, "threshold": -0.946144028110905}, "Test": {"roc_auc": 0.8962703962703963, "threshold": -0.3952364076723205}, "description": "Indicates the modulation or interaction with human Vascular Endothelial Growth Factor Receptor 2 as per the NVS enzyme assay."}, "NVS_ENZ_oCOX1": {"Train": {"roc_auc": 0.7586913528297917, "threshold": 4.007875579016822}, "Val": {"roc_auc": 0.904705882352941, "threshold": 3.1671165088275526}, "Test": {"roc_auc": 0.6936619718309859, "threshold": 2.6045986797000555}, "description": "Denotes the response or activity of ovine Cyclooxygenase 1 under the NVS enzyme study guidelines."}, "NVS_ENZ_oCOX2": {"Train": {"roc_auc": 0.769555198622659, "threshold": 2.6668990295570527}, "Val": {"roc_auc": 0.8247663551401869, "threshold": 1.5964592168996998}, "Test": {"roc_auc": 0.5862573099415205, "threshold": 2.1257321541015806}, "description": "Captures the interaction or modulation of ovine Cyclooxygenase 2 in the NVS enzyme assay."}, "NVS_ENZ_rAChE": {"Train": {"roc_auc": 0.8297588561673068, "threshold": 3.126320351590146}, "Val": {"roc_auc": 0.7801169590643275, "threshold": 2.7945379805159165}, "Test": {"roc_auc": 0.6557632398753894, "threshold": 2.8486603337365226}, "description": "Reflects the modulation or interaction with rat Acetylcholinesterase as measured in the NVS enzyme study."}, "NVS_ENZ_rCNOS": {"Train": {"roc_auc": 0.7824627801940448, "threshold": 1.7042886630908871}, "Val": {"roc_auc": 0.4251173708920188, "threshold": -0.3768954377274616}, "Test": {"roc_auc": 0.5218835482610394, "threshold": 1.0721954177688424}, "description": "Details the response or activity of rat Constitutive Nitric Oxide Synthase in the context of the NVS enzyme assay."}, "NVS_ENZ_rMAOAC": {"Train": {"roc_auc": 0.8253186421053631, "threshold": 2.492392395351742}, "Val": {"roc_auc": 0.6719077568134172, "threshold": 2.6789615023004876}, "Test": {"roc_auc": 0.6206583015093654, "threshold": 3.0755093968785676}, "description": "Describes the interaction or modulation of rat Monoamine Oxidase A in its cytoplasmic form under the NVS enzyme guidelines."}, "NVS_ENZ_rMAOAP": {"Train": {"roc_auc": 0.8660360341464438, "threshold": 5.431953473134085}, "Val": {"roc_auc": 0.76, "threshold": 5.247152471685553}, "Test": {"roc_auc": 0.8290246768507639, "threshold": 4.326314069367982}, "description": "Signifies the response or modulation of rat Monoamine Oxidase A in its plasma membrane-bound form according to the NVS enzyme assay."}, "NVS_ENZ_rMAOBC": {"Train": {"roc_auc": 0.8287611809153176, "threshold": 3.8031313440821197}, "Val": {"roc_auc": 0.6311837455830389, "threshold": 3.6362340132872744}, "Test": {"roc_auc": 0.5177856301531213, "threshold": 2.4067031432677792}, "description": "Indicates the activity or interaction of rat Monoamine Oxidase B in its cytoplasmic form, as measured in the NVS enzyme study."}, "NVS_ENZ_rMAOBP": {"Train": {"roc_auc": 0.7348159342001888, "threshold": 2.194929024120709}, "Val": {"roc_auc": 0.5279088050314465, "threshold": 0.28826615044304527}, "Test": {"roc_auc": 0.4347826086956522, "threshold": 0.5961332681539422}, "description": "Details the modulation or interaction with rat Monoamine Oxidase B in its plasma membrane-bound variant under NVS enzyme guidelines."}, "NVS_ENZ_rabI2C": {"Train": {"roc_auc": 0.8720711669283098, "threshold": 2.543413780831002}, "Val": {"roc_auc": 0.7078991596638655, "threshold": 2.0306870467192653}, "Test": {"roc_auc": 0.7519677292404565, "threshold": 2.8752537012338877}, "description": "Captures the response or activity of rabbit Isoform 2 of enzyme (specific enzyme to be determined based on actual context) in the NVS enzyme assay."}, "NVS_GPCR_bAdoR_NonSelective": {"Train": {"roc_auc": 0.9249925278694571, "threshold": 2.1513532002766924}, "Val": {"roc_auc": 0.6840562719812427, "threshold": 2.962953100214013}, "Test": {"roc_auc": 0.5209048027444254, "threshold": 1.6162986340107501}, "description": "Denotes the interaction or modulation of a non-selective beta Adenosine Receptor as studied in the NVS GPCR assay."}, "NVS_GPCR_bDR_NonSelective": {"Train": {"roc_auc": 0.9700643950176567, "threshold": 7.1490539688247825}, "Val": {"roc_auc": 0.7713486454652532, "threshold": 2.543891488610802}, "Test": {"roc_auc": 0.9562060889929742, "threshold": 3.4365156248167104}, "description": "Reflects the activity or interaction with a non-selective beta Dopamine Receptor under the NVS GPCR study guidelines."}, "NVS_GPCR_g5HT4": {"Train": {"roc_auc": 0.9360042749315342, "threshold": 4.023155536976185}, "Val": {"roc_auc": 0.7908224076281287, "threshold": 3.2887020893879715}, "Test": {"roc_auc": 0.8458284140102321, "threshold": 3.36119477670114}, "description": "Indicates the modulation or response of gamma 5-Hydroxytryptamine Receptor 4 as per the NVS GPCR assay."}, "NVS_GPCR_gH2": {"Train": {"roc_auc": 0.920303019181836, "threshold": 5.406586913375168}, "Val": {"roc_auc": 0.7909270216962525, "threshold": 3.4089948636991476}, "Test": {"roc_auc": 0.8424619253877322, "threshold": 3.331395585496386}, "description": "Describes the interaction or activity of gamma Histamine 2 Receptor in the NVS GPCR study."}, "NVS_GPCR_gLTB4": {"Train": {"roc_auc": 0.8538165995463592, "threshold": 2.335893830021581}, "Val": {"roc_auc": 0.569775678866588, "threshold": 0.40206976624222523}, "Test": {"roc_auc": 0.5250585480093677, "threshold": 1.713988286954863}, "description": "Signifies the response or modulation of gamma Leukotriene B4 Receptor as measured in the NVS GPCR assay."}, "NVS_GPCR_gLTD4": {"Train": {"roc_auc": 0.9079051961513758, "threshold": 2.502588727452734}, "Val": {"roc_auc": 0.8070175438596491, "threshold": 0.7467915703942465}, "Test": {"roc_auc": 0.6343457943925234, "threshold": -0.36691134541600334}, "description": "Details the interaction or activity of gamma Leukotriene D4 Receptor under the NVS GPCR guidelines."}, "NVS_GPCR_gMPeripheral_NonSelective": {"Train": {"roc_auc": 0.9218620643213931, "threshold": 5.312607048271415}, "Val": {"roc_auc": 0.7623038899634644, "threshold": 2.31973371563015}, "Test": {"roc_auc": 0.9121568627450981, "threshold": 2.4080580977706223}, "description": "Denotes the modulation or interaction with a non-selective gamma Muscarinic Peripheral Receptor as per NVS GPCR study."}, "NVS_GPCR_gOpiateK": {"Train": {"roc_auc": 0.8896846490582695, "threshold": 5.0058273180827}, "Val": {"roc_auc": 0.7800475059382422, "threshold": 3.8493033768059135}, "Test": {"roc_auc": 0.7390434624477178, "threshold": 3.4144080394023177}, "description": "Indicates the response or activity of gamma Opiate K Receptor in the context of the NVS GPCR assay."}, "NVS_GPCR_h5HT2A": {"Train": {"roc_auc": 0.9569205296341728, "threshold": 5.222384248529231}, "Val": {"roc_auc": 0.7520661157024794, "threshold": 5.939781224286115}, "Test": {"roc_auc": 0.9011457109283196, "threshold": 3.395570536394855}, "description": "Describes the interaction or activity of human 5-Hydroxytryptamine Receptor 2A as per the NVS GPCR assay."}, "NVS_GPCR_h5HT5A": {"Train": {"roc_auc": 0.9282792841112366, "threshold": 5.399170840228045}, "Val": {"roc_auc": 0.6939068100358423, "threshold": 1.8952276771133016}, "Test": {"roc_auc": 0.7435637663885578, "threshold": 2.220640245500628}, "description": "Indicates the modulation or response of human 5-Hydroxytryptamine Receptor 5A in the NVS GPCR assay context."}, "NVS_GPCR_h5HT6": {"Train": {"roc_auc": 0.9178751037546995, "threshold": 5.121459640182174}, "Val": {"roc_auc": 0.7809320437131013, "threshold": 2.8028079024306294}, "Test": {"roc_auc": 0.8624295326422986, "threshold": 3.1649653727824507}, "description": "Captures the response or activity of human 5-Hydroxytryptamine Receptor 6 according to the NVS GPCR assay."}, "NVS_GPCR_h5HT7": {"Train": {"roc_auc": 0.8317602554654876, "threshold": 6.224714756011963}, "Val": {"roc_auc": 0.6072359503701388, "threshold": 4.09148089090983}, "Test": {"roc_auc": 0.6391332681655262, "threshold": 4.27295430501302}, "description": "Signifies the interaction or modulation of human 5-Hydroxytryptamine Receptor 7 as measured in the NVS GPCR study."}, "NVS_GPCR_hAT1": {"Train": {"roc_auc": 0.9594626680303916, "threshold": 4.817251574885738}, "Val": {"roc_auc": 0.8208430913348945, "threshold": 3.407407418862954}, "Test": {"roc_auc": 0.691948658109685, "threshold": 0.6675748037504361}, "description": "Reflects the activity or interaction with human Angiotensin II Receptor Type 1 under the NVS GPCR guidelines."}, "NVS_GPCR_hAdoRA1": {"Train": {"roc_auc": 0.8796281476739223, "threshold": 5.276057127359751}, "Val": {"roc_auc": 0.7191100516487883, "threshold": 2.015495566634444}, "Test": {"roc_auc": 0.6073096556967524, "threshold": 2.092194800143008}, "description": "Denotes the modulation or response of human Adenosine Receptor A1 as per the NVS GPCR study."}, "NVS_GPCR_hAdoRA2a": {"Train": {"roc_auc": 0.8349947599783961, "threshold": 3.4489065271478765}, "Val": {"roc_auc": 0.5931523022432114, "threshold": 1.085050864262624}, "Test": {"roc_auc": 0.6126382306477094, "threshold": 2.9321119183892597}, "description": "Details the response or interaction of human Adenosine Receptor A2a in the context of the NVS GPCR assay."}, "NVS_GPCR_hAdra2A": {"Train": {"roc_auc": 0.8799606084733689, "threshold": 5.199661494017363}, "Val": {"roc_auc": 0.7659853249475891, "threshold": 3.8937847067763256}, "Test": {"roc_auc": 0.7698468786808009, "threshold": 3.0688281875472887}, "description": "Captures the activity or modulation of human Adrenoceptor Alpha 2A according to the NVS GPCR study."}, "NVS_GPCR_hAdra2C": {"Train": {"roc_auc": 0.8952993545999717, "threshold": 4.9589383795454705}, "Val": {"roc_auc": 0.7189349112426034, "threshold": 4.725627589870143}, "Test": {"roc_auc": 0.8481042654028436, "threshold": 4.286966712386519}, "description": "Indicates the interaction or modulation of human Adrenoceptor Alpha 2C in the NVS GPCR assay."}, "NVS_GPCR_hAdrb1": {"Train": {"roc_auc": 0.9255185515622018, "threshold": 7.83720757080628}, "Val": {"roc_auc": 0.7615384615384615, "threshold": 4.112230619272074}, "Test": {"roc_auc": 0.8100157418339236, "threshold": 4.09336610599323}, "description": "Details the activity or interaction of human Beta-1 Adrenergic Receptor under the NVS GPCR study guidelines."}, "NVS_GPCR_hAdrb2": {"Train": {"roc_auc": 0.9372404626997604, "threshold": 7.572968958376407}, "Val": {"roc_auc": 0.6824085005903188, "threshold": 2.714704006641835}, "Test": {"roc_auc": 0.863011401743796, "threshold": 1.7049771901723503}, "description": "Signifies the response or modulation of human Beta-2 Adrenergic Receptor as measured by the NVS GPCR assay."}, "NVS_GPCR_hAdrb3": {"Train": {"roc_auc": 0.9131913995258046, "threshold": 6.701239823579073}, "Val": {"roc_auc": 0.6463700234192038, "threshold": 2.7551505887830583}, "Test": {"roc_auc": 0.9190058479532164, "threshold": 1.306172654435442}, "description": "Denotes the interaction or modulation of human Beta-3 Adrenergic Receptor as per the NVS GPCR guidelines."}, "NVS_GPCR_hDRD1": {"Train": {"roc_auc": 0.9118254304002354, "threshold": 5.653262409004004}, "Val": {"roc_auc": 0.6599286563614745, "threshold": 3.4053906540016268}, "Test": {"roc_auc": 0.8537455410225923, "threshold": 2.413424083301136}, "description": "Captures the activity or response of human Dopamine Receptor D1 according to NVS GPCR study."}, "NVS_GPCR_hDRD2s": {"Train": {"roc_auc": 0.9084829216597375, "threshold": 5.229162629540857}, "Val": {"roc_auc": 0.7197941409342834, "threshold": 1.1277366266832933}, "Test": {"roc_auc": 0.8209366391184573, "threshold": 1.7676920356215895}, "description": "Indicates the interaction or modulation of human Dopamine Receptor D2 short form in the NVS GPCR assay."}, "NVS_GPCR_hDRD4.4": {"Train": {"roc_auc": 0.94296274586427, "threshold": 5.77738652787767}, "Val": {"roc_auc": 0.6940393729493256, "threshold": 2.79410592070571}, "Test": {"roc_auc": 0.8622209165687427, "threshold": 3.506762985710626}, "description": "Details the modulation or activity of human Dopamine Receptor D4.4 under the NVS GPCR study guidelines."}, "NVS_GPCR_hH1": {"Train": {"roc_auc": 0.948186208705581, "threshold": 4.775564059122905}, "Val": {"roc_auc": 0.7387316561844863, "threshold": 4.518994707960983}, "Test": {"roc_auc": 0.8032979976442874, "threshold": 3.4097448431097117}, "description": "Reflects the interaction or response of human Histamine H1 Receptor according to the NVS GPCR assay."}, "NVS_GPCR_hLTB4_BLT1": {"Train": {"roc_auc": 0.9062408679135008, "threshold": 2.4802628040791035}, "Val": {"roc_auc": 0.48633879781420764, "threshold": -0.6403429143063653}, "Test": {"roc_auc": 0.5588006230529595, "threshold": -0.5876819727060436}, "description": "Captures the modulation or activity of human Leukotriene B4 Receptor BLT1 as per NVS GPCR guidelines."}, "NVS_GPCR_hM1": {"Train": {"roc_auc": 0.9461015175300889, "threshold": 5.360637744506439}, "Val": {"roc_auc": 0.692134107027724, "threshold": 3.3708685783294587}, "Test": {"roc_auc": 0.7437821612349913, "threshold": 5.260696024508089}, "description": "Signifies the response or interaction of human Muscarinic Acetylcholine Receptor M1 in the NVS GPCR study."}, "NVS_GPCR_hM2": {"Train": {"roc_auc": 0.8534027709755009, "threshold": 4.373250082090452}, "Val": {"roc_auc": 0.8065764023210832, "threshold": 3.9696465521842033}, "Test": {"roc_auc": 0.8161366313309776, "threshold": 2.725080989383243}, "description": "Indicates the modulation or activity of human Muscarinic Acetylcholine Receptor M2 as measured by the NVS GPCR assay."}, "NVS_GPCR_hM3": {"Train": {"roc_auc": 0.879245247664821, "threshold": 6.470267865750882}, "Val": {"roc_auc": 0.6390812978490703, "threshold": 4.306388320865574}, "Test": {"roc_auc": 0.8143698468786809, "threshold": 1.7883914178078832}, "description": "Details the interaction or modulation of human Muscarinic Acetylcholine Receptor M3 according to the NVS GPCR study guidelines."}, "NVS_GPCR_hM4": {"Train": {"roc_auc": 0.8701010002067892, "threshold": 4.387319798703427}, "Val": {"roc_auc": 0.7647856295543127, "threshold": 3.126940307674465}, "Test": {"roc_auc": 0.9039825422804146, "threshold": 3.057405061549969}, "description": "Captures the response or interaction of human Muscarinic Acetylcholine Receptor M4 in the NVS GPCR assay."}, "NVS_GPCR_hNK2": {"Train": {"roc_auc": 0.9279662472557157, "threshold": 2.594966166728252}, "Val": {"roc_auc": 0.7987455197132617, "threshold": 0.7664804587493075}, "Test": {"roc_auc": 0.8162140889413616, "threshold": 1.183988084783544}, "description": "Denotes the activity or modulation of human Neurokinin Receptor 2 as per NVS GPCR guidelines."}, "NVS_GPCR_hOpiate_D1": {"Train": {"roc_auc": 0.9391513417555712, "threshold": 5.379842358189183}, "Val": {"roc_auc": 0.7609727164887308, "threshold": -0.22334007744316597}, "Test": {"roc_auc": 0.8202479338842975, "threshold": 0.07165754163587401}, "description": "Reflects the modulation or interaction of human Opiate D1 Receptor in the context of the NVS GPCR study."}, "NVS_GPCR_hOpiate_mu": {"Train": {"roc_auc": 0.9171229457212073, "threshold": 2.7904150550429883}, "Val": {"roc_auc": 0.8416965352449224, "threshold": 1.690355804470089}, "Test": {"roc_auc": 0.8687954816987075, "threshold": 1.3210258584122752}, "description": "Indicates the response or activity of human Mu Opioid Receptor according to the NVS GPCR assay."}, "NVS_GPCR_hTXA2": {"Train": {"roc_auc": 0.8692781690140845, "threshold": 4.774676250862527}, "Val": {"roc_auc": 0.6446280991735537, "threshold": 4.045878445660627}, "Test": {"roc_auc": 0.641683433936955, "threshold": 2.32350535053868}, "description": "Details the interaction or activity of human Thromboxane A2 Receptor as measured by the NVS GPCR study."}, "NVS_GPCR_p5HT2C": {"Train": {"roc_auc": 0.8995363847563035, "threshold": 3.5552790868986346}, "Val": {"roc_auc": 0.8586860947117197, "threshold": 3.4271342799708897}, "Test": {"roc_auc": 0.9485898942420681, "threshold": 2.0712629696270373}, "description": "Describes the interaction or activity of presumably a porcine 5-Hydroxytryptamine Receptor 2C in the NVS GPCR assay."}, "NVS_GPCR_r5HT1_NonSelective": {"Train": {"roc_auc": 0.9481064665952126, "threshold": 4.3326464243479315}, "Val": {"roc_auc": 0.7279151943462898, "threshold": 2.067732363253146}, "Test": {"roc_auc": 0.6814641744548287, "threshold": 1.2843323684669485}, "description": "Details the non-selective interaction or response of rodent 5-Hydroxytryptamine Receptor 1 as per the NVS GPCR study."}, "NVS_GPCR_r5HT_NonSelective": {"Train": {"roc_auc": 0.965247574439612, "threshold": 6.656856544979581}, "Val": {"roc_auc": 0.7588652482269503, "threshold": 2.594964483717421}, "Test": {"roc_auc": 0.9109803921568628, "threshold": 1.723038720655012}, "description": "Denotes the non-selective modulation or activity of a rodent 5-Hydroxytryptamine Receptor in the NVS GPCR context."}, "NVS_GPCR_rAdra1B": {"Train": {"roc_auc": 0.9307584578207382, "threshold": 3.87852155553686}, "Val": {"roc_auc": 0.6884033613445378, "threshold": 3.9654343789284887}, "Test": {"roc_auc": 0.9449035812672175, "threshold": 2.9649523471568795}, "description": "Captures the response or interaction of rodent Adrenoceptor Alpha 1B based on the NVS GPCR assay guidelines."}, "NVS_GPCR_rAdra1_NonSelective": {"Train": {"roc_auc": 0.927321323960164, "threshold": 5.769880226066521}, "Val": {"roc_auc": 0.7535502958579882, "threshold": 3.77097166288603}, "Test": {"roc_auc": 0.941045751633987, "threshold": 4.208177187540629}, "description": "Reflects the non-selective interaction or activity of a rodent Adrenoceptor Alpha 1 in the NVS GPCR study."}, "NVS_GPCR_rAdra2_NonSelective": {"Train": {"roc_auc": 0.9426352821367403, "threshold": 8.64454654601959}, "Val": {"roc_auc": 0.7687394957983193, "threshold": 6.160984341924017}, "Test": {"roc_auc": 0.8531139835487661, "threshold": 3.9700804902268594}, "description": "Signifies the non-selective modulation or interaction of a rodent Adrenoceptor Alpha 2 as per NVS GPCR guidelines."}, "NVS_GPCR_rAdrb_NonSelective": {"Train": {"roc_auc": 0.9264638370685697, "threshold": 5.838528893731379}, "Val": {"roc_auc": 0.447538100820633, "threshold": 1.1883029899558988}, "Test": {"roc_auc": 0.7250585480093676, "threshold": 1.241261868863492}, "description": "Details the non-selective response or activity of a rodent Beta Adrenergic Receptor under the NVS GPCR assay."}, "NVS_GPCR_rNK1": {"Train": {"roc_auc": 0.9103912928001907, "threshold": 2.304244770779385}, "Val": {"roc_auc": 0.7943329397874852, "threshold": 1.5810525066501748}, "Test": {"roc_auc": 0.8581699346405228, "threshold": 0.17311919272482967}, "description": "Denotes the interaction or modulation of rodent Neurokinin Receptor 1 based on the NVS GPCR study."}, "NVS_GPCR_rNK3": {"Train": {"roc_auc": 0.8940497076023393, "threshold": 5.045037936877918}, "Val": {"roc_auc": 0.8443661971830986, "threshold": 2.762505531311035}, "Test": {"roc_auc": 0.6351246105919003, "threshold": 2.077342436239645}, "description": "Reflects the activity or modulation of rodent Neurokinin Receptor 3 according to the NVS GPCR assay."}, "NVS_GPCR_rOpiate_NonSelective": {"Train": {"roc_auc": 0.9067301536491678, "threshold": 5.074361632178137}, "Val": {"roc_auc": 0.767910225921522, "threshold": 3.299004748060897}, "Test": {"roc_auc": 0.8242817788272334, "threshold": 2.8808458087680577}, "description": "Captures the non-selective response or interaction of a rodent Opiate Receptor in the NVS GPCR context."}, "NVS_GPCR_rOpiate_NonSelectiveNa": {"Train": {"roc_auc": 0.9134875276800833, "threshold": 4.934464595935964}, "Val": {"roc_auc": 0.7345238095238096, "threshold": 2.691421861047143}, "Test": {"roc_auc": 0.7739079102715467, "threshold": 1.9932593884052814}, "description": "Indicates the non-selective modulation or activity of a rodent Opiate Receptor with a sodium channel component, as per the NVS GPCR study."}, "NVS_GPCR_rSST": {"Train": {"roc_auc": 0.6737948363423648, "threshold": 4.209900006875619}, "Val": {"roc_auc": 0.5019140164899882, "threshold": -0.010963470012217869}, "Test": {"roc_auc": 0.47309941520467835, "threshold": 0.14732510119945053}, "description": "Details the response or interaction of rodent Somatostatin Receptor based on the NVS GPCR guidelines."}, "NVS_GPCR_rTRH": {"Train": {"roc_auc": 0.8181124444359654, "threshold": -0.18178332030952227}, "Val": {"roc_auc": 0.8679906542056075, "threshold": -3.632196838194663}, "Test": {"roc_auc": 0.3214146150840172, "threshold": -6.1226854737814485}, "description": "Signifies the activity or interaction of rodent Thyrotropin-Releasing Hormone Receptor as measured in the NVS GPCR assay."}, "NVS_GPCR_rV1": {"Train": {"roc_auc": 0.7667470760233918, "threshold": 3.0829153017954782}, "Val": {"roc_auc": 0.6532863849765258, "threshold": 1.6943402023048133}, "Test": {"roc_auc": 0.5728337236533958, "threshold": 1.5683119748089762}, "description": "Indicates the modulation or response of rodent Vasopressin Receptor 1 in the context of the NVS GPCR study."}, "NVS_GPCR_rabPAF": {"Train": {"roc_auc": 0.9090361067503925, "threshold": 6.261514329576158}, "Val": {"roc_auc": 0.7446745562130177, "threshold": 4.60404576195611}, "Test": {"roc_auc": 0.8598842195540307, "threshold": 3.27552278335388}, "description": "Reflects the interaction or activity of rodent Platelet-Activating Factor Receptor according to the NVS GPCR guidelines."}, "NVS_GPCR_rmAdra2B": {"Train": {"roc_auc": 0.8856199639106247, "threshold": 6.106469556256696}, "Val": {"roc_auc": 0.7511216056670602, "threshold": 5.077377217190641}, "Test": {"roc_auc": 0.8702451394759086, "threshold": 3.5130122765167817}, "description": "Denotes the modulation or response of a rodent mouse-specific Adrenoceptor Alpha 2B in the NVS GPCR context."}, "NVS_IC_hKhERGCh": {"Train": {"roc_auc": 0.9478915824864016, "threshold": 2.7472072664323868}, "Val": {"roc_auc": 0.7673949579831933, "threshold": 2.2050972404900016}, "Test": {"roc_auc": 0.8499577345731192, "threshold": 0.26090484768062705}, "description": "Captures the interaction or activity of human Ether-a-go-go-Related Gene Potassium Channel based on the NVS Ion Channel assay."}, "NVS_IC_rCaBTZCHL": {"Train": {"roc_auc": 0.9171938846473372, "threshold": 3.7744666272336183}, "Val": {"roc_auc": 0.8023186682520809, "threshold": 2.9953259362114792}, "Test": {"roc_auc": 0.870699881376038, "threshold": 2.6284008455706065}, "description": "Details the response or modulation of rodent Calcium Channel with a specific marker, as per the NVS Ion Channel study."}, "NVS_IC_rCaDHPRCh_L": {"Train": {"roc_auc": 0.9232655152224825, "threshold": 5.188035541110569}, "Val": {"roc_auc": 0.6298495645288994, "threshold": 2.8294596862983887}, "Test": {"roc_auc": 0.7907375643224699, "threshold": 1.0912029268266679}, "description": "Signifies the activity or interaction of rodent Calcium Channel, Dihydropyridine Receptor, L-type, according to the NVS Ion Channel guidelines."}, "NVS_IC_rNaCh_site2": {"Train": {"roc_auc": 0.864531458516421, "threshold": 4.9100870892808235}, "Val": {"roc_auc": 0.7725563909774437, "threshold": 4.690072847200227}, "Test": {"roc_auc": 0.8590225563909775, "threshold": 4.148245953940773}, "description": "Indicates the interaction or activity at site 2 of a rodent Sodium Channel under the NVS Ion Channel assay."}, "NVS_LGIC_bGABARa1": {"Train": {"roc_auc": 0.8214912280701755, "threshold": 4.631421985568943}, "Val": {"roc_auc": 0.24551131928181102, "threshold": -1.8489836014068877}, "Test": {"roc_auc": 0.6563593932322054, "threshold": -0.08371575243838203}, "description": "Reflects the modulation or response of bovine Gamma-Aminobutyric Acid Receptor Alpha 1 based on the NVS Ligand-Gated Ion Channel study."}, "NVS_LGIC_h5HT3": {"Train": {"roc_auc": 0.7537026210659651, "threshold": 2.4119278933550863}, "Val": {"roc_auc": 0.20994152046783626, "threshold": -3.653147730383429}, "Test": {"roc_auc": 0.8165887850467289, "threshold": -0.5366239681377545}, "description": "Denotes the activity or interaction of human 5-Hydroxytryptamine Receptor 3 in the context of the NVS Ligand-Gated Ion Channel assay."}, "NVS_LGIC_hNNR_NBungSens": {"Train": {"roc_auc": 0.7639387901122489, "threshold": 1.689767238972066}, "Val": {"roc_auc": 0.6760233918128655, "threshold": 1.9331301666714173}, "Test": {"roc_auc": 0.5915690866510539, "threshold": 0.33931936706985866}, "description": "Captures the response or modulation of human Nicotinic Acetylcholine Receptor sensitive to Alpha-Bungarotoxin according to the NVS Ligand-Gated Ion Channel guidelines."}, "NVS_LGIC_rGABAR_NonSelective": {"Train": {"roc_auc": 0.9055883642365319, "threshold": 1.7533304435951456}, "Val": {"roc_auc": 0.470335675253708, "threshold": -1.3796692023406156}, "Test": {"roc_auc": 0.5765807962529275, "threshold": 0.032225335085833695}, "description": "Details the non-selective activity or interaction of a rodent Gamma-Aminobutyric Acid Receptor in the NVS Ligand-Gated Ion Channel study."}, "NVS_LGIC_rNNR_BungSens": {"Train": {"roc_auc": 0.9113557398394363, "threshold": 4.917888801735085}, "Val": {"roc_auc": 0.5199296600234468, "threshold": 3.2389530868262977}, "Test": {"roc_auc": 0.7440406408753419, "threshold": 1.7968569221916617}, "description": "Signifies the modulation or interaction of rodent Nicotinic Acetylcholine Receptor sensitive to Alpha-Bungarotoxin based on the NVS Ligand-Gated Ion Channel assay."}, "NVS_MP_hPBR": {"Train": {"roc_auc": 0.8279796494275186, "threshold": 3.346758931726069}, "Val": {"roc_auc": 0.6312465977136636, "threshold": 0.8204644564035775}, "Test": {"roc_auc": 0.6977937649880096, "threshold": 2.6171948329822436}, "description": "Describes the interaction or modulation of human Peripheral Benzodiazepine Receptor based on the NVS Membrane Protein assay."}, "NVS_MP_rPBR": {"Train": {"roc_auc": 0.8736504502141794, "threshold": 1.9861117783967446}, "Val": {"roc_auc": 0.7098028325465149, "threshold": 1.4199014683743494}, "Test": {"roc_auc": 0.7887656867801272, "threshold": 1.1144743557568182}, "description": "Details the activity or interaction of rodent Peripheral Benzodiazepine Receptor in the context of the NVS Membrane Protein study."}, "NVS_NR_bER": {"Train": {"roc_auc": 0.8670043178900688, "threshold": -0.010319477802998023}, "Val": {"roc_auc": 0.9555707450444292, "threshold": -0.34569058213028736}, "Test": {"roc_auc": 0.8635672020287405, "threshold": 0.5364447265296608}, "description": "Indicates the modulation or response of bovine Estrogen Receptor according to the NVS Nuclear Receptor assay guidelines."}, "NVS_NR_bPR": {"Train": {"roc_auc": 0.9163988279309331, "threshold": 2.15942511830602}, "Val": {"roc_auc": 0.78767258382643, "threshold": 2.45240014021819}, "Test": {"roc_auc": 0.7337357478202549, "threshold": 3.2518148551116113}, "description": "Captures the interaction or activity of bovine Progesterone Receptor based on the NVS Nuclear Receptor study."}, "NVS_NR_cAR": {"Train": {"roc_auc": 0.8758916769846377, "threshold": 2.6987874486424905}, "Val": {"roc_auc": 0.772130121989365, "threshold": 0.7605218195223111}, "Test": {"roc_auc": 0.7925939606611876, "threshold": 1.1897644294990792}, "description": "Signifies the modulation or response of canine Androgen Receptor in the NVS Nuclear Receptor assay."}, "NVS_NR_hAR": {"Train": {"roc_auc": 0.9081655604719765, "threshold": 1.3736633247322025}, "Val": {"roc_auc": 0.8310924369747898, "threshold": 1.8926285609110698}, "Test": {"roc_auc": 0.7704581358609794, "threshold": 1.8000046407376917}, "description": "Denotes the interaction or activity of human Androgen Receptor under the NVS Nuclear Receptor assay guidelines."}, "NVS_NR_hCAR_Antagonist": {"Train": {"roc_auc": 0.8338931231449176, "threshold": 1.6838623782893913}, "Val": {"roc_auc": 0.856706114398422, "threshold": 1.7596410898355623}, "Test": {"roc_auc": 0.8272084805653711, "threshold": 1.1559823134520633}, "description": "Describes the antagonistic activity or interaction of human Constitutive Androstane Receptor in the context of the NVS Nuclear Receptor study."}, "NVS_NR_hER": {"Train": {"roc_auc": 0.8398872358376032, "threshold": 0.45725567610533524}, "Val": {"roc_auc": 0.8288822017428373, "threshold": 0.3089587953355579}, "Test": {"roc_auc": 0.8121248499399761, "threshold": 0.3220657906136113}, "description": "Details the response or modulation of human Estrogen Receptor as per the NVS Nuclear Receptor guidelines."}, "NVS_NR_hFXR_Agonist": {"Train": {"roc_auc": 0.9735687711699705, "threshold": 4.237942235963837}, "Val": {"roc_auc": 0.9543859649122807, "threshold": 1.1596108399353948}, "Test": {"roc_auc": 0.9474912485414235, "threshold": 1.8130991151024993}, "description": "Reflects the agonistic activity or interaction of human Farnesoid X Receptor under the NVS Nuclear Receptor assay."}, "NVS_NR_hFXR_Antagonist": {"Train": {"roc_auc": 0.7526709802953727, "threshold": 0.9827581926867053}, "Val": {"roc_auc": 0.481301531213192, "threshold": 1.198010985438411}, "Test": {"roc_auc": 0.49731989708404806, "threshold": 0.3961336953981265}, "description": "Indicates the antagonistic modulation or response of human Farnesoid X Receptor according to the NVS Nuclear Receptor study."}, "NVS_NR_hGR": {"Train": {"roc_auc": 0.8588212197078298, "threshold": 2.6023139209002712}, "Val": {"roc_auc": 0.7511911270795908, "threshold": 0.5250574337230911}, "Test": {"roc_auc": 0.77273986517684, "threshold": 0.43112007204118763}, "description": "Captures the interaction or modulation of human Glucocorticoid Receptor in the NVS Nuclear Receptor context."}, "NVS_NR_hPPARa": {"Train": {"roc_auc": 0.8335615608181116, "threshold": 0.01203984612817166}, "Val": {"roc_auc": 0.619170427681066, "threshold": 0.6267843160543354}, "Test": {"roc_auc": 0.861111111111111, "threshold": -0.11687875390649438}, "description": "Signifies the activity or interaction of human Peroxisome Proliferator-Activated Receptor alpha as measured in the NVS Nuclear Receptor assay."}, "NVS_NR_hPPARg": {"Train": {"roc_auc": 0.811207953724281, "threshold": -0.07662221547719561}, "Val": {"roc_auc": 0.6839177750906892, "threshold": -1.3062339394658178}, "Test": {"roc_auc": 0.8139724310776942, "threshold": -0.17655363240399513}, "description": "Denotes the modulation or response of human Peroxisome Proliferator-Activated Receptor gamma based on the NVS Nuclear Receptor study."}, "NVS_NR_hPR": {"Train": {"roc_auc": 0.8050213562939765, "threshold": 3.81692564069807}, "Val": {"roc_auc": 0.7352991018471445, "threshold": -0.4642016694352433}, "Test": {"roc_auc": 0.584452296819788, "threshold": 4.264509150931786}, "description": "Details the interaction or activity of human Progesterone Receptor in the context of the NVS Nuclear Receptor assay."}, "NVS_NR_hPXR": {"Train": {"roc_auc": 0.8292987837620147, "threshold": 1.4326865952294154}, "Val": {"roc_auc": 0.5434911242603551, "threshold": -0.7801445917085603}, "Test": {"roc_auc": 0.7679030874785592, "threshold": 0.11165616318986249}, "description": "Reflects the modulation or response of human Pregnane X Receptor according to the NVS Nuclear Receptor guidelines."}, "NVS_NR_hRAR_Antagonist": {"Train": {"roc_auc": 0.9597093716935683, "threshold": 1.6335393621160215}, "Val": {"roc_auc": 0.9, "threshold": 0.3010500224383623}, "Test": {"roc_auc": 0.9049008168028005, "threshold": -1.0885625797229732}, "description": "Indicates the antagonistic activity or interaction of human Retinoic Acid Receptor in the NVS Nuclear Receptor context."}, "NVS_NR_hRARa_Agonist": {"Train": {"roc_auc": 0.9643918980079237, "threshold": 3.9033149312566344}, "Val": null, "Test": {"roc_auc": 0.9277389277389277, "threshold": -0.36455396130994266}, "description": "Captures the agonistic response or modulation of human Retinoic Acid Receptor alpha as per the NVS Nuclear Receptor study."}, "NVS_NR_hTRa_Antagonist": {"Train": {"roc_auc": 0.8896653117098996, "threshold": 2.5638196790540544}, "Val": {"roc_auc": 0.5973036342321218, "threshold": -0.10154325181657509}, "Test": {"roc_auc": 0.7780392156862745, "threshold": 1.0469503312020212}, "description": "Denotes the antagonistic activity or interaction of human Thyroid Hormone Receptor alpha based on the NVS Nuclear Receptor assay guidelines."}, "NVS_NR_mERa": {"Train": {"roc_auc": 0.8407181920909007, "threshold": 0.42080187582754913}, "Val": {"roc_auc": 0.7956854905880393, "threshold": 0.37941905805417786}, "Test": {"roc_auc": 0.8305937759719273, "threshold": 0.6038772309267966}, "description": "Details the response or interaction of murine Estrogen Receptor alpha in the NVS Nuclear Receptor context."}, "NVS_NR_rAR": {"Train": {"roc_auc": 0.9293733224413583, "threshold": 2.7896107453125722}, "Val": {"roc_auc": 0.8562724014336918, "threshold": 1.0063246792859148}, "Test": {"roc_auc": 0.7760972716488731, "threshold": 1.2048339235174046}, "description": "Reflects the modulation or activity of rodent Androgen Receptor under the NVS Nuclear Receptor study."}, "NVS_NR_rMR": {"Train": {"roc_auc": 0.9707602339181286, "threshold": 3.5586156749629883}, "Val": {"roc_auc": 0.9591121495327103, "threshold": -1.2954784680653857}, "Test": null, "description": "Signifies the interaction or response of rodent Mineralocorticoid Receptor as measured in the NVS Nuclear Receptor assay."}, "NVS_OR_gSIGMA_NonSelective": {"Train": {"roc_auc": 0.7444998048446324, "threshold": 3.8830848974031253}, "Val": {"roc_auc": 0.6608201999661074, "threshold": 1.5280541123093307}, "Test": {"roc_auc": 0.656578947368421, "threshold": 3.1520630838396073}, "description": "Indicates the non-selective modulation or interaction of a guinea pig Sigma Receptor in the NVS Orphan Receptor context."}, "NVS_TR_gDAT": {"Train": {"roc_auc": 0.856501750485826, "threshold": 2.9671615928978294}, "Val": {"roc_auc": 0.6552621048419368, "threshold": 2.6926214945566906}, "Test": {"roc_auc": 0.8319695419934083, "threshold": 2.154777085339582}, "description": "Captures the activity or interaction of guinea pig Dopamine Transporter based on the NVS Transporter study."}, "NVS_TR_hAdoT": {"Train": {"roc_auc": 0.9028302489671791, "threshold": 4.592086050245497}, "Val": {"roc_auc": 0.7158245201723463, "threshold": 2.086185399953787}, "Test": {"roc_auc": 0.8100820633059789, "threshold": 2.024686214802143}, "description": "Denotes the response or modulation of human Adenosine Transporter as per the NVS Transporter guidelines."}, "NVS_TR_hDAT": {"Train": {"roc_auc": 0.7838500100397164, "threshold": 3.575446275858072}, "Val": {"roc_auc": 0.710302272904788, "threshold": 2.6992262599465846}, "Test": {"roc_auc": 0.7288202841596131, "threshold": 2.732771583147593}, "description": "Details the activity or interaction of human Dopamine Transporter in the context of the NVS Transporter assay."}, "NVS_TR_hNET": {"Train": {"roc_auc": 0.8572357953911998, "threshold": 3.523465871094942}, "Val": {"roc_auc": 0.7708645677161419, "threshold": 3.235010514626871}, "Test": {"roc_auc": 0.8599624060150376, "threshold": 2.1080637450690745}, "description": "Describes the interaction or modulation of the human Norepinephrine Transporter according to the NVS Transporter study."}, "NVS_TR_hSERT": {"Train": {"roc_auc": 0.9021620943459352, "threshold": 5.349337680919751}, "Val": {"roc_auc": 0.698356807511737, "threshold": 3.6010229341737983}, "Test": {"roc_auc": 0.8509183274716686, "threshold": 2.854593104667015}, "description": "Indicates the activity or interaction with the human Serotonin Transporter based on the NVS Transporter assay guidelines."}, "NVS_TR_rNET": {"Train": {"roc_auc": 0.9137579289648305, "threshold": 3.5422120280451956}, "Val": {"roc_auc": 0.764667956157318, "threshold": 1.956706314831525}, "Test": {"roc_auc": 0.7929242119382964, "threshold": -0.13380294948726856}, "description": "Captures the response or modulation of rodent Norepinephrine Transporter in the NVS Transporter context."}, "NVS_TR_rSERT": {"Train": {"roc_auc": 0.9009310089538896, "threshold": 5.565913743562287}, "Val": {"roc_auc": 0.769916142557652, "threshold": 6.430121293893686}, "Test": {"roc_auc": 0.9199057714958775, "threshold": 4.121606010097164}, "description": "Reflects the interaction or activity of rodent Serotonin Transporter under the NVS Transporter study."}, "NVS_TR_rVMAT2": {"Train": {"roc_auc": 0.9014153245485602, "threshold": 5.171922350073004}, "Val": {"roc_auc": 0.7348126232741616, "threshold": 4.119702267575192}, "Test": {"roc_auc": 0.7962690951821386, "threshold": 2.5407722189619744}, "description": "Signifies the modulation or response of rodent Vesicular Monoamine Transporter 2 as measured in the NVS Transporter assay."}, "OT_AR_ARELUC_AG_1440": {"Train": {"roc_auc": 0.7314566519820698, "threshold": 0.4410126144821582}, "Val": {"roc_auc": 0.57018779342723, "threshold": -1.7063189927522124}, "Test": {"roc_auc": 0.5857428623386071, "threshold": 2.2912514123830707}, "description": "Denotes the results from an OT Androgen Receptor assay using a LUC reporter gene, with AG as the substrate and 1440 as a potential parameter or condition."}, "OT_AR_ARSRC1_0480": {"Train": {"roc_auc": 0.9217190457921648, "threshold": 0.6591980011016876}, "Val": {"roc_auc": 0.7165680473372781, "threshold": -1.2742377315555604}, "Test": {"roc_auc": 0.8655210038188761, "threshold": -1.6017432513537706}, "description": "Details the findings from an OT Androgen Receptor study involving the SRC1 coactivator and 0480 as a potential parameter or condition."}, "OT_AR_ARSRC1_0960": {"Train": {"roc_auc": 0.9102535045272713, "threshold": -0.3230549236675646}, "Val": {"roc_auc": 0.822427871529668, "threshold": -1.6125054669690453}, "Test": {"roc_auc": 0.8006704486848891, "threshold": -1.1918011914502387}, "description": "Indicates the results from an OT Androgen Receptor assay involving the SRC1 coactivator and 0960 as a specific parameter or condition."}, "OT_ER_ERaERa_0480": {"Train": {"roc_auc": 0.9544871163630395, "threshold": -0.5815416971842442}, "Val": {"roc_auc": 0.9224970847909378, "threshold": -0.5861599991868083}, "Test": {"roc_auc": 0.9119273301737757, "threshold": -0.015670855840047793}, "description": "Details the interaction or modulation of Estrogen Receptor alpha in an OT assay with 0480 as a defining condition."}, "OT_ER_ERaERa_1440": {"Train": {"roc_auc": 0.8514276524006732, "threshold": 0.07656540741791584}, "Val": {"roc_auc": 0.8943381180223285, "threshold": -0.4714287200847549}, "Test": {"roc_auc": 0.9167255594817432, "threshold": 0.9532553684246068}, "description": "Captures the activity or interaction of Estrogen Receptor alpha in an OT assay, with 1440 as a specific parameter or condition."}, "OT_ER_ERaERb_0480": {"Train": {"roc_auc": 0.9570919549501686, "threshold": 0.973397055426398}, "Val": {"roc_auc": 0.9094924192485169, "threshold": 1.3332721435271946}, "Test": {"roc_auc": 0.9087964541425162, "threshold": -0.047273750419731364}, "description": "Reflects the results of an OT assay focusing on both Estrogen Receptor alpha and beta, with 0480 as a defining condition."}, "OT_ER_ERaERb_1440": {"Train": {"roc_auc": 0.8568494036378927, "threshold": 0.6525221238503827}, "Val": {"roc_auc": 0.8638990861516833, "threshold": -0.04110801398933184}, "Test": {"roc_auc": 0.7870616179963672, "threshold": 2.809589902440587}, "description": "Signifies the interaction or response in an OT assay that studies both Estrogen Receptor alpha and beta, with 1440 as a parameter or condition."}, "OT_ER_ERbERb_0480": {"Train": {"roc_auc": 0.9513262836205002, "threshold": 0.18793478002538677}, "Val": {"roc_auc": 0.8542227662178703, "threshold": 0.21086680447613748}, "Test": {"roc_auc": 0.911773428232503, "threshold": 0.7918080500773605}, "description": "Details the results from an OT assay focusing solely on Estrogen Receptor beta, with 0480 as a specific condition."}, "OT_ER_ERbERb_1440": {"Train": {"roc_auc": 0.8657071466929404, "threshold": 0.11147998259948189}, "Val": {"roc_auc": 0.8259620189905047, "threshold": 0.04144267062167106}, "Test": {"roc_auc": 0.8119273301737757, "threshold": 3.260334312259495}, "description": "Indicates the findings from an OT assay examining Estrogen Receptor beta, with 1440 as a defining parameter or condition."}, "OT_ERa_EREGFP_0120": {"Train": {"roc_auc": 0.9111989941707623, "threshold": 0.28461259072487977}, "Val": {"roc_auc": 0.7980160899789112, "threshold": -0.4878305028508727}, "Test": {"roc_auc": 0.76838275225372, "threshold": 0.08781967077169295}, "description": "Captures the activity or interaction of Estrogen Receptor alpha in an OT assay using a GFP reporter, with 0120 as a condition or parameter."}, "OT_ERa_EREGFP_0480": {"Train": {"roc_auc": 0.8856685049538487, "threshold": -0.3835432808678423}, "Val": {"roc_auc": 0.8104807692307693, "threshold": 0.2318044610925618}, "Test": {"roc_auc": 0.8766080617495712, "threshold": 1.7140422263541613}, "description": "Describes the results of an OT assay focusing on Estrogen Receptor alpha using a GFP reporter, with 0480 as a specific condition."}, "OT_FXR_FXRSRC1_0480": {"Train": {"roc_auc": 0.8906180559964445, "threshold": 0.06602153739891037}, "Val": {"roc_auc": 0.7860153256704981, "threshold": -0.6427871844432023}, "Test": {"roc_auc": 0.8328488372093024, "threshold": -0.8716338594873863}, "description": "Reflects the modulation or activity of Farnesoid X Receptor in an OT study involving the SRC1 coactivator and 0480 as a condition or parameter."}, "OT_FXR_FXRSRC1_1440": {"Train": {"roc_auc": 0.8807443248166006, "threshold": -0.9787627683506832}, "Val": {"roc_auc": 0.7006302521008403, "threshold": -1.0733686884840932}, "Test": {"roc_auc": 0.6568899458316819, "threshold": -0.8534243338637877}, "description": "Indicates the results of an OT assay examining Farnesoid X Receptor with the SRC1 coactivator and 1440 as a specific condition."}, "OT_NURR1_NURR1RXRa_0480": {"Train": {"roc_auc": 0.8485550536397061, "threshold": -0.6337375420111195}, "Val": {"roc_auc": 0.7277403846153846, "threshold": -1.0273386035953562}, "Test": {"roc_auc": 0.763921568627451, "threshold": -1.480227328635551}, "description": "Denotes the findings from an OT assay focusing on NURR1 interaction with Retinoid X Receptor alpha, with 0480 as a defining condition."}, "OT_NURR1_NURR1RXRa_1440": {"Train": {"roc_auc": 0.8091594202898551, "threshold": -1.0927065800618125}, "Val": {"roc_auc": 0.753755868544601, "threshold": -0.7816190583569869}, "Test": {"roc_auc": 0.755032679738562, "threshold": -0.19131601322162517}, "description": "Details the results from an OT assay studying the interaction of NURR1 with Retinoid X Receptor alpha, and 1440 as a specific parameter."}, "TOX21_ARE_BLA_Agonist_ch1": {"Train": {"roc_auc": 0.9803719901316882, "threshold": -0.03494876330798391}, "Val": {"roc_auc": 0.8951027233635929, "threshold": -0.5905238737215139}, "Test": {"roc_auc": 0.8476687186502508, "threshold": -1.8412905312157246}, "description": "Reflects the agonistic activity in a TOX21 assay focusing on the Antioxidant Response Element, using a beta-lactamase reporter in channel 1."}, "TOX21_ARE_BLA_Agonist_ch2": {"Train": {"roc_auc": 0.8966342429755408, "threshold": -1.0888726460683102}, "Val": {"roc_auc": 0.7849417076622414, "threshold": -1.6653930432087662}, "Test": {"roc_auc": 0.7400604510578935, "threshold": -1.0392616308248552}, "description": "Details the agonistic response in a TOX21 assay involving the Antioxidant Response Element, with a beta-lactamase reporter in channel 2."}, "TOX21_ARE_BLA_agonist_ratio": {"Train": {"roc_auc": 0.8546803167668995, "threshold": -0.8023795286814366}, "Val": {"roc_auc": 0.7189197203321056, "threshold": -1.3324822398635368}, "Test": {"roc_auc": 0.7465217391304347, "threshold": -0.9121405655915318}, "description": "Indicates the ratio of agonistic activity for the Antioxidant Response Element in a TOX21 assay using a beta-lactamase reporter."}, "TOX21_ARE_BLA_agonist_viability": {"Train": {"roc_auc": 0.7911697875026299, "threshold": -3.5772786435183583}, "Val": {"roc_auc": 0.6101939203354297, "threshold": -3.210415246369722}, "Test": {"roc_auc": 0.5165995975855131, "threshold": -4.132276122395818}, "description": "Captures the viability measurements in an agonist-based TOX21 assay focusing on the Antioxidant Response Element, using a beta-lactamase reporter."}, "TOX21_AR_BLA_Agonist_ch1": {"Train": {"roc_auc": 0.9937719298245614, "threshold": 1.037701951132881}, "Val": {"roc_auc": 0.9157894736842105, "threshold": -5.277487846048506}, "Test": {"roc_auc": 0.9066511085180864, "threshold": -2.503698749585194}, "description": "Denotes the results from a TOX21 assay examining the agonistic activity on the Androgen Receptor, using a beta-lactamase reporter in channel 1."}, "TOX21_AR_BLA_Agonist_ch2": {"Train": {"roc_auc": 0.9351245438027661, "threshold": 0.2605262886177204}, "Val": {"roc_auc": 0.7901652559451834, "threshold": -0.7827999701609727}, "Test": {"roc_auc": 0.7491042301727365, "threshold": -0.9964411452009871}, "description": "Reflects the agonistic response of the Androgen Receptor in a TOX21 assay with a beta-lactamase reporter in channel 2."}, "TOX21_AR_BLA_Agonist_ratio": {"Train": {"roc_auc": 0.9508484172455169, "threshold": -0.5793020145313168}, "Val": {"roc_auc": 0.8377353640511536, "threshold": -1.3989483014241344}, "Test": {"roc_auc": 0.7800684528584415, "threshold": -1.2048335280623643}, "description": "Represents the ratio of agonistic activity on the Androgen Receptor in a TOX21 assay, using a beta-lactamase reporter system."}, "TOX21_AR_BLA_Antagonist_ch1": {"Train": {"roc_auc": 0.9579654631083202, "threshold": -2.3671086221127897}, "Val": {"roc_auc": 0.9204225352112676, "threshold": -2.5206838327127166}, "Test": {"roc_auc": 0.8430571761960327, "threshold": -5.348619853889381}, "description": "Details the antagonistic activity of the Androgen Receptor in a TOX21 assay with a beta-lactamase reporter, recorded in channel 1."}, "TOX21_AR_BLA_Antagonist_ch2": {"Train": {"roc_auc": 0.9762672349603306, "threshold": -0.38795744692599143}, "Val": {"roc_auc": 0.859280303030303, "threshold": -1.9716811113887367}, "Test": {"roc_auc": 0.828392094017094, "threshold": -2.7883838737333146}, "description": "Signifies the results of the antagonistic response of the Androgen Receptor in a TOX21 assay, using a beta-lactamase reporter in channel 2."}, "TOX21_AR_BLA_Antagonist_ratio": {"Train": {"roc_auc": 0.9519437972805149, "threshold": -0.05523531095640344}, "Val": {"roc_auc": 0.8147960873886283, "threshold": -1.7587216523316531}, "Test": {"roc_auc": 0.8257566512082012, "threshold": -1.464356104532878}, "description": "Indicates the ratio of antagonistic activity on the Androgen Receptor in a TOX21 assay, using the beta-lactamase reporter."}, "TOX21_AR_BLA_Antagonist_viability": {"Train": {"roc_auc": 0.9613390681870213, "threshold": -0.12024607959094347}, "Val": {"roc_auc": 0.8227155727155727, "threshold": -0.42670287264956563}, "Test": {"roc_auc": 0.7971754481260185, "threshold": -1.946626507126175}, "description": "Reports the viability measurements related to the antagonistic activity on the Androgen Receptor in a TOX21 assay using a beta-lactamase reporter."}, "TOX21_AR_LUC_MDAKB2_Agonist": {"Train": {"roc_auc": 0.884590664115742, "threshold": -1.0974949262998948}, "Val": {"roc_auc": 0.7189891907683318, "threshold": -1.4261117253575595}, "Test": {"roc_auc": 0.79142893775242, "threshold": -0.9607254377714503}, "description": "Denotes the agonistic response in a TOX21 assay focusing on the Androgen Receptor, using a luciferase reporter in the MDA-KB2 cell line."}, "TOX21_AR_LUC_MDAKB2_Antagonist": {"Train": {"roc_auc": 0.9628415076182838, "threshold": -0.10193395041846642}, "Val": {"roc_auc": 0.7800551114754846, "threshold": -1.924972099823517}, "Test": {"roc_auc": 0.8114710967450951, "threshold": -1.4096427966166543}, "description": "Details the antagonistic response on the Androgen Receptor in a TOX21 assay with a luciferase reporter system in the MDA-KB2 cell line."}, "TOX21_AR_LUC_MDAKB2_Antagonist2": {"Train": {"roc_auc": 0.9425922842076048, "threshold": -0.630459771141993}, "Val": {"roc_auc": 0.8101962874145128, "threshold": -0.8747550813524096}, "Test": {"roc_auc": 0.8212481760017959, "threshold": -0.6529472855118303}, "description": "Reflects another (potentially varying condition or measurement) antagonistic activity for the Androgen Receptor in a TOX21 assay with a luciferase reporter, using the MDA-KB2 cell line."}, "TOX21_AhR_LUC_Agonist": {"Train": {"roc_auc": 0.919074149539242, "threshold": -0.7543766395943061}, "Val": {"roc_auc": 0.8550014009526479, "threshold": -1.2374595629202352}, "Test": {"roc_auc": 0.8441787631735932, "threshold": -1.5929481431886598}, "description": "Indicates the agonistic activity on the Aryl Hydrocarbon Receptor in a TOX21 assay utilizing a luciferase reporter."}, "TOX21_Aromatase_Inhibition": {"Train": {"roc_auc": 0.9328701701127007, "threshold": -0.37372031989875687}, "Val": {"roc_auc": 0.8314239960581423, "threshold": -1.4618713834264252}, "Test": {"roc_auc": 0.816497426133559, "threshold": -1.9440279111967191}, "description": "Reports results from a TOX21 assay that measures the inhibitory activity on aromatase, an enzyme crucial for the synthesis of estrogen."}, "TOX21_AutoFluor_HEK293_Cell_blue": {"Train": {"roc_auc": 0.9563805331376866, "threshold": -1.506225028195539}, "Val": {"roc_auc": 0.9801401869158879, "threshold": -4.079095489389307}, "Test": {"roc_auc": 0.8535087719298247, "threshold": -3.38892954319447}, "description": "Measures autofluorescence in HEK293 cells, specifically capturing the blue spectrum."}, "TOX21_AutoFluor_HEK293_Media_blue": {"Train": {"roc_auc": 0.9597796452963826, "threshold": -0.9710916885742549}, "Val": {"roc_auc": 0.9883177570093458, "threshold": -2.7356007800803894}, "Test": {"roc_auc": 0.6774853801169591, "threshold": -2.880137666329011}, "description": "Measures autofluorescence in the media of cultured HEK293 cells, focusing on the blue spectrum."}, "TOX21_AutoFluor_HEPG2_Cell_blue": {"Train": {"roc_auc": 0.976802795656614, "threshold": -0.9145544842556799}, "Val": {"roc_auc": 0.9836448598130841, "threshold": -3.147749286036831}, "Test": {"roc_auc": 0.7811526479750779, "threshold": -3.352829435566166}, "description": "Reports autofluorescence in HEPG2 cells, with an emphasis on the blue spectrum."}, "TOX21_AutoFluor_HEPG2_Cell_green": {"Train": {"roc_auc": 0.9906578755113968, "threshold": -0.7701715624726226}, "Val": {"roc_auc": 0.9769711163153787, "threshold": -2.5818429637599625}, "Test": {"roc_auc": 0.9320843091334895, "threshold": -2.2630607294845397}, "description": "Represents autofluorescence in HEPG2 cells, capturing the green spectrum."}, "TOX21_AutoFluor_HEPG2_Media_blue": {"Train": {"roc_auc": 0.9725237117434243, "threshold": -1.4352730511425733}, "Val": {"roc_auc": 0.8473684210526315, "threshold": -3.86138208253725}, "Test": {"roc_auc": 0.6583138173302108, "threshold": -3.2875116966866162}, "description": "Describes autofluorescence in the media of cultured HEPG2 cells in the blue spectrum."}, "TOX21_AutoFluor_HEPG2_Media_green": {"Train": {"roc_auc": 0.9961042123204286, "threshold": -0.5357176090503941}, "Val": {"roc_auc": 0.9781420765027323, "threshold": -2.162914610123849}, "Test": {"roc_auc": 0.9451990632318501, "threshold": -2.871236778594353}, "description": "Indicates autofluorescence in the media of HEPG2 cells, focusing on the green spectrum."}, "TOX21_ELG1_LUC_Agonist": {"Train": {"roc_auc": 0.9551725712767327, "threshold": -1.174598858998463}, "Val": {"roc_auc": 0.7947731755424062, "threshold": -0.607160655675349}, "Test": {"roc_auc": 0.6699052132701422, "threshold": -0.7700476760083852}, "description": "Measures agonistic activity using an ELG1 luciferase reporter assay."}, "TOX21_ERa_BLA_Agonist_ch1": {"Train": {"roc_auc": 0.9542492018930416, "threshold": -0.7459496392144089}, "Val": {"roc_auc": 0.8605631276901003, "threshold": -0.30616511954917414}, "Test": {"roc_auc": 0.8382323929769185, "threshold": -0.6084717105220143}, "description": "Denotes the agonistic response on the Estrogen Receptor alpha using a beta-lactamase reporter in channel 1."}, "TOX21_ERa_BLA_Agonist_ch2": {"Train": {"roc_auc": 0.88823605143714, "threshold": -0.6011603310540155}, "Val": {"roc_auc": 0.8290751370247292, "threshold": -0.27782879219398815}, "Test": {"roc_auc": 0.7701059676519799, "threshold": -0.7943759585047392}, "description": "Represents the agonistic activity on the Estrogen Receptor alpha with a beta-lactamase reporter in channel 2."}, "TOX21_ERa_BLA_Agonist_ratio": {"Train": {"roc_auc": 0.9376697292324538, "threshold": -0.6483749660763056}, "Val": {"roc_auc": 0.8422234121426806, "threshold": -1.0233836159691796}, "Test": {"roc_auc": 0.821297557907976, "threshold": -0.03625857818114753}, "description": "Provides the ratio of agonistic response on the Estrogen Receptor alpha using a beta-lactamase reporting system."}, "TOX21_ERa_BLA_Antagonist_ch1": {"Train": {"roc_auc": 0.9514835206234392, "threshold": -1.4338767422331475}, "Val": {"roc_auc": 0.8311986863711002, "threshold": -2.756371118642904}, "Test": {"roc_auc": 0.8516051114227832, "threshold": -3.5916037862603964}, "description": "Details the antagonistic activity on the Estrogen Receptor alpha, recorded using a beta-lactamase reporter in channel 1."}, "TOX21_ERa_BLA_Antagonist_ch2": {"Train": {"roc_auc": 0.9831545703006378, "threshold": 0.37222704729876455}, "Val": {"roc_auc": 0.9018404907975459, "threshold": -1.1227393606164906}, "Test": {"roc_auc": 0.8309098462816784, "threshold": -2.4170039910095955}, "description": "Reflects the antagonistic activity on the Estrogen Receptor alpha with a beta-lactamase reporter in channel 2."}, "TOX21_ERa_BLA_Antagonist_ratio": {"Train": {"roc_auc": 0.9513973132344564, "threshold": -0.5238999528092538}, "Val": {"roc_auc": 0.839568345323741, "threshold": -2.0960749634751332}, "Test": {"roc_auc": 0.8515360983102919, "threshold": -1.6243414024452312}, "description": "Provides the ratio of antagonistic response on the Estrogen Receptor alpha with the beta-lactamase reporter."}, "TOX21_ERa_BLA_Antagonist_viability": {"Train": {"roc_auc": 0.9915168073317656, "threshold": 0.7866265780932906}, "Val": {"roc_auc": 0.9414590330391315, "threshold": -1.7347387250837265}, "Test": {"roc_auc": 0.8643595863166269, "threshold": -1.28687551668337}, "description": "Describes viability measures related to the antagonistic activity on the Estrogen Receptor alpha using a beta-lactamase reporter."}, "TOX21_ERa_LUC_BG1_Agonist": {"Train": {"roc_auc": 0.7417997031251176, "threshold": -1.7465713250863777}, "Val": {"roc_auc": 0.6991338844348439, "threshold": -0.979272815677616}, "Test": {"roc_auc": 0.6583215258855586, "threshold": -1.3763893717402098}, "description": "Reports agonistic activity on the Estrogen Receptor alpha in a luciferase-based assay using the BG1 cell line."}, "TOX21_ERa_LUC_BG1_Antagonist": {"Train": {"roc_auc": 0.9569430201556444, "threshold": -0.4870060327890773}, "Val": {"roc_auc": 0.8262952863264511, "threshold": -1.5038760159466715}, "Test": {"roc_auc": 0.8152569169960474, "threshold": -2.6337301945901137}, "description": "Details the antagonistic response on the Estrogen Receptor alpha using a luciferase reporting system in the BG1 cell line."}, "TOX21_ESRE_BLA_ch1": {"Train": {"roc_auc": 0.9925982968606313, "threshold": -0.6260748859401701}, "Val": {"roc_auc": 0.9144801306477953, "threshold": -2.0784805690920027}, "Test": {"roc_auc": 0.9408074195308238, "threshold": -4.277713570270214}, "description": "Reflects the response in an Estrogen Response Element-based assay using a beta-lactamase reporter in channel 1."}, "TOX21_ESRE_BLA_ch2": {"Train": {"roc_auc": 0.9524382975285476, "threshold": -1.0911665564184787}, "Val": {"roc_auc": 0.8163025210084034, "threshold": -1.6938139358917628}, "Test": {"roc_auc": 0.9150058616647128, "threshold": -0.9147303536370224}, "description": "Indicates the results from an Estrogen Response Element-based assay with a beta-lactamase reporter in channel 2."}, "TOX21_ESRE_BLA_ratio": {"Train": {"roc_auc": 0.9560055763714069, "threshold": 0.33540185388024746}, "Val": {"roc_auc": 0.8425267820354347, "threshold": -1.4819620464657168}, "Test": {"roc_auc": 0.8292233839679095, "threshold": -1.562805505128237}, "description": "Shows the ratio of responses in an Estrogen Response Element-based assay using the beta-lactamase reporting system."}, "TOX21_ESRE_BLA_viability": {"Train": {"roc_auc": 0.9739658673639702, "threshold": -0.1245663454821404}, "Val": {"roc_auc": 0.8503857084855866, "threshold": -2.0571674555987567}, "Test": {"roc_auc": 0.8564508393285372, "threshold": -1.7007246208381837}, "description": "Provides viability metrics from an Estrogen Response Element-based assay using a beta-lactamase reporter."}, "TOX21_FXR_BLA_Antagonist_ch1": {"Train": {"roc_auc": 0.9349556400506971, "threshold": -0.1908055955583272}, "Val": {"roc_auc": 0.8426382047071703, "threshold": -2.229276771898623}, "Test": {"roc_auc": 0.7267390430237234, "threshold": -0.2539297014146715}, "description": "Details the antagonistic activity related to the Farnesoid X Receptor (FXR) measured using a beta-lactamase reporter in channel 1."}, "TOX21_FXR_BLA_Antagonist_ch2": {"Train": {"roc_auc": 0.9762312244645623, "threshold": 0.0876432309995554}, "Val": {"roc_auc": 0.8909424724602203, "threshold": -1.8388950631425178}, "Test": {"roc_auc": 0.7899201596806388, "threshold": -1.599709988117695}, "description": "Represents the FXR antagonistic activity using a beta-lactamase reporter in channel 2."}, "TOX21_FXR_BLA_agonist_ch2": {"Train": {"roc_auc": 0.9652933473695021, "threshold": -0.6791585458291536}, "Val": {"roc_auc": 0.8177830940988835, "threshold": -1.524327268590918}, "Test": {"roc_auc": 0.7877526753864448, "threshold": -4.249804349752278}, "description": "Reports the agonistic activity on the FXR using a beta-lactamase reporter in channel 2."}, "TOX21_FXR_BLA_agonist_ratio": {"Train": {"roc_auc": 0.9816709029274486, "threshold": 0.3373092469033043}, "Val": {"roc_auc": 0.8915865384615385, "threshold": -1.3681062346583488}, "Test": {"roc_auc": 0.847867298578199, "threshold": -3.091724179528496}, "description": "Provides the ratio of agonistic activity for the FXR using a beta-lactamase reporting system."}, "TOX21_FXR_BLA_antagonist_ratio": {"Train": {"roc_auc": 0.9446457432594071, "threshold": 0.08546550281054976}, "Val": {"roc_auc": 0.8543215566822309, "threshold": -1.625286873157795}, "Test": {"roc_auc": 0.8366883911293014, "threshold": -1.525282395852579}, "description": "Describes the ratio of antagonistic activity against FXR recorded with the beta-lactamase reporter."}, "TOX21_FXR_BLA_antagonist_viability": {"Train": {"roc_auc": 0.9863278317223738, "threshold": 0.7545564668672569}, "Val": {"roc_auc": 0.9220230737536054, "threshold": -0.7043942324034091}, "Test": {"roc_auc": 0.8348700120918984, "threshold": -2.338956038634459}, "description": "Denotes viability measurements related to the antagonistic activity on FXR via a beta-lactamase reporting system."}, "TOX21_GR_BLA_Agonist_ch1": {"Train": {"roc_auc": 0.9866203021370671, "threshold": 0.6597841251361842}, "Val": {"roc_auc": 0.9092496032645658, "threshold": -0.7415693278785209}, "Test": {"roc_auc": 0.8649781113195748, "threshold": -1.7648599827969758}, "description": "Details the agonistic activity on the Glucocorticoid Receptor (GR) using a beta-lactamase reporter in channel 1."}, "TOX21_GR_BLA_Agonist_ch2": {"Train": {"roc_auc": 0.9534620997834005, "threshold": -0.43278037606775044}, "Val": {"roc_auc": 0.6796844181459566, "threshold": -3.6178241313040793}, "Test": {"roc_auc": 0.7716779019300029, "threshold": -1.6995528624938423}, "description": "Indicates the agonistic activity on the GR measured using a beta-lactamase reporter in channel 2."}, "TOX21_GR_BLA_Agonist_ratio": {"Train": {"roc_auc": 0.9648843284927401, "threshold": -0.13390371152707914}, "Val": {"roc_auc": 0.8667443667443668, "threshold": -1.197535082384631}, "Test": {"roc_auc": 0.814201209749155, "threshold": -2.717153179752934}, "description": "Reports the ratio of agonistic activity for the GR using the beta-lactamase reporter."}, "TOX21_GR_BLA_Antagonist_ch2": {"Train": {"roc_auc": 0.9781194738782119, "threshold": -0.45688366245579104}, "Val": {"roc_auc": 0.8537844217151849, "threshold": -2.5764078592752906}, "Test": {"roc_auc": 0.8376646104038149, "threshold": -1.651147840497968}, "description": "Represents the antagonistic activity against the GR recorded with a beta-lactamase reporter in channel 2."}, "TOX21_GR_BLA_Antagonist_ratio": {"Train": {"roc_auc": 0.9679036960439572, "threshold": -0.8591952109122065}, "Val": {"roc_auc": 0.8534896563442504, "threshold": -1.5552477867634327}, "Test": {"roc_auc": 0.8301877800019064, "threshold": 0.21434865508590306}, "description": "Provides the ratio of antagonistic activity for the GR based on a beta-lactamase reporting system."}, "TOX21_GR_BLA_Antagonist_viability": {"Train": {"roc_auc": 0.9857424027712173, "threshold": 0.0807720772377607}, "Val": {"roc_auc": 0.9096587326607819, "threshold": -1.4667172560820703}, "Test": {"roc_auc": 0.830793090539601, "threshold": -1.5085700474701849}, "description": "Describes viability measurements linked with antagonistic activities on the GR via the beta-lactamase reporter."}, "TOX21_HSE_BLA_agonist_ch1": {"Train": {"roc_auc": 0.9755614893971241, "threshold": -0.25416755294417825}, "Val": {"roc_auc": 0.9127554383651945, "threshold": -0.05959234438143035}, "Test": {"roc_auc": 0.8811524609843937, "threshold": -2.913101176241854}, "description": "Measures agonistic activity through a Heat Shock Element (HSE) pathway using a beta-lactamase reporter in channel 1."}, "TOX21_HSE_BLA_agonist_ch2": {"Train": {"roc_auc": 0.8915411836790836, "threshold": -0.7258679640066399}, "Val": {"roc_auc": 0.7512180267965896, "threshold": -1.7998989487553505}, "Test": {"roc_auc": 0.7575574365175333, "threshold": -1.1964393096404518}, "description": "Represents the agonistic activity via the HSE pathway with a beta-lactamase reporter in channel 2."}, "TOX21_HSE_BLA_agonist_ratio": {"Train": {"roc_auc": 0.9350508539345179, "threshold": -0.13553315430909407}, "Val": {"roc_auc": 0.8566345979306589, "threshold": -1.7016868419475388}, "Test": {"roc_auc": 0.8187887752167303, "threshold": -1.8799108356326908}, "description": "Shows the ratio of responses from an HSE-based assay using the beta-lactamase reporting system."}, "TOX21_HSE_BLA_agonist_viability": {"Train": {"roc_auc": 0.9808032127574725, "threshold": -0.12455091700778276}, "Val": {"roc_auc": 0.9492232301115628, "threshold": -0.7027987585411406}, "Test": {"roc_auc": 0.8885338345864662, "threshold": -3.4861045429059807}, "description": "Details viability metrics from an HSE pathway-focused assay using a beta-lactamase reporter."}, "TOX21_MMP_ratio_down": {"Train": {"roc_auc": 0.9386756555597248, "threshold": -0.5773754234428523}, "Val": {"roc_auc": 0.8875633232016211, "threshold": -0.4074989861554217}, "Test": {"roc_auc": 0.8194080384447358, "threshold": -0.9663377080235751}, "description": "Indicates the ratio of decreased activity in the Matrix Metalloproteinases (MMP) assay."}, "TOX21_MMP_ratio_up": {"Train": {"roc_auc": 0.9326685219542362, "threshold": -0.024781334030258506}, "Val": {"roc_auc": 0.7780112044817927, "threshold": -0.8736609682306504}, "Test": {"roc_auc": 0.8785458879618594, "threshold": -1.5345086784095496}, "description": "Shows the ratio of increased activity in the MMP assay."}, "TOX21_MMP_viability": {"Train": {"roc_auc": 0.9621647476552787, "threshold": -0.6406777547047771}, "Val": {"roc_auc": 0.7966549924951756, "threshold": -1.3050399251408997}, "Test": {"roc_auc": 0.8225459859033866, "threshold": -1.0575084056224195}, "description": "Provides a measure of cell viability in the context of the MMP assay."}, "TOX21_NFkB_BLA_agonist_ch1": {"Train": {"roc_auc": 0.9668456856426781, "threshold": 0.5083723669653555}, "Val": {"roc_auc": 0.8948515891778303, "threshold": -1.2006612582965648}, "Test": {"roc_auc": 0.8390869293308317, "threshold": -2.99666425725958}, "description": "Details the agonistic activity on the Nuclear Factor kappa B (NF-kB) pathway using a beta-lactamase reporter in channel 1."}, "TOX21_NFkB_BLA_agonist_ch2": {"Train": {"roc_auc": 0.915585372905143, "threshold": -1.2941590281458835}, "Val": {"roc_auc": 0.841676505312869, "threshold": -1.8260134822494152}, "Test": {"roc_auc": 0.7958641889059662, "threshold": -1.7993239178671843}, "description": "Describes the agonistic activity on the Nuclear Factor kappa B (NF-kB) pathway using a beta-lactamase reporter in channel 2."}, "TOX21_NFkB_BLA_agonist_ratio": {"Train": {"roc_auc": 0.9418750391677634, "threshold": -0.5584351613118237}, "Val": {"roc_auc": 0.8759179926560587, "threshold": -0.8415967628165886}, "Test": {"roc_auc": 0.844087303953724, "threshold": -2.449972384923452}, "description": "Provides the ratio of agonistic activity for the NF-kB using the beta-lactamase reporter."}, "TOX21_NFkB_BLA_agonist_viability": {"Train": {"roc_auc": 0.9119929757230893, "threshold": 0.6317329965196219}, "Val": {"roc_auc": 0.862040981943599, "threshold": 0.18801548698165593}, "Test": {"roc_auc": 0.8100339087546239, "threshold": -1.374187780214144}, "description": "Indicates viability measurements associated with agonistic activity on the NF-kB pathway using a beta-lactamase reporting system."}, "TOX21_PPARd_BLA_Agonist_viability": {"Train": {"roc_auc": 0.9622969949988357, "threshold": 0.3570719796258057}, "Val": {"roc_auc": 0.8803931230836619, "threshold": -0.9952851086407453}, "Test": {"roc_auc": 0.8266958779617007, "threshold": -1.4204570256673303}, "description": "Represents cell viability in response to agonists targeting Peroxisome Proliferator-Activated Receptor delta (PPARd) via a beta-lactamase assay."}, "TOX21_PPARd_BLA_Antagonist_ch1": {"Train": {"roc_auc": 0.8190582729881131, "threshold": -1.9535217204609427}, "Val": {"roc_auc": 0.6512054507337526, "threshold": -2.0561518541446793}, "Test": {"roc_auc": 0.6550972501676726, "threshold": -1.7329460137241224}, "description": "Measures the antagonistic activity against the PPARd using a beta-lactamase reporter in channel 1."}, "TOX21_PPARd_BLA_agonist_ch1": {"Train": {"roc_auc": 0.8220612945645821, "threshold": -3.9778143665096053}, "Val": {"roc_auc": 0.7409356725146199, "threshold": -5.486997869756964}, "Test": {"roc_auc": 0.20945157526254377, "threshold": -8.402478578928354}, "description": "Details the agonistic activity on PPARd using a beta-lactamase reporter in channel 1."}, "TOX21_PPARd_BLA_agonist_ch2": {"Train": {"roc_auc": 0.9540680576254347, "threshold": -1.3295599891616785}, "Val": {"roc_auc": 0.8686928883591577, "threshold": -2.541006476134509}, "Test": {"roc_auc": 0.8595238095238095, "threshold": -1.911163887820086}, "description": "Indicates the agonistic activity on PPARd recorded with a beta-lactamase reporter in channel 2."}, "TOX21_PPARd_BLA_agonist_ratio": {"Train": {"roc_auc": 0.98348348639133, "threshold": -0.009985433087811302}, "Val": {"roc_auc": 0.8524151287309182, "threshold": -3.318182594425327}, "Test": {"roc_auc": 0.8591478696741854, "threshold": -1.2449676525127416}, "description": "Describes the ratio of agonistic activity for the PPARd based on a beta-lactamase reporting system."}, "TOX21_PPARd_BLA_antagonist_ratio": {"Train": {"roc_auc": 0.9332014615662215, "threshold": -0.19023467017126983}, "Val": {"roc_auc": 0.7816290761496241, "threshold": -1.6125314414680183}, "Test": {"roc_auc": 0.7619484330782936, "threshold": -1.6139328749449522}, "description": "Shows the ratio of antagonistic activity against PPARd using the beta-lactamase reporter."}, "TOX21_PPARd_BLA_antagonist_viability": {"Train": {"roc_auc": 0.974793267568933, "threshold": -1.4479272878683123}, "Val": {"roc_auc": 0.918135526831179, "threshold": -2.667265539770728}, "Test": {"roc_auc": 0.920608899297424, "threshold": -2.747844411088183}, "description": "Provides a measure of cell viability in the context of PPARd antagonistic activity through a beta-lactamase assay."}, "TOX21_PPARg_BLA_Agonist_ch1": {"Train": {"roc_auc": 0.9990544222950031, "threshold": 0.5101815682870345}, "Val": {"roc_auc": 0.9568075117370891, "threshold": -1.9083096553255476}, "Test": {"roc_auc": 0.9469078179696616, "threshold": -4.7843136486706435}, "description": "Represents the agonistic activity on Peroxisome Proliferator-Activated Receptor gamma (PPARg) using a beta-lactamase reporter in channel 1."}, "TOX21_PPARg_BLA_Agonist_ch2": {"Train": {"roc_auc": 0.9589594594594595, "threshold": -1.3846321425757715}, "Val": {"roc_auc": 0.7702333211811885, "threshold": -0.2596448405726903}, "Test": {"roc_auc": 0.8606091601318332, "threshold": -0.835508039167097}, "description": "Details the agonistic activity on the PPARg pathway recorded with a beta-lactamase reporter in channel 2."}, "TOX21_PPARg_BLA_Agonist_ratio": {"Train": {"roc_auc": 0.9475407123335362, "threshold": -0.7159336756418888}, "Val": {"roc_auc": 0.812591938805531, "threshold": -2.5058255193231105}, "Test": {"roc_auc": 0.840053849605744, "threshold": -2.6753810805243416}, "description": "Shows the ratio of agonistic responses for the PPARg using a beta-lactamase reporting system."}, "TOX21_PPARg_BLA_Antagonist_ch1": {"Train": {"roc_auc": 0.9096476334013773, "threshold": -1.8522623217738303}, "Val": {"roc_auc": 0.7544600938967136, "threshold": -4.417575533086951}, "Test": {"roc_auc": 0.11771561771561767, "threshold": -9.239796648035059}, "description": "Indicates the antagonistic activity against the PPARg pathway via a beta-lactamase reporter in channel 1."}, "TOX21_PPARg_BLA_antagonist_ratio": {"Train": {"roc_auc": 0.944928886074428, "threshold": -1.3673644481120526}, "Val": {"roc_auc": 0.7925512655936275, "threshold": -1.87311641876404}, "Test": {"roc_auc": 0.8086747973525694, "threshold": -1.415657658596059}, "description": "Measures the ratio of antagonistic activity against PPARg recorded with the beta-lactamase reporter."}, "TOX21_PPARg_BLA_antagonist_viability": {"Train": {"roc_auc": 0.9891200415523911, "threshold": 0.8798626278255792}, "Val": {"roc_auc": 0.933020972780009, "threshold": -1.6061176723904076}, "Test": {"roc_auc": 0.8862781954887218, "threshold": -1.2534037123213295}, "description": "Details viability metrics related to PPARg antagonistic activity using a beta-lactamase reporting system."}, "TOX21_TR_LUC_GH3_Agonist": {"Train": {"roc_auc": 0.8225062469171938, "threshold": -2.8951196670532227}, "Val": {"roc_auc": 0.9042056074766355, "threshold": -5.024488938821329}, "Test": {"roc_auc": 0.8050647820965843, "threshold": -4.727180426543182}, "description": "Represents an assay measuring the agonistic activity on Thyroid Receptor (TR) using a luciferase reporter in GH3 cells."}, "TOX21_TR_LUC_GH3_Antagonist": {"Train": {"roc_auc": 0.9481474063297534, "threshold": -0.16441777948144587}, "Val": {"roc_auc": 0.8504919323101141, "threshold": -0.5879677924307982}, "Test": {"roc_auc": 0.851062039957939, "threshold": -0.11972809792519534}, "description": "Provides information on the antagonistic activity against TR measured using a luciferase reporter system in GH3 cells."}, "TOX21_VDR_BLA_Agonist_viability": {"Train": {"roc_auc": 0.9370320240695709, "threshold": 0.7654338226662016}, "Val": {"roc_auc": 0.8220928496790566, "threshold": -0.2573656300763352}, "Test": {"roc_auc": 0.8186770283334573, "threshold": -1.3480019039577913}, "description": "Indicates cell viability in response to agonists targeting the Vitamin D Receptor (VDR) through a beta-lactamase assay."}, "TOX21_VDR_BLA_Antagonist_ch1": {"Train": {"roc_auc": 0.972783719357021, "threshold": -0.6287983568819655}, "Val": {"roc_auc": 0.86159936658749, "threshold": -0.43802222785529743}, "Test": {"roc_auc": 0.7865595942519019, "threshold": -1.1539901920983038}, "description": "Measures the antagonistic activity against the VDR using a beta-lactamase reporter in channel 1."}, "TOX21_VDR_BLA_agonist_ch2": {"Train": {"roc_auc": 0.9858469777227106, "threshold": -0.786680857340496}, "Val": {"roc_auc": 0.8983193277310925, "threshold": -3.771095389181429}, "Test": {"roc_auc": 0.8736842105263158, "threshold": -0.511563919447326}, "description": "Details the agonistic activity on the Vitamin D Receptor (VDR) pathway using a beta-lactamase reporter in channel 2."}, "TOX21_VDR_BLA_agonist_ratio": {"Train": {"roc_auc": 0.9486760292432176, "threshold": -0.9422491494122447}, "Val": {"roc_auc": 0.8701183431952663, "threshold": -2.453174467022354}, "Test": {"roc_auc": 0.8977272727272727, "threshold": -3.895934841892979}, "description": "Describes the ratio of agonistic activity for the VDR using a beta-lactamase reporting system."}, "TOX21_VDR_BLA_antagonist_ratio": {"Train": {"roc_auc": 0.9773516891951872, "threshold": 0.029730576294678457}, "Val": {"roc_auc": 0.8687370452433707, "threshold": -0.525849836366671}, "Test": {"roc_auc": 0.7893829334507301, "threshold": -0.751833623593992}, "description": "Measures the ratio of antagonistic activity against the VDR through the beta-lactamase reporter."}, "TOX21_VDR_BLA_antagonist_viability": {"Train": {"roc_auc": 0.9874184106403635, "threshold": 0.32502661524592114}, "Val": {"roc_auc": 0.925185318029651, "threshold": -0.9376683507237704}, "Test": {"roc_auc": 0.8807398472054684, "threshold": -1.9337790530245833}, "description": "Indicates cell viability metrics related to VDR antagonistic activity via the beta-lactamase reporter assay."}, "TOX21_p53_BLA_p1_ch1": {"Train": {"roc_auc": 0.9753336105048765, "threshold": -0.6329648635528233}, "Val": {"roc_auc": 0.8830212439772229, "threshold": -1.4192149030553693}, "Test": {"roc_auc": 0.8403590944574552, "threshold": -2.003348825930118}, "description": "Presents the activity of the p53 pathway, specifically the first phase, recorded using a beta-lactamase reporter in channel 1."}, "TOX21_p53_BLA_p1_ch2": {"Train": {"roc_auc": 0.965368376068376, "threshold": -1.0478529543490023}, "Val": {"roc_auc": 0.7635381696102759, "threshold": -1.653130493125877}, "Test": {"roc_auc": 0.7795160617438465, "threshold": -2.16212759779261}, "description": "Reports the activity of the p53 pathway during its first phase, using a beta-lactamase reporter in channel 2."}, "TOX21_p53_BLA_p1_ratio": {"Train": {"roc_auc": 0.9738514304973497, "threshold": -0.5973910225762253}, "Val": {"roc_auc": 0.8529689184333452, "threshold": -2.292958217101532}, "Test": {"roc_auc": 0.8230565985259352, "threshold": -2.432985265691717}, "description": "Gives the ratio of activity for the first phase of the p53 pathway, determined via a beta-lactamase reporting system."}, "TOX21_p53_BLA_p1_viability": {"Train": {"roc_auc": 0.9837551405090195, "threshold": 0.673517407597723}, "Val": {"roc_auc": 0.8867702974726012, "threshold": -1.154441514888683}, "Test": {"roc_auc": 0.8642857142857143, "threshold": -1.099532064374861}, "description": "Provides an understanding of cell viability in relation to the activity of the p53 pathway's first phase, based on a beta-lactamase assay."}, "TOX21_p53_BLA_p2_ch1": {"Train": {"roc_auc": 0.9135932550200042, "threshold": -0.25309361065472125}, "Val": {"roc_auc": 0.843273013375295, "threshold": -2.596509956382775}, "Test": {"roc_auc": 0.7583688374923919, "threshold": -1.4566232415887566}, "description": "Details the activity of the p53 pathway's second phase, as measured by a beta-lactamase reporter in channel 1."}, "TOX21_p53_BLA_p2_ch2": {"Train": {"roc_auc": 0.8966900286087874, "threshold": -1.3837866429929386}, "Val": {"roc_auc": 0.753467345505618, "threshold": -2.4089507068599665}, "Test": {"roc_auc": 0.7491030454735086, "threshold": -1.8180924874764903}, "description": "Describes the activity on the p53 pathway during its second phase, via a beta-lactamase reporter in channel 2."}, "TOX21_p53_BLA_p2_ratio": {"Train": {"roc_auc": 0.9287822213806343, "threshold": -1.2247964192677783}, "Val": {"roc_auc": 0.8061342592592592, "threshold": -2.1160223075935436}, "Test": {"roc_auc": 0.7733405994550409, "threshold": -1.7726858748091354}, "description": "Shows the activity ratio for the p53 pathway's second phase, derived from a beta-lactamase reporting system."}, "TOX21_p53_BLA_p2_viability": {"Train": {"roc_auc": 0.8211133156699164, "threshold": -1.0275541635843606}, "Val": {"roc_auc": 0.7749226178857254, "threshold": -1.9243502206391874}, "Test": {"roc_auc": 0.6936677325797576, "threshold": -0.5795389493783789}, "description": "Indicates cell viability metrics tied to the activity of the p53 pathway's second phase, using the beta-lactamase reporter."}, "TOX21_p53_BLA_p3_ch1": {"Train": {"roc_auc": 0.8683465957621974, "threshold": -0.5149232861515989}, "Val": {"roc_auc": 0.8125521267723103, "threshold": -1.6686575477187704}, "Test": {"roc_auc": 0.6926578146090341, "threshold": -1.398615054301433}, "description": "Presents the activity of the p53 pathway's third phase, recorded through a beta-lactamase reporter in channel 1."}, "TOX21_p53_BLA_p3_ch2": {"Train": {"roc_auc": 0.893941617214311, "threshold": -1.0358920312142583}, "Val": {"roc_auc": 0.7062133566951951, "threshold": -1.218796482315292}, "Test": {"roc_auc": 0.776746271631182, "threshold": -1.74871258215384}, "description": "Gives information on the activity of the p53 pathway during its third phase, measured using a beta-lactamase reporter in channel 2."}, "TOX21_p53_BLA_p3_ratio": {"Train": {"roc_auc": 0.9042536720810773, "threshold": -0.9889270946666882}, "Val": {"roc_auc": 0.7978638609915512, "threshold": -1.0706234579687726}, "Test": {"roc_auc": 0.762283693318176, "threshold": -1.854250007921511}, "description": "Describes the ratio of activity for the p53 pathway's third phase, determined via a beta-lactamase reporting method."}, "TOX21_p53_BLA_p3_viability": {"Train": {"roc_auc": 0.9487266074601396, "threshold": -0.026602419527682386}, "Val": {"roc_auc": 0.8334714024369198, "threshold": -1.7888031256449475}, "Test": {"roc_auc": 0.8185464463340286, "threshold": -2.2034584180012837}, "description": "Indicates cell viability related to the activity of the third phase of the p53 pathway, based on a beta-lactamase reporter."}, "TOX21_p53_BLA_p4_ch1": {"Train": {"roc_auc": 0.9236054569279858, "threshold": -0.3277316737819369}, "Val": {"roc_auc": 0.829503526858383, "threshold": -1.945675938217728}, "Test": {"roc_auc": 0.7822861077638148, "threshold": -1.8234978676796914}, "description": "Details the activity of the fourth phase of the p53 pathway as measured by a beta-lactamase reporter in channel 1."}, "TOX21_p53_BLA_p4_ch2": {"Train": {"roc_auc": 0.8903108367994992, "threshold": -1.5610464714668897}, "Val": {"roc_auc": 0.6890012642225032, "threshold": -2.2071840779798046}, "Test": {"roc_auc": 0.7790693463697266, "threshold": -2.4747222088001393}, "description": "Highlights the activity of the p53 pathway during its fourth phase via a beta-lactamase reporter in channel 2."}, "TOX21_p53_BLA_p4_ratio": {"Train": {"roc_auc": 0.9169998432512831, "threshold": -0.9219117608514269}, "Val": {"roc_auc": 0.771042514699231, "threshold": -2.0276802357014}, "Test": {"roc_auc": 0.7749338655033183, "threshold": -2.1776386510144476}, "description": "Provides a ratio representing the activity for the fourth phase of the p53 pathway, obtained through the beta-lactamase reporting method."}, "TOX21_p53_BLA_p4_viability": {"Train": {"roc_auc": 0.896673139576102, "threshold": -0.2589305857638342}, "Val": {"roc_auc": 0.8283487450462351, "threshold": -1.7763963285031856}, "Test": {"roc_auc": 0.767257703563436, "threshold": -1.8402014733315468}, "description": "Describes the cell viability metrics in association with the activity of the p53 pathway's fourth phase, measured via the beta-lactamase reporter."}, "TOX21_p53_BLA_p5_ch1": {"Train": {"roc_auc": 0.969683812790653, "threshold": 0.0838509961530125}, "Val": {"roc_auc": 0.9007912355447352, "threshold": -1.5067757517248541}, "Test": {"roc_auc": 0.8591269841269841, "threshold": -1.80393260234111}, "description": "Sheds light on the activity of the p53 pathway's fifth phase, using a beta-lactamase reporter in channel 1."}, "TOX21_p53_BLA_p5_ch2": {"Train": {"roc_auc": 0.8891170274211188, "threshold": -1.4371478860681357}, "Val": {"roc_auc": 0.7654040404040404, "threshold": -1.2932245366208184}, "Test": {"roc_auc": 0.705046359629123, "threshold": -1.6755909934058204}, "description": "Signifies the activity of the p53 pathway during its fifth phase through a beta-lactamase reporter in channel 2."}, "TOX21_p53_BLA_p5_ratio": {"Train": {"roc_auc": 0.923338992541514, "threshold": -1.1629981030453669}, "Val": {"roc_auc": 0.8283197507190795, "threshold": -1.7963771252064138}, "Test": {"roc_auc": 0.7883341823739175, "threshold": -2.1918536607209624}, "description": "Presents the activity ratio for the fifth phase of the p53 pathway, derived from the beta-lactamase reporting system."}, "TOX21_p53_BLA_p5_viability": {"Train": {"roc_auc": 0.9599699758628215, "threshold": 0.15352246854398288}, "Val": {"roc_auc": 0.8496787214762337, "threshold": -2.395093847204137}, "Test": {"roc_auc": 0.8604634581105169, "threshold": -1.2008636176765144}, "description": "Indicates the cell viability related to the activity of the fifth phase of the p53 pathway, captured using the beta-lactamase reporter method."}, "Tanguay_ZF_120hpf_AXIS_up": {"Train": {"roc_auc": 0.8794316853089771, "threshold": 0.15317129587625988}, "Val": {"roc_auc": 0.8489792198323005, "threshold": -0.6285284703916263}, "Test": {"roc_auc": 0.7235841081994928, "threshold": -1.8952331409320697}, "description": "Represents an assay related to zebrafish (ZF) development at 120 hours post-fertilization, focusing on changes in the axis."}, "Tanguay_ZF_120hpf_ActivityScore": {"Train": {"roc_auc": 0.8847615180617017, "threshold": 0.4404331795326808}, "Val": {"roc_auc": 0.7912964228753703, "threshold": -0.2632019223870934}, "Test": {"roc_auc": 0.7969107551487414, "threshold": -1.172717871966662}, "description": "Provides a score detailing the activity or behavior of zebrafish larvae at 120 hours post-fertilization."}, "Tanguay_ZF_120hpf_BRAI_up": {"Train": {"roc_auc": 0.9365642013669364, "threshold": 0.3782296629400701}, "Val": {"roc_auc": 0.9312573443008225, "threshold": 0.06397601935240615}, "Test": {"roc_auc": 0.775117508813161, "threshold": -0.6096898178915842}, "description": "Denotes an assay measuring changes or disruptions in zebrafish brain development at 120 hours post-fertilization."}, "Tanguay_ZF_120hpf_CFIN_up": {"Train": {"roc_auc": 0.9013986872700048, "threshold": -0.7486745781368676}, "Val": {"roc_auc": 0.7026991614255764, "threshold": -0.7500532086308418}, "Test": {"roc_auc": 0.672514619883041, "threshold": -3.396626730461617}, "description": "Describes findings related to zebrafish caudal fin development at 120 hours post-fertilization."}, "Tanguay_ZF_120hpf_CIRC_up": {"Train": {"roc_auc": 0.9037984069384682, "threshold": -0.30074784401300825}, "Val": {"roc_auc": 0.8064012490241999, "threshold": -2.495755292810836}, "Test": {"roc_auc": 0.7461988304093568, "threshold": -4.1305854915379285}, "description": "Highlights observations pertaining to zebrafish circulatory system development at 120 hours post-fertilization."}, "Tanguay_ZF_120hpf_EYE_up": {"Train": {"roc_auc": 0.9023161764705881, "threshold": -0.49192762231683673}, "Val": {"roc_auc": 0.8100150440575973, "threshold": 0.1452215211885477}, "Test": {"roc_auc": 0.7409893992932862, "threshold": -1.4323934568418517}, "description": "Sheds light on assays focused on zebrafish eye development at 120 hours post-fertilization."}, "Tanguay_ZF_120hpf_JAW_up": {"Train": {"roc_auc": 0.8972259604948991, "threshold": 0.06497874274268156}, "Val": {"roc_auc": 0.7241488519398258, "threshold": 0.5527883124900406}, "Test": {"roc_auc": 0.7227488151658767, "threshold": -0.49683216599014735}, "description": "Denotes changes or disruptions in zebrafish jaw development at 120 hours post-fertilization."}, "Tanguay_ZF_120hpf_MORT_up": {"Train": {"roc_auc": 0.913263797089377, "threshold": 0.028083052840438327}, "Val": {"roc_auc": 0.8540077952889341, "threshold": 0.08730619913106885}, "Test": {"roc_auc": 0.8627932351336607, "threshold": -1.237093686580181}, "description": "Indicates mortality rates or metrics in zebrafish at 120 hours post-fertilization."}, "Tanguay_ZF_120hpf_OTIC_up": {"Train": {"roc_auc": 0.937335237258348, "threshold": 0.30552129010419193}, "Val": {"roc_auc": 0.8845378151260503, "threshold": -0.11243011428787142}, "Test": {"roc_auc": 0.7859484777517565, "threshold": -2.214775646771038}, "description": "Represents an assay related to the otic (ear) development of zebrafish at 120 hours post-fertilization."}, "Tanguay_ZF_120hpf_PE_up": {"Train": {"roc_auc": 0.8766018386058948, "threshold": -0.12089555327956703}, "Val": {"roc_auc": 0.7534633612832665, "threshold": 0.28635190079758654}, "Test": {"roc_auc": 0.6988221436984687, "threshold": -1.157107559410301}, "description": "Details observations about zebrafish pectoral fin evolution at 120 hours post-fertilization."}, "Tanguay_ZF_120hpf_PFIN_up": {"Train": {"roc_auc": 0.9181648018550336, "threshold": -0.552836733179408}, "Val": {"roc_auc": 0.8436835891381346, "threshold": -0.017856191705774904}, "Test": {"roc_auc": 0.8060889929742387, "threshold": -2.0732717429314764}, "description": "Captures details about the zebrafish's pelvic fin development at 120 hours post-fertilization."}, "Tanguay_ZF_120hpf_PIG_up": {"Train": {"roc_auc": 0.9433582586597008, "threshold": 0.4125531302080745}, "Val": {"roc_auc": 0.8534453781512605, "threshold": -0.16292301956955768}, "Test": {"roc_auc": 0.7669281045751635, "threshold": -3.120022763003101}, "description": "Highlights findings related to pigmentation or coloration changes in zebrafish larvae at 120 hours post-fertilization."}, "Tanguay_ZF_120hpf_SNOU_up": {"Train": {"roc_auc": 0.8875093112600912, "threshold": 0.8024199049513392}, "Val": {"roc_auc": 0.7415238789646373, "threshold": 1.2609179747832542}, "Test": {"roc_auc": 0.7020537124802527, "threshold": -1.5697939975841626}, "description": "Presents observations on the development or abnormalities of the snout in zebrafish at 120 hours post-fertilization."}, "Tanguay_ZF_120hpf_SOMI_up": {"Train": {"roc_auc": 0.9482803414281599, "threshold": -0.10958666772813785}, "Val": {"roc_auc": 0.8974178403755868, "threshold": -0.4323101864682055}, "Test": {"roc_auc": 0.8415204678362572, "threshold": -1.5113227119197603}, "description": "Details any changes or observations in the somite (segments in the early embryo) development of zebrafish at 120 hours post-fertilization."}, "Tanguay_ZF_120hpf_SWIM_up": {"Train": {"roc_auc": 0.9395554747878585, "threshold": 0.5814814825315722}, "Val": {"roc_auc": 0.910023446658851, "threshold": 0.13922446888607531}, "Test": {"roc_auc": 0.822637106184364, "threshold": -2.0647460619608555}, "description": "Indicates behaviors or abnormalities related to swimming patterns in zebrafish larvae at 120 hours post-fertilization."}, "Tanguay_ZF_120hpf_TRUN_up": {"Train": {"roc_auc": 0.9319758064516128, "threshold": 0.4209699372987501}, "Val": {"roc_auc": 0.7817537072856222, "threshold": -0.3315746419064638}, "Test": {"roc_auc": 0.736780258519389, "threshold": -0.8685465978311218}, "description": "Describes observations on the trunk development in zebrafish at 120 hours post-fertilization."}, "Tanguay_ZF_120hpf_TR_up": {"Train": {"roc_auc": 0.9189310446217643, "threshold": 0.13402470859798576}, "Val": {"roc_auc": 0.8671782762691853, "threshold": -0.23921948748904498}, "Test": {"roc_auc": 0.7018167456556083, "threshold": -2.385884109918062}, "description": "Focuses on the thymus and thyroid development or related abnormalities in zebrafish at 120 hours post-fertilization."}, "Tanguay_ZF_120hpf_YSE_up": {"Train": {"roc_auc": 0.8807107335387543, "threshold": 0.5330281944962234}, "Val": {"roc_auc": 0.7577988915281078, "threshold": 0.07358538137899906}, "Test": {"roc_auc": 0.7549193231011413, "threshold": -0.5413541822462102}, "description": "Highlights observations related to yolk sac edema, a condition where fluid accumulates in the yolk sac of zebrafish larvae, at 120 hours post-fertilization."}}, "description": "This dataset offers predictions related to the potential toxicological effects of molecules on various cellular and genetic targets. Each entry represents a distinct biological or cellular response."}, "tox21": {"tasks": {"NR-AR": {"Train": {"roc_auc": 0.9015793054156226, "threshold": -0.6498447347570346}, "Val": {"roc_auc": 0.906653944887435, "threshold": -0.7543724936407967}, "Test": {"roc_auc": 0.6366576819407008, "threshold": 0.1930612429484233}, "description": "Androgen Receptor."}, "NR-AR-LBD": {"Train": {"roc_auc": 0.9473695853943284, "threshold": -1.9426708765574041}, "Val": {"roc_auc": 0.9477216916780354, "threshold": -0.12888390643221825}, "Test": {"roc_auc": 0.7955592105263157, "threshold": -2.5176025453630517}, "description": "Androgen Receptor Ligand Binding Domain."}, "NR-AhR": {"Train": {"roc_auc": 0.9494540877331281, "threshold": -0.4690463187338949}, "Val": {"roc_auc": 0.8451515256950002, "threshold": -0.48786156599944075}, "Test": {"roc_auc": 0.8397055848622069, "threshold": -1.701854837549341}, "description": "Aryl Hydrocarbon Receptor."}, "NR-Aromatase": {"Train": {"roc_auc": 0.9196120536916558, "threshold": -0.9957593367980397}, "Val": {"roc_auc": 0.8208237986270024, "threshold": -0.8910949502263339}, "Test": {"roc_auc": 0.7673790917364969, "threshold": -0.7514970739324536}, "description": "Aromatase enzyme."}, "NR-ER": {"Train": {"roc_auc": 0.8128684933922666, "threshold": -0.9617717530992294}, "Val": {"roc_auc": 0.7337759834506691, "threshold": -1.1177923629233786}, "Test": {"roc_auc": 0.7603618311454654, "threshold": -0.3001013432179125}, "description": "Estrogen Receptor."}, "NR-ER-LBD": {"Train": {"roc_auc": 0.9219783787578315, "threshold": -0.9690226706656606}, "Val": {"roc_auc": 0.8304004037685061, "threshold": -0.18473637784207586}, "Test": {"roc_auc": 0.873495085995086, "threshold": -0.4779928181622477}, "description": "Estrogen Receptor Ligand Binding Domain."}, "NR-PPAR-gamma": {"Train": {"roc_auc": 0.9403035368144316, "threshold": -1.0264576772550447}, "Val": {"roc_auc": 0.9183816183816185, "threshold": -1.4110646985314625}, "Test": {"roc_auc": 0.83945605845342, "threshold": -1.7576654102351217}, "description": "Peroxisome Proliferator-Activated Receptor Gamma."}, "SR-ARE": {"Train": {"roc_auc": 0.8767463837372881, "threshold": -0.6435597007339071}, "Val": {"roc_auc": 0.7557415214245266, "threshold": -0.03775022218415991}, "Test": {"roc_auc": 0.8016244795090948, "threshold": -0.5268051359388561}, "description": "Antioxidant Response Element."}, "SR-ATAD5": {"Train": {"roc_auc": 0.9634501088487957, "threshold": -1.3150114551320806}, "Val": {"roc_auc": 0.8313737017440721, "threshold": -1.5730017097862632}, "Test": {"roc_auc": 0.8863265002970885, "threshold": -1.6723212486690473}, "description": "ATAD5 protein, related to DNA damage response."}, "SR-HSE": {"Train": {"roc_auc": 0.8973708959270317, "threshold": -0.9433982999952466}, "Val": {"roc_auc": 0.8565877781702579, "threshold": -0.7008273112284646}, "Test": {"roc_auc": 0.8163992869875222, "threshold": -1.4412044237803165}, "description": "Heat Shock Element."}, "SR-MMP": {"Train": {"roc_auc": 0.9449290485863391, "threshold": 0.9957927745861088}, "Val": {"roc_auc": 0.8515566455480619, "threshold": 1.6586055860624427}, "Test": {"roc_auc": 0.8734576210346839, "threshold": 0.07029318594717804}, "description": "Mitochondrial Membrane Potential."}, "SR-p53": {"Train": {"roc_auc": 0.9441279143475039, "threshold": -0.6615476844547032}, "Val": {"roc_auc": 0.8318879855465222, "threshold": -0.40316957324832714}, "Test": {"roc_auc": 0.8343196607940503, "threshold": -0.8079218191427513}, "description": "p53 pathway related to cell cycle and apoptosis."}}, "description": "This dataset revolves around predicting the toxicity of molecules against various nuclear receptors and stress response pathways. The different outputs such as 'NR-AR', 'NR-AhR', etc., represent different biological targets and pathways, and the goal is to predict how molecules will interact with or affect them."}, "metstab": {"tasks": {"high": {"Train": {"roc_auc": 0.9991874338197406, "threshold": 0.7220212604190479}, "Val": {"roc_auc": 0.8578947368421053, "threshold": -3.5523318084510596}, "Test": {"roc_auc": 0.9152659850979032, "threshold": -0.49177773411686765}, "description": "Predicts high metabolic stability of a molecule."}, "low": {"Train": {"roc_auc": 0.9989039948770997, "threshold": -0.1700232718680592}, "Val": {"roc_auc": 0.8815049504950495, "threshold": -3.4964176565557867}, "Test": {"roc_auc": 0.8465443825745169, "threshold": -2.8825881650617298}, "description": "Predicts low metabolic stability of a molecule."}}, "description": "This dataset gives insights into the metabolic stability of molecules. High metabolic stability often results in a longer half-life, influencing drug dosage and frequency."}, "bace": {"tasks": {"Class": {"Train": {"roc_auc": 0.9999220709099056, "threshold": 2.8799530626894594}, "Val": {"roc_auc": 0.7999645641389085, "threshold": -3.7012767533998225}, "Test": {"roc_auc": 0.8395083406496927, "threshold": -1.3647682220489532}, "description": "Predicts whether a given molecule will inhibit the enzyme beta-secretase 1 (BACE1), which is important in Alzheimer's disease pathology."}}, "description": "A dataset focused on predicting the inhibitory effects of molecules on the enzyme beta-secretase 1 (BACE1). BACE1 inhibition is a potential target for Alzheimer's disease treatment."}, "sider": {"tasks": {"Hepatobiliary disorders": {"Train": {"roc_auc": 0.9105454098259853, "threshold": -0.1426962574681001}, "Val": {"roc_auc": 0.7, "threshold": -0.6106410005071143}, "Test": {"roc_auc": 0.7391971923667471, "threshold": -0.6423367458778819}, "description": "Predicts if a molecule is associated with disorders of the liver, gallbladder, or bile ducts."}, "Metabolism and nutrition disorders": {"Train": {"roc_auc": 0.8873428510547625, "threshold": 0.3327660209781773}, "Val": {"roc_auc": 0.6357442348008384, "threshold": -0.8752111792564392}, "Test": {"roc_auc": 0.6438502673796792, "threshold": 0.27608735329873335}, "description": "Predicts if a molecule is related to metabolic or nutritional disturbances."}, "Product issues": {"Train": {"roc_auc": 0.8862174730384882, "threshold": -2.071713634678074}, "Val": null, "Test": {"roc_auc": 0.3839285714285714, "threshold": -4.10227441763854}, "description": "Predicts if there are any issues with the molecule as a product."}, "Eye disorders": {"Train": {"roc_auc": 0.8735115588273279, "threshold": 0.3052308838646689}, "Val": {"roc_auc": 0.7376086445853889, "threshold": -0.6668092946748476}, "Test": {"roc_auc": 0.6376641191456007, "threshold": -1.0372276420707816}, "description": "Predicts if a molecule is linked with eye-related disorders."}, "Investigations": {"Train": {"roc_auc": 0.9228507618805304, "threshold": 0.4858105676668183}, "Val": {"roc_auc": 0.7155303030303031, "threshold": -0.11960533261299133}, "Test": {"roc_auc": 0.744758064516129, "threshold": -0.6656094193458557}, "description": "Predicts if a molecule requires further investigations."}, "Musculoskeletal and connective tissue disorders": {"Train": {"roc_auc": 0.8979833546734955, "threshold": 0.14366862318059948}, "Val": {"roc_auc": 0.611111111111111, "threshold": -1.203676683766706}, "Test": {"roc_auc": 0.5419238683127573, "threshold": -1.4604448080062866}, "description": "Predicts if a molecule affects the muscles, bones, or connective tissues."}, "Gastrointestinal disorders": {"Train": {"roc_auc": 0.9438511738282904, "threshold": 0.7468960270867333}, "Val": {"roc_auc": 0.7192982456140351, "threshold": 0.7894272804260254}, "Test": {"roc_auc": 0.6733812949640288, "threshold": 0.7089040279388428}, "description": "Predicts if a molecule is associated with disorders of the digestive system."}, "Social circumstances": {"Train": {"roc_auc": 0.8845135706363656, "threshold": -0.2128756134598344}, "Val": {"roc_auc": 0.6729996346364633, "threshold": -0.7544532099046983}, "Test": {"roc_auc": 0.5875, "threshold": -1.1709777647787865}, "description": "Predicts if a molecule has effects influenced by social factors."}, "Immune system disorders": {"Train": {"roc_auc": 0.8550623167155424, "threshold": 0.22139873447360925}, "Val": {"roc_auc": 0.5474519377479402, "threshold": -0.745877206325531}, "Test": {"roc_auc": 0.5593775593775594, "threshold": -0.3478469243636718}, "description": "Predicts if a molecule impacts the immune system."}, "Reproductive system and breast disorders": {"Train": {"roc_auc": 0.8986322842389968, "threshold": 0.48531487754157343}, "Val": {"roc_auc": 0.716294956801286, "threshold": 0.18901267758122198}, "Test": {"roc_auc": 0.6335227272727274, "threshold": 0.22465806250815623}, "description": "Predicts if a molecule affects reproductive organs or breasts."}, "Neoplasms benign, malignant and unspecified (incl cysts and polyps)": {"Train": {"roc_auc": 0.9328272908751368, "threshold": -0.5228836703467534}, "Val": {"roc_auc": 0.711969111969112, "threshold": -1.351725401463093}, "Test": {"roc_auc": 0.6546140195208519, "threshold": -1.1281648345657058}, "description": "Predicts if a molecule is associated with tumors, whether benign, malignant or unspecified."}, "General disorders and administration site conditions": {"Train": {"roc_auc": 0.8873873873873874, "threshold": 0.7672731461109701}, "Val": {"roc_auc": 0.675, "threshold": 1.7071791093748014}, "Test": {"roc_auc": 0.8844696969696969, "threshold": 0.6832999587059021}, "description": "Predicts general disorders or issues at the administration site caused by a molecule."}, "Endocrine disorders": {"Train": {"roc_auc": 0.9082322857378538, "threshold": -0.8430920249826315}, "Val": {"roc_auc": 0.6721649484536083, "threshold": -2.180619135633245}, "Test": {"roc_auc": 0.7019659239842725, "threshold": -1.370155811429143}, "description": "Predicts if a molecule is associated with hormone-related disorders."}, "Surgical and medical procedures": {"Train": {"roc_auc": 0.8833994029266383, "threshold": -0.8664699674726606}, "Val": {"roc_auc": 0.6532786885245901, "threshold": -1.7306564101824413}, "Test": {"roc_auc": 0.5384873949579831, "threshold": -1.6101170488305994}, "description": "Predicts if a molecule is related to complications in surgical or medical procedures."}, "Vascular disorders": {"Train": {"roc_auc": 0.9084897407692907, "threshold": 0.38313325246175145}, "Val": {"roc_auc": 0.696286472148541, "threshold": -0.7932263016700745}, "Test": {"roc_auc": 0.5871345029239767, "threshold": -1.0975883930653065}, "description": "Predicts if a molecule affects the vascular system."}, "Blood and lymphatic system disorders": {"Train": {"roc_auc": 0.901476968227638, "threshold": -0.06773602425515124}, "Val": {"roc_auc": 0.7485294117647059, "threshold": -1.4686068560148742}, "Test": {"roc_auc": 0.7272081458678665, "threshold": -1.014729186221286}, "description": "Predicts if a molecule is related to disorders of the blood or lymphatic system."}, "Skin and subcutaneous tissue disorders": {"Train": {"roc_auc": 0.9028023329065822, "threshold": 0.3819554704087633}, "Val": {"roc_auc": 0.6948717948717948, "threshold": 1.5265907049179077}, "Test": {"roc_auc": 0.8628841607565012, "threshold": 1.7071534395217896}, "description": "Predicts if a molecule causes disorders of the skin or underlying tissue."}, "Congenital, familial and genetic disorders": {"Train": {"roc_auc": 0.8988889465759825, "threshold": -0.9553489599141991}, "Val": {"roc_auc": 0.6061475409836065, "threshold": -1.9389245445663863}, "Test": {"roc_auc": 0.5751820196264641, "threshold": -1.438017322673454}, "description": "Predicts if a molecule is linked to hereditary or birth-related disorders."}, "Infections and infestations": {"Train": {"roc_auc": 0.8838544157933643, "threshold": -0.22891194326383557}, "Val": {"roc_auc": 0.6975354742345032, "threshold": -0.10111848322359518}, "Test": {"roc_auc": 0.6614973262032086, "threshold": -2.1823031902313232}, "description": "Predicts if a molecule is associated with increased risk of infections or infestations."}, "Respiratory, thoracic and mediastinal disorders": {"Train": {"roc_auc": 0.8859714487410777, "threshold": 0.2285663320256901}, "Val": {"roc_auc": 0.5694232529752823, "threshold": -0.7889289259910583}, "Test": {"roc_auc": 0.6781326781326782, "threshold": 0.14069747161101542}, "description": "Predicts if a molecule impacts the respiratory system or surrounding regions."}, "Psychiatric disorders": {"Train": {"roc_auc": 0.8929866724928992, "threshold": 0.6609476385889828}, "Val": {"roc_auc": 0.6664632285627098, "threshold": -0.9067655205726624}, "Test": {"roc_auc": 0.6678454155089668, "threshold": 0.46932816827619384}, "description": "Predicts if a molecule causes or exacerbates mental health disorders."}, "Renal and urinary disorders": {"Train": {"roc_auc": 0.8874194200196845, "threshold": 0.06148599886202133}, "Val": {"roc_auc": 0.7200834879406308, "threshold": 0.11319892232243856}, "Test": {"roc_auc": 0.6087388282025818, "threshold": -0.5426589350800615}, "description": "Predicts if a molecule affects the kidneys or urinary system."}, "Pregnancy, puerperium and perinatal conditions": {"Train": {"roc_auc": 0.8641321783766442, "threshold": -1.589357492324707}, "Val": {"roc_auc": 0.5232974910394266, "threshold": -2.677305745171594}, "Test": {"roc_auc": 0.6647482014388489, "threshold": -2.1068989509218805}, "description": "Predicts if a molecule is associated with conditions related to pregnancy or the period immediately after childbirth."}, "Ear and labyrinth disorders": {"Train": {"roc_auc": 0.8757838476119449, "threshold": 0.01997697245967256}, "Val": {"roc_auc": 0.65625, "threshold": -1.645636796951294}, "Test": {"roc_auc": 0.6790338164251207, "threshold": -1.0286688620860394}, "description": "Predicts if a molecule is linked to disorders of the ear or inner ear."}, "Cardiac disorders": {"Train": {"roc_auc": 0.9176285156633949, "threshold": 0.10134990604312799}, "Val": {"roc_auc": 0.6128542510121456, "threshold": -1.2423975467681885}, "Test": {"roc_auc": 0.6448102678571429, "threshold": -0.8720352048272484}, "description": "Predicts if a molecule affects the heart."}, "Nervous system disorders": {"Train": {"roc_auc": 0.9333429394812679, "threshold": 0.43078550454732545}, "Val": {"roc_auc": 0.7939393939393941, "threshold": 1.3680740014926807}, "Test": {"roc_auc": 0.8573106283029946, "threshold": 1.5975020028449394}, "description": "Predicts if a molecule impacts the nervous system."}, "Injury, poisoning and procedural complications": {"Train": {"roc_auc": 0.8553711097741071, "threshold": 0.18614020063593095}, "Val": {"roc_auc": 0.5844414893617021, "threshold": -0.6783940196037292}, "Test": {"roc_auc": 0.6297727272727273, "threshold": -0.22519328614493628}, "description": "Predicts if a molecule is related to injuries, poisonings, or complications from procedures."}}, "description": "A dataset highlighting the potential side effects of molecules. Each field represents a category of adverse effects. This dataset aids in understanding the safety profile and potential side effects associated with molecules."}}